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ABSTRACT 
KAREN ELAINE AINSWORTH LANDRY 
HEALTH STATUS AND HEALTH-RELATED QUALITY OF LIFE 
IN CONGESTIVE HEART F AlLURE 
DECEMBER 2008 
Congestive heart failure (CHF) is a major public health concern today with a high 
mortality rate. The major purpose of this study was to examine the health status and health-
related quality of life (HRQOL) of men and women with a diagnosis of CHF. A cross-sectional 
exploratory design was used. Specific study aims were to determine (a) whether there were 
differences in self-reported health status and HRQOL of men and women with CHF, (b) whether 
the variables of age, race/ethnicity, living status, number of comorbidities, perceived general 
health status, and perceived symptom management differ by gender, and (c) whether gender, age, 
race, number of comorbidities, living status, perceived general health status, perceived symptom 
management perceived physical health status, and perceived mental health status predict 
HRQOL. A non-probability convenience sample of 113 participants, who met the criteria for 
participation, were recruited from two cardiac clinics. There were no significant differences 
among gender categories on the variables of health status and HRQOL. Independent samples t-
test showed no significant differences in age, total number of comorbidities, perceived general 
health status, and perceived symptoms management by gender. Chi-square test results revealed 
that gender and living status were independent, as were gender and race/ethnicity. Hierarchical 
Vll 
regression analysis showed all predictors for each hypothesized dependent variable in the model 
contributed to the outcome. Perceived symptoms management was a direct predictor of functional 
status, and its prediction of the mental health component of functional status represented the 
model's highest relationship. The model's only nonsignificant path was from comorbidities to 
HRQOL. The variables of perceived general health status, physical health status, mental health 
status, and perceived symptom management contributed to the HRQOL outcome when age, but 
not comorbidities, was the exogenous variable. Using kappa, agreement regarding functional 
status was only 44% between patients and their healthcare providers, adjusted to 37% for chance 
agreement. The understanding gained from this stu<ty will provide guidance in planning future 
education and interventions for CHf patients. 
VJll 
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CHAPTER I 
INTRODUCTION 
Congestive heart failure (CHF) is a chronic illness resulting in frequent 
hospitalizations and death. Those living with CHF experience progressive effects that 
lead to reduced health status and quality oflife (QOL). Overall poor QOL is a predictor 
of mortality and hospital readmissions (Mejhert, Kahan, Person, & Edner, 2006). 
Hospital discharges for CHF increased from 399,000 in I 979 to I ,093,000 in 2003, 
representing an increase of I 74%. In 2003, there were 2.4 million males and 2.6 million 
females with CHF, and the related mortality during that year was 22,300 for males and 
34,900 for females (American Heart Association [AHA), 2006). 
Research related to gender differences, health status, and health-related quality of 
life (HRQOL) in persons with CHF has been limited. Riedinger, Dracup, Brecht, Padilla, 
Sarna, and Ganz (200I) found that women had a poorer QOL than men. Specifically, 
women had lower physical and social functioning. In seeming opposition to these 
findings, a study by Evangelista, Kagawa-Singer, and Dracup (200I) showed that health 
perceptions in women were higher than those of men. Women had better psychosocial 
adjustment to their illness than did men who verbalized a greater negative feeling 
concerning their illness. In a more recent study, Jessup and Pina (2004) proposed a theory 
of gender-related survival rates in myocardial injury. This theory demonstrates injury to 
the myocardial muscle as it relates to gender differences in cardiac decomposition or 
CHF, suggesting why survival rates are different between women and men. This theory 
that hypothesizes that women have a later onset of cardiac decomposition than men could 
support the explanation of the larger number of female deaths as compared to males. 
Within the nursing literature, limited information on gender specific evidence-
based nursing interventions for CHF patients has been found. The proposed study will 
improve the understanding of gender differences in health status and health-related 
quality-of-life (HRQOL). This knowledge will help provide future guidance in gender-
specific education and interventions for CHF patients. 
Problem of Study 
The purpose of this proposed study is to examine the health status and HRQOL of 
men and women with a diagnosis of CHF. The following specific aims initially identified 
were to determine (a) whether there are differences in self-reported health status and 
HRQOL of men and women with CHF; (b) whether the variables of age, race/ethnicity, 
living status, number of comorbidities, perceived general health status, and perceived 
symptom management differ by gender; and (c) whether gender, age, race, number of 
comorbidities, living status, perceived general health status, perceived symptom 
management, perceived physical health status, and perceived mental health status predict 
HRQOL. The knowledge gained by this study will help healthcare providers understand 
and create evidence-based nursing interventions to improve health status and HRQOL 
with attention to gender differences. 
2 
Rationale for the Study 
CHF is a serious chronic disease with high mortality. It affects 5 million 
Americans, and approximately 550,000 new cases will be diagnosed each year (AHA, 
2006). According to the AHA (2004), 5 years after being diagnosed with CHF, the 
mortality rate is more than 50%. Under the age of 65, about 80% of men and 70% of 
women who have heart failure will die within 8 years (AHA, 2004). Clearly then, CHF 
has a profound impact on individuals in a relatively short span of time. The problem is 
that there is very little information on gender differences and health outcomes as it relates 
to HRQOL and health status in CHF patients. Understanding the variables that impact the 
quality of life can help clinicians target interventions to support and maximize quality of 
life among individuals with CHF. 
CHF is a major economic concern. The amount of dollars spent on the care and 
treatment of individuals diagnosed with CHF is on the rise. Patients who have Medicare 
represent the largest insurance group with hospitalizations related to heart failure, with 
African-Americans having a higher number of hospital admissions than Caucasians 
(CDC, 2005). The cost of CHF is staggering with an estimated direct cost of26.8 billion 
dollars (AHA, 2006). As a result of soaring health care costs and a rise in readmissions, 
research on the effects of HRQOL on people diagnosed with CHF is greatly needed. 
The proposed study will focus on possible gender differences related to health 
status and HRQOL of persons diagnosed with CHF and on variables that influence 
HRQOL. Wilson and Cleary (1995) developed a conceptual model of patient outcomes as 
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it relates to HRQOL. The model is based on a continuum beginning with biological and 
physiological variables at one end and moving progressively to symptom status, 
functional status, general health perceptions and overall quality of life. For example, 
coronary artery disease can lead to CHF. Symptoms of CHF are dyspnea or shortness of 
breath, fatigue, swelling of the extremities, and coughing. These symptoms can alter the 
individual's functional capacity and difficulties with activities of daily living. 
Socialization and psychological functions can be affected by the decrease in physical 
function. All of the concepts identified by Wilson and Cleary contribute to the patient's 
health perception and the patient's HRQOL is formed from the relationships in this 
process. In summary, HRQOL is grounded in the patient's biological and physiological 
properties, symptom and functional status, and health perceptions. 
Key concepts in this proposed study based on Wilson and Cleary's (1995) model 
are biological and physiological variables (age, gender, race, comorbidities), symptom 
status (perceived management of sympfoms), functional status (perceived physical status 
and perceived mental status), general health perceptions, and overall quality of life 
(HRQOL). 
HRQOL will be used in this study as it specifically addresses the quality of life of 
patients with CHF. Mejhert, Kahan, Person, and Edner (2006) found that poorer QOL 
was associated with mortality andre-hospitalizations. Age and functional class were 
predictive of mortality in patients with CHF (Cowie et al., 2002). Research studies have 
shown that there are gender differences (Chin & Goldman, 1998; Friedman, 2003; Gott et 
al., 2006; Hussey & Hardin, 2003; Jessup & Pina, 2004; Riedinger, Dracup, Brecht, 
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Padilla, Sarna, & Ganz, 2001; Riedinger, Dracup, Brecht, Padilla, Sarna, & Ganz, 2002). 
By determining the variables that predict HRQOL and whether there are gender 
differences in health status and HRQOL in individual's diagnosed with heart failure, 
knowledge will be generated that can assist nurses in planning relevant interventions that 
could improve the lives of CHF patients. 
Conceptual Framework 
Wilson and Cleary's (1995) health-related quality of life conceptual model will 
guide this study (Figure 1 ). The model incorporates a multifaceted approach using five 
main concepts which are staged so that they occur in order: biological and physiological 
variables, symptom status, functional status, general health perceptions, and overall 
quality of life. In the proposed model, the exogenous variables (i.e., gender, age, 
race/ethnicity, and comorbidities) and the end-stage variable ofHRQOL are mediated by 
symptom status (i.e., perceived symptom management) functional status (i .e., living 
status, perceived physical health status and perceived mental health status) and general 
health perceptions (i.e., perceived general health status). 
5 
Figure 1. Wilson and Cleary's (1995) Health-Related Quality of Life Conceptual Model 
Assumptions 
The following assumptions were made: 
1. Participants can read and understand the study instruments. 
2. Participants will respond honestly to the study questionnaires. 
Research Questions 
Research questions for this proposed study include the following: 
1. Are there differences in self-reported health status and HRQOL of men and 
women with a diagnosis of CHF? 
2. Are there differences in age, race/ethnicity, living status, number of 
comorbidities, perceived general health status, and perceived symptom 
management of men and women with a diagnosis of CHF? 
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Age 
3. Are gender, age, race/ethnicity, number of comorbidities, living status, 
perceived general health status, perceived physical health status, perceived 
mental health status and perceived symptom management significant 
predictors of HRQOL? 
4. Do symptom status (i.e., perceived symptom management), functional status 
(i.e., living status, perceived physical health status and perceived mental 
health status), and general health perceptions (i.e., perceived general health 
status) serve as mediating variables between the exogenous variables (i.e., 
gender, age, race/ethnicity, and comorbidity) and overall quality of life. 
Definition of Terms 
Age is defined as the time, in years, from birth to the present year (Taber's 
Cyclopedic Medical Dictionary, 2005). Operationally, age will be the individual's self-
reported age in years. 
Ethnicity/Race 
The conceptual definition of ethnicity/race is defined as "of or relating to large 
groups of people classes according to common racial, national, tribal, religious, linguistic, 
or cultural -origin or background" (Merriam-Webster Online Dictionary, 2006, p. 1 ). The 
operational definition will be the respondent's answer(s) on the General Information 
Form (GIF) to ethnic identification: American Indian or Alaska Native, Asian, Black or 
African American, Hispanic or Latino, Not Hispanic or Latino, Native Hawaiian or Other 
7 
Pacific Islander, and White. 
Living Status 
Living status is defined as whether the individual lives alone, lives with someone, 
or lives in a residential setting. The operational definition is the participant's choice of 
one of these on the GIF. 
Perceived General Health Status 
Perceived general health status is defined as the individual's perceptions ofhow 
he or she views his or her health status. Operationally, the participant will choose one of 
the following categories on the SF-36v2: excellent, very good, good, fair, or poor. 
Perceived Symptom Management 
Perceived symptom management is defined as individuals' perceptions ofhow 
their symptoms are being managed or controlled as related to their heart failure. 
Symptom management will be measured by a one-item Likert-type rating scale on the 
GIF, from 1 (symptoms not being managed well at all) to I 0 (symptoms being managed 
extremely well). The higher the score, the better the symptom management. 
Number of Comorbidities 
Number of comorbidities is defined as the individual's self-report of how many 
different disease diagnoses he or she has. The participant will choose from the following 
diseases listed on the GIF: heart disease, high blood pressure, lung disease, diabetes, 
ulcer or stomach disease, kidney disease, liver disease, anemia or other blood disease, 
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cancer, depression, osteoarthritis, degenerative arthritis, back pain, rheumatoid arthritis, 
thyroid disease, obesity, and autoimmune disease. An option of "other" will also be 
provided. 
Health-Related Quality of Life with CHF Diagnosis 
The conceptual definition ofHRQOL with CHF is defined as "the relationship 
between two concepts, health or disease (in this case heart failure) and QOL" (A. Brown, 
personal communication, July 12, 2006). The operational definition of QOL will be 
measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The 
MLHFQ is a QOL instrument specifically for heart failure patients. This questionnaire 
consists of 21 questions. Persons may respond to each question using a 6-point Likert-
type scale where 0 ="no," I ="very little," and 5 ="very much." On the original scoring 
instructions, the lower the score, the better the QOL; a higher score represents a poorer 
QOL. However, for the purpose of this research study the scoring was recoded so that the 
higher the scoring indicates the better the QOL. 
Health Status 
The conceptual definition of health status is "an overall evaluation of an 
individual's degree ofwellness or illness with a number of indicators, including quality of 
life and functionality'' (Ware, Kosinski, & Dewey, 2002, p. 1 0). The SF-36v2 is a 36-
item instrument used to measure the two components of physical and mental health 
status. It also yields 8 profile scores. The SF-36v2 items and subscales (i.e., components) 
are scored so that a higher score indicates better health status. 
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Limitations 
Participants' knowledge of the study's purpose may influence their responses to 
the questionnaires, thus altering the study results. Another limitation is related to the use 
of a cross-sectional study design which will only capture how the person feels at the time 
of instrument completion. 
Delimitations 
Participants will have a medical diagnosis of CHF and be attending one of two 
clinics for treatment. This study will use only English versions of the instruments; thus, 
reading English is a requirement for study participation. 
Summary 
This chapter provided an introduction to the chronic disease of CHF and some of 
the issues associated with it. The problem of the study and rationale for the study were 
identified. Little is known about the difference between men and women's responses to 
CHF or about the factors that predict their quality of life. An overview of the conceptual 
framework that will guide the study was presented. Assumptions, research questions and 
definition of terms were identified. Finally, limitations and delimitations were noted. 
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CHAPTER II 
REVIEW OF THE LITERA TORE 
An increase in hospitalizations and mortality in congestive heart failure (CHF) 
patients has led researchers to examine health-related quality of life (HRQOL) and health 
status in patients who suffer from this disease. Hospital discharges for CHF increased 
from 399,000 in 1979 to 1,093,000 in 2003, an increase of 174%. In 2003, there were 2.4 
million males and 2.6 million females with CHF, and the mortality during that year from 
CHF was 22,300 for males and 34,900 for females (American Heart Association [AHA], 
2006 ). The effects of CHF are progressive and lead to reduced health status and quality 
of life. Thus, the purpose of this literature review is an ongoing review to examine 
research st:udies that link certain characteristics to health status and HRQOL. Reviewing 
the literature and finding areas where further research is needed will lay the foundation 
for this research study. 
Historical Review of Gender Differences 
Historically, research studies in the medical field have been predominantly 
conducted on men. The knowledge gained by this study will help healthcare providers 
understand and create evidence-based nursing interventions to improve health status and 
HRQOL acknowledging gender differences. 
A briefhistorical perspective of men and women within the medical literature will 
be reviewed. In the first section gender differences will be discussed, followed by quality 
II 
of life and health status in CHF. Predictors ofhealth status and quality of life will be 
discussed. A summary and implications of the findings will be discussed. 
An exhaustive literature review was performed. Materials, both printed and 
electronic were utilized from the published literature of nursing, medicine, mental health, 
and psychology in the last five years. Databases that were used in the search were 
CINAHL, EBSCO, OVID, Proquest, PubMed, MEDLINE, and Web of Science. The 
following guidelines were used to select the literature for review: 
1. A 5-year span (200 1 - 2006) of research literature was utilized. 
2. The literature review included national and international studies ofhealth 
status and quality of life in CHF patients. 
3. Only research articles written in or translated to English were used. 
4. Literary search keywords were: "Congestive Heart Failure," "CHF," "Heart 
Failure," "HF, cross-referenced with "health-related quality oflife," 
"HRQOL," "quality of life," "QOL," "health status," "gender differences," 
"sex differences", "age," "gender," "ethnicity," "race," "living status," 
"comorbidity," "New York Heart Association functional status," "NYHA 
functional status," "perceived NYHA functional status," "perceived 
functional status," and "perceived symptom management." 
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Up to and during the late 1950s to the mid-1960s, women were associated with 
nurturing and caring, but were subordinate to men in status. The emphasis was placed on 
the health and fitness of men, who were known for comprising the primary work force 
and serving as sole provider for the family. Women were viewed as caretakers of others 
and, therefore, seen to be of lesser value (Miller & Kollauf, 2002). 
Before 1986, issues concerning women's health focused on reproduction. The 
male population dominated cardiac research. Men were viewed as the standard by which 
to measure all people. Beginning in 1986, the National Institutes of Health (NIH) 
required that women be included in funded studies unless researchers provided adequate 
justification for not including them. Following that regulation, federal legislation insisted 
that all funding agencies include women and other underrepresented groups in funded 
studies. Finally, the NIH Revitalization Act of 1993 required that all funding by the NIH 
include both sexes (Miller & Kollauf, 2002). This Act gave NIH the ability to deny 
federal funding to proposed studies that excluded women without adequate justification. 
Until the last decade, the literature that included women was more likely to 
discuss how they could best manage the care of their husbands' heart disease. Women 
have been significantly underserved and overlooked concerning heart disease. Following 
the NIH actions to promote the inclusion of women study participants, the literature 
reporting studies involving women with heart disease has increased, reflecting the change 
in standards of care (i .e., procedures, medications, and treatments) for women with heart 
disease today (Banks, 2008 ; Bundy, Gonzalez, Barnard, Hardy, & DuPont, 2006; Efre, 
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2004; Guru, Fremes, Austin, Blackstone, & Tu, 2006; Hussey & Hardin, 2003; Miller, 
2002). This is reflected in Table I. 
Cardiac care and treatment is being provided to millions of women each day with 
treatments that were originally established for men from previous studies conducted only 
on men. Also, there have been few studies conducted on differences between the different 
cultures. This deficiency in cultural differences related to cardiac disease continues 
(Correa-de-Araujo, Stevens, Moy, Nilasena, Chesley, & McDermott, 2006; Miller, 2002). 
Table I 
Summary of Gender Differences Studies 
Author(s) Number of Type of Design 
Subjects/Sample 
King (2002) Convenience 
sample 
N=24 
participants 
(I2 men, I2 
women) 
Qualitative 
I4 
Method of 
measuring 
variables 
Interviews 
Key Findings 
Illness was due to 
stress in both 
genders 
Men stated 
behavioral or 
lifestyle as factors 
of illness onset. 
Women stated 
smoking or diet 
as influential to 
illness. 
Women were in 
the lowest socio-
economic group. 
Table 1 (Continued) 
Summary of Gender Difforences Studies 
Author(s) Number of Type of Design 
Subjects/Sample 
Miller 
(2002) 
Ng, Tam, 
Man, 
Cheng, and 
Chiu (2003) 
N=94 
participants 
(44 males 
50 females) 
Integrative 
Literature 
Reviews and 
Meta-Analyses 
Quantitative 
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Method of 
measunng 
variables 
Chinese Adult 
Source of Self-
Esteem 
Inventory 
(ASSEI) 
Questionnaire 
Key Findings 
Women have 
many symptoms 
during an acute 
myocardial 
infarction (AMI): 
chest pain, 
fatigue, shortness 
ofbreath (SOB), 
back pain, edema, 
and transient non-
specific chest 
discomfort. 
Women with 
cardiac disease 
found both 
personal and 
interpersonal life 
aspects to be 
higher than men. 
Women had a 
higher life 
satisfaction than 
menm 
appearance, 
grooming, and 
popularity. 
Table 1 (Continued 2) 
Summary o[ Gender Differences Studies 
Author(s) Number of Type of Design Method of Key Findings 
Subjects/Sample measunng 
variables 
Devon and N=IOO Nonexperimental, Unstable Women 
Zerwic parti ci pants exploratory, Angina expenence more 
(2003) (50 women, 50 descriptive Symptoms SOB, weakness, 
men) quantitative Questionnaire difficulty 
design (UASQ) breathing, nausea, 
and loss of 
appetite than 
Canadian men. 
Cardiovascular 
Women had more Society (CCS) 
upper back pain, Classification 
of Angina stabbing pain, 
and knife-like 
pam. 
Hospital Women were 
Anxiety and more likely to 
Depression experience 
Scale (HADS) depression. 
Bundy, N=3,878 Retrospective Retrospective Women had a 
Gonzalez, patients epidemiologic review greater risk of 
Barnard, (957 females, cohort study having surgical 
Hardy, and site infection 
DuPont 
2921 males) (SSI) than men. 
(2006) Predictors of 
acquiring SSI 
were being 
female, diabetes, 
BMI, and 
urgency of 
surgery. 
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Table 1 (Continued 3) 
Summary of Gender Differences Studies 
Author(s) Number of Type of Design 
Subjects/Sample 
Guru, 
Fremes, 
Austin, 
Blacksone, 
and Tu 
(2006) 
N=66,193 
patients ( 14,3 93 
females, 51,800 
males) 
Retrospective 
cohort study 
Method of 
measuring 
variables 
Retrospective 
review using 
four databases 
Empirical Studies of Gender Differences 
Key Findings 
Women were 
older, were 
urgent or acute 
emergency status, 
and arterial grafts 
were not often 
used. 
Women had a 
higher I year 
cardiac 
readmission rate 
following 
surgery; that rate 
continued after I 
year. 
Readmissions 
were due to CHF 
and unstable 
angina. 
Within the literature, gender differences have been the focus of several research 
studies (see Table I). The Table is followed by a brief summary of each publication. 
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King (2002) conducted a qualitative study on illness attributions involving 24 
men and women diagnosed with a myocardial infarction. Findings from the study 
revealed that both men and women agreed that stress was a cause of their illness. Men 
believed that stress resulted from work-related factors, while women believed that their 
stress was secondary to relationship issues. Women were more likely to have a lower 
socioeconomic status and voiced a concern of decreased autonomy and self-efficacy 
following a myocardial infarction. 
Miller (2002) conducted a literature review of symptoms that women have with 
coronary artery disease. She searched the literature from 1995 to 2000 using CINAHL 
and Medline. Results of studies located from this search demonstrated that women had 
symptoms such as nausea, bloatedness, fatigue, dizziness, and shortness ofbreath. 
Women did have chest pain, although it was perceived by them as not significant and/or 
was not necessarily the first symptom to appear. Women most often did not seek medical 
care for symptoms of heart failure. 
Ng, Tam, Man, Cheng, and Chiu (2003) conducted a study examining gender 
differences in self-esteem in Hong Kong Chinese population with cardiac disease. Forty-
four males and 54 women who had been diagnosed with cardiac disease for 1 year or 
longer participated in this study. Analysis of the Adult Source of Self-Esteem Inventory 
(ASSEI) questionnaire revealed women under the age of 60 demonstrated better 
adjustments than men, including QOL. The authors found that this study contained 
cultural uniqueness. 
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Devon and Zerwic (2003) conducted a descriptive study on gender differences in 
symptoms of unstable angina. A convenience sample of 50 men and 50 women 
participated in the study. Ages for women ranged from 4 I -88 years (M = 64.88, SD = 
11.88) and men ranged from 35-85 years (M = 61.44, SD = 11.51) with no statistical 
significance. Shortness of breath, weakness, difficulty breathing, nausea, and loss of 
appetite were experienced significantly (p< .05) more often by women than men. Women 
continued to have weakness (p= .03), difficulty breathing (p = .02), nausea (p = .03), and 
loss of appetite (p = .02) after controlling for age, diabetes, anxiety, depression and 
functional status. Women reported more upper back pain, stabbing pain, and knife-like 
pain (p < .05). They also experienced a significantly higher occurrence of depression (p < 
.01 ). 
Bundy, Gonzalez, Barnard, Hardy, and DuPont (2006) conducted a retrospective 
epidemiologic study of gender risk differences linked to postoperative coronary artery 
bypass graft (CABG) surgical site infections. There were 957 (24.7%) women and 2921 
(75.3 %) males who had significant differences prior to surgery for characteristics of age, 
body weight, and height (p < .0001). On an average, women were older by 4 years, were 
35 pounds lighter, and 6 inches shorter in height. Results of the study found that women 
had a significantly higher incidence of postoperative CABG nosocomial surgical site 
infections (SSI) (p = .004) than men. Women had a higher occurrence of urgent surgeries 
and emergency procedures then men, as well as a higher incidence rate of surgical site 
infections at the chest and leg sites. A study limitation was that the patient population was 
from only one institution. 
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Guru, Fremes, Austin, Blacksone, and Tu (2006) explored gender differences in 
outcomes after hospital discharge in patients who had undergone a CABG. The study 
used the Cardiac Care Network database (September 1, 1991 and March 31, 2002). Of 
the 66,193 patients, 51,800 (78%) were males and 14,393 (22%) were females. Women 
were older, had a lower socioeconomic status, and had more comorbidities than men. 
Arterial grafts were not used in women as often as in men, and· women received fewer 
numbers of grafts regardless of their presenting coronary disease status. The study found 
that women were much more likely to have either early cardiac readmission (~1 year) or 
late cardiac readmission(> 1 year) following CABG; however, they were not as likely to 
die after discharge following CABG surgery. Readmissions for strokes were more often 
seen in women than men; however, after risk adjustment, men were slightly higher than 
women. Men had a higher repeat revascularization than did women; however, after risk 
adjustment, there was not a significant difference statistically. Preoperatively, women had 
better ventricular function than men, however, they were found to have higher 
readmission rates for CHF. 
Quality of Life and Health Status in Congestive Heart Failure 
Health status and quality of life have been studied within the cardiac literature. 
These two concepts can reflect a person's perception of their perceived health status. A 
summary of health status and HRQOL studies is provided in Table 2, and discussion of 
these studies follows. 
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Table 2 -
Summary of Health Status and HRQOL Studies 
Author(s) 
Conard, 
Heidenreich, 
Rumsfeld, 
Weintraub, 
and Spertus 
(2006) 
Subjects 
N=539 
patients 
Type of Design 
Prospective 
cohort 
quantitative study 
21 
Method of 
measuring 
variables 
Kansas City 
Cardiomyopathy 
Questionnaire 
(KCCQ) 
Short Form-12 
(SF-12) 
questionnaire 
Medical 
Outcomes 
Study-
Depression 
(MOS-D) 
questionnaire 
Question asked 
for economic 
burden 
Brain natriuretic 
peptide (BNP) 
Key Findings 
Patients who 
perceived to have 
economic burden 
had poorer health 
status 
Table 2 (Continued) 
Summary of Health Status and HRQOL Studies 
Author(s) Subjects Type of Design Method of Key Findings 
measuring 
variables 
Morgan et al. N=522 Quantitative Question for Patients who had 
(2006) patients Study difficulty taking difficulty taking 
medications (5- medications had 
level Likert poorer health status 
scale) and greater 
depressive 
symptoms. These 
MOS-D relationships 
questionnaire weaken once 
demographic and 
clinical factors were 
KCCQ adjusted. 
So to, Jones, N=l516 Prospective, KCCQ The greater the 
Weintraub, (401 international HRQOL there was 
Krumholz, females, cohort 
an 84% 1-year 
and Spertus 1115 quantitative study 
event-free of 
(2004) 
males) cardiovascular 
mortality and 
hospitalization. 
Juenger et al. N=205 Quantitative New York Heart As theNYHA 
(2002) Study Association functional class 
(NYHA) increases (functional 
functional class class becomes 
SF-36 worse) the QOL 
questionnaire decreases. 
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Table 2 (Continued 2) 
Summary of Health Status and HRQOL Studies 
Author(s) 
Riedinger et 
al., 2002 
Subjects 
N=691 
women 
from 
SOLVD 
trials 
Type of Design 
Secondary 
Analysis 
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Method of 
measuring 
variables 
Profile of Mood 
States Inventory 
(POMS) 
Functional 
Status 
Questionnaire 
(FSQ) 
Beta Blocker 
Heart Attack 
Trial instrument 
Symptoms Scale 
Ladder of Life 
RAND Medical 
Outcomes Study 
instrument 
Key Findings 
Women with CHF 
have a poorer QOL, 
vigor, activities of 
daily living, social 
activity, and ratings 
for general health as 
compared to a 
normative group. 
Women with CHF 
had greater levels of 
anxiety and 
depression as 
compared to a 
normative group. 
Table 2 (Continued 3) 
Summary of Health Status and HRQOL Studies 
Author(s) Subjects 
Clark, Tu, N=212 
Weiner, & patients 
Murray, 2003 
Type of Design 
Randomized 
controlled trial 
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Method of 
measuring 
variables 
KCCQ 
Chronic Heart 
Failure 
Questionnaire 
(CHQ) 
Single question 
asking about 
perceived health 
NYHA 
classification 
tool 
Charlson Index 
Income 
satisfaction 
Social support 
Health Belief 
Scale (HBS) 
Short Test of 
Functional 
Health Literacy 
in Adults 
Key Findings 
Greater age, males, 
and African-
American 
participants stated 
better HRQOL. 
Positive health 
beliefs, higher 
income, social 
support, and patient-
physician 
communication 
demonstrated 
increase HRQOL 
Table 2 (Continued 4) 
Summary of Health Status and HRQOL Studies 
Author(s) 
Rodriguez-
Artalejo eta!. 
(2005) 
Bosworth et 
al. (2004) 
Subjects 
N=394 
patients 
(221 
females, 
173 
males 
N=15 
male 
patients 
Type of Design 
Prospective, 
quantitative study 
Cross-sectional 
qualitative study 
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Method of 
measuring 
variables 
Biomedical and 
psychosocial 
variables 
Medical 
Outcomes Study 
36-Item Short 
Form (SF-36) 
questionnaire 
Minnesota 
Living with 
Heart Failure 
Questionnaire 
(MLWHF) 
Focus Groups 
Key Findings 
Poorer SF-36 scores 
(worse health status) 
indicated higher 
frequency of 
hospital 
readmissions. 
Higher ML WHF 
scores (poorer 
HRQOL) indicated 
a higher mortality. 
Five domains: 
symptoms, role loss, 
affective response, 
coping, social 
support. 
Patients were 
concerned with 
physical and 
cognitive function. 
Patients expressed a 
concern for family 
and the uncertainty 
of the illness on 
their mortality. 
Table 2 (Continued 5) 
Summary of Health Status and HRQOL Studies 
Author(s) 
Rhodes and 
Bowles 
(2002) 
Subjects 
N 5 
Type of Design Method of 
measuring 
variables 
Phenomenological Semi-structured 
qualitative study interviews 
Key Findings 
Four main themes: 
"Acknowledging 
losses in their 
1 i ves," "accepting 
the losses," 
"changing their 
lives," "deepening 
relationships" 
CHF has had an economic impact on patients and their medical costs. Conard, 
Heidenreich, Rumsfeld, Weintraub, and Spertus (2006) conducted a cross-sectional, 
longitudinal study (one year) of perceived economic burden and health status of 539 
patients. At baseline, 238 (44%) of the patients thought that their medical costs were 
creating a considerable financial burden. Those with economic burden were noted to be 
younger (59.5 ± 23.6) as compared to those who did not perceive economic burden (63.6 
± 23 .5, p = .001) and whose income was greater than $30,000 per year (p < .001). The 
Kansas City Cardiomyopathy Questionnaire (KCCQ) summary score was significantly 
lower in patients who perceived economic burden (p = .001), meaning that patients who 
demonstrated a lower disease-specific health status had greater economic burden. 
Progressively worse health status was demonstrated by Likert-type responses which were 
significant (p < .001). For generic health status and economic burden, patients who 
perceived that they had economic burdens reported more physical limitations (p = .001) 
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and worse mental health (p = .001). During an assessment of participants one year 
following baseline, their difficulty affording health care was greater and their health 
status was significantly (p = .002) lower. 
Morgan et al. (2006) conducted a study related to the difficulty of taking medicine 
with 522 CHF patients. Sixty-four (12.2%) patients stated that they had difficulty taking 
their prescribed medications, while 458 (87. 7%) did not. Those who had difficulty taking 
their medication were noted to have a significant an increase in heart failure symptoms, 
increase in social limitation, decrease in self-efficacy, and decrease in quality of life (p > 
.05 for each subscale). Symptoms of depression were significantly higher (p < .01) in 
patients who had difficulty taking their medication (43.8%) as compared to patients who 
had no difficulty taking medications (27.1 %). Symptoms of depression were also greater 
(p < . 00 1) in those with decreased health status. 
Soto, Jones, Weintraub, Krumholz, and Spertus (2004) conducted a study of 1516 
acute myocardial infarction (AMI) patients using the Kansas City Cardiomyopathy 
Questionnaire (KCCQ) which measures disease-specific health status. Seventy-three 
percent (n = 1115) were male and 26.4% (n = 401) were female. There was a strong 
association with cardiovascular events and scores of2: 75 were noted to have an 84% 1-
year event-free survival versus 59% in scores< 25 (p < .001). 
An outcome measure seen in many research studies is quality of life (QOL) 
(Brubaker, Witta, & Angelopoulos, 2003 ; Juenger et al. , 2002; Riedinger, Dracup, 
Brecht, Padilla, Sarna, Ganz, 2002). It is recognized as a key indicator of the 
effectiveness of medical treatment in women diagnosed with CHF. QOL varies as the 
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course of disease progresses and treatment regimens change. Individuals greater in age, 
male, and black were noted to have higher CHF-specific HRQOL scores (better 
HRQOL). This was also true of individuals who reported an increase in positive health 
beliefs, higher income, greater social support, and greater communication with their 
health care provider (Clark, Tu, Weiner, & Murray, 2003). 
Rodriguez-Artalejo et al. (2005) conducted a study on HRQOL as a predictor of 
hospital readmission and death in heart failure patients. This study was conducted in four 
Spanish hospitals with 394 patients, 173 (43.9%) were males and 221 (56.1 %) females. 
The authors reported a higher readmission rate for patients with lower scores (worse 
function) on the physical functioning (p = .01), general health (p = .003), and mental 
health (p = .02) subscales of the Medical Outcomes Study 36-Item Short Form (SF-36) 
questionnaire. Using the Minnesota Living with Heart Failure (MLHFQ) questionnaire, 
researchers found that there was a greater mortality rate with higher overall scores (worse 
HRQOL) along with higher physical and emotional scores (worse HRQOL). Individuals 
whose scores were higher than the median on the MLHFQ had a higher mortality, 
approximately 2 or more times greater, than observed in patients with lower scores. 
Bosworth, Steinhauser, Orr, Lindquist, Grambow, & Oddone, (2004) conducted a 
qualitative study involving focus groups of 15 male patients with CHF, ranging in age 
from 4 7 to 82 years. The study examined patients' perceptions of quality of life involving 
physical and psychosocial characteristics. Five themes emerged: physical symptoms, role 
loss, affective responses, coping, and social support. In addition to these themes, 
concerns were identified by patients for their families, the uncertainty of their illness 
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and/or prognosis, and concern of their cognitive functions which all contribute to their 
QOL. The authors found that patients with CHF who developed adaptation and coping 
mechanisms to deal with their illness had potential personal growth. 
Rhodes and Bowles (2002) conducted a phenomenological study involving 5 
women and their experience of living with CHF. Ages ranged from 60 to 90 years of age. 
Semi-structured interviews were conducted with each of the participants. Acknowledging 
losses in their lives, accepting the losses, changing their lives and deepening relationships 
were the four main themes that emerged from the data. The authors noted that CHF 
affected every aspect of the women's' life, which led to changes within their day living. 
The women drew from their inner self for strength and courage to have productive lives 
while living with CHF. 
Recent studies demonstrate that QOL affects patient's physical and mental health 
status. Furthermore, the social and economic impact ofCHF also impacts patient's 
perception of their QOL. Gender and racial differences were discussed, along with 
hospital readmissions. Future investigations are needed to assess gender differences and 
interventions to improve QOL in individuals with CHF. The next section will discuss 
predictors on health status and QOL. 
Predictors of Health Status and Quality of Life 
This section of the literature review focuses on the demographic and personal 
characteristics of age, gender, race, living status, comorbidities, NYHA function status, 
and perceived symptom management. These are characteristics that affect health status 
and QOL. 
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Mejhert, Kahan, Persson, and Edner (2006) conducted a study with 208 CHF 
patients: 58% were male, and the mean age was 76. Ofthe 208 patients, 36% (n = 74) 
died and 82% (n = 171) had readmissions to the hospital. Independent predictors of 
mortality were age, male, elevated brain natriuretic peptide (BNP), mitral end point septal 
separation (EPSS), and creatinine level. Predictors of readmissions were poor QOL (p < 
0.001). 
Age is a variable that is discussed throughout studies conducted on CHF patients. 
Hou, Chui, Eckert, Oldridge, Murray, & Bennett (2004) conducted a study focused on 
age and sex as it relates to HRQOL in patients with CHF. There were 165 patients in the 
study; mean age was 57.6 years (range 26-85). Fifty-two percent were female and 48% 
were male. Sixty-two percent of females and 84% ofmales were less than 65 years of 
age. Interviews were conducted at baseline and 26 weeks later. At baseline, patients 
under 65 years of age had HRQOL scores that were poorer than did the older patients. 
Women had poorer HRQOL then men on some scales. During the 261h week, patients less 
than 65 years old had significantly worse HRQOL than patients ' 65 years of age or older. 
During this same timeframe, women had significantly worse HRQOL than did men. 
Similar findings were found by Gottlieb et al. (2004) who reported that patients 64 years 
or younger had worse QOL. 
In another study, Cowie et al. (2002) examined factors that predicted 
hospitalization and mortality. Mortality was linked to advancing age, increase in serum 
creatinine and a greater severity of symptoms noted during the first presentation to the 
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hospital. Age was the only independent predictor of the total time spent in hospital for 
readmissions during the follow-up time frame. 
In a recent study, African-Americans were noted to have a higher incidence of 
delaying treatment among heart failure patients (Evangelista, Dracup, & Doering, 2002). 
Rathore et al. (2003) stated that African-American patients have an increase in 
readmission rates into the hospital. 
According to Luttik, Jaarsma, Veeger, and van Veldhuisen (2006), most of the 
patients who were living alone were elderly women with low incomes. They also 
reported having a decreased QOL and were at risk for having recurrent hospitalizations as 
compared to those women who were married or living with someone. Hamner and 
Ellison (2005) reported patients living with family members, as opposed to living in a 
facility or living alone, were linked to hospital readmissions. 
In the majority of studies reviewed it was noted that as the NYHA functional class 
score increased or heart failure worsened, the QOL decreased in patients with heart 
failure (Juenger et al., 2002; Riedinger, Dracup, Brecht, Padilla, Sarna, & Ganz, 2001). 
In a qualitative study by Crowder (2006), patients with worsening symptoms of 
CHF noted increased mortality along with an increase in comorbidities. A study by 
Alred, Gott, and Gariballa (2005) found that CHF had a significant negative impact on 
the patient's life as well as that of their partners. The participants and their partners felt as 
if symptoms associated with CHF were an isolating factor in their lives. The partner took 
on a role as supporter, maintained household tasks, and helped with physical care of the 
patient. In this study, symptoms such as fatigue and breathlessness had a physical impact 
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as well as a social one. This group of participants believed that the professional care their 
partner received was inadequate in coverage and was poorly coordinated. 
In one study, patients who were depressed had a higher incidence of hypertension 
than those who were not depressed (Gottlieb et al., 2004). There are several research 
studies that indicate patients who have diabetes have a higher incidence of mortality 
associated with CHF (Bell, 2003; Bertoni, Hundley, Massing, Bonds, Burke, & Goff, 
2004). A study by Clark, Tu, Weiner, and Murray (2003), however, found no significant 
association between comorbidity and any of the HRQL measures. 
Shahar, Lee, Kim, Duval, Barber, and Luepker (2004) examined hospitalization 
and mortality examined, studying a.total of2887 hospital records that met the criteria for 
heart failure patients. The authors found that within 1 year of hospitalization, 37% 
(550/1472) of males and 30% (419/1415) of females had died. Five to 6 years after the 
initial hospitalization, the cumulative mortality was 72% for men and 66% for women. 
Hospitalization rate increased by age; there were a few dozen patients hospitalized per 
100,000 residents from 35 to 44 years of age; the rate was 2000 patients per 100,000 for 
residents from 75 to 84 years of age. The hospitalization rate of men was 50% greater 
than that of women. They also found that heart failure patients have a higher mortality 
than the general population. Heart failure-related hospitalizations had at least 10,000 
deaths per 100,000 and that increased to more than 30,000 per 100,000 in the elderly. 
Thus, on average heart failure-related hospitalizations had 10 times a mortality risk. 
Yu, Lee, and Woo (2004) conducted a study of227 elderly Chinese CHF patients 
and their health-related quality of life; 52.4% were female, and the mean age was 77.1 
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(SD = 7.9; range: 60-~5). The authors found that the health perception scores (i.e., a 
reflection of the patient's perceived health status) were generally low. A correlation 
matrix of HRQOL with a number of variables demonstrated the highest correlation to be 
with psychological distress (r =-.58). Other correlations in the matrix were health 
perception (r = .50), functional status (r = -.40), and perceived social support (r = .35), 
age (r = -.20), educational level ( r = .23), presence of spouse (r = .22) and living 
condition (r = .23). However gender, income, length of time participants had suffered HF, 
number of medications, number of comorbidities, and hospitalization did not significantly 
relate to HRQOL. This study demonstrated that CHF patients who have increased 
psychological distress, poor health perception, increased functional impairment, or 
decreased perceived social support had decreased HRQOL. 
Todero, LaFramboise, and Zimmerman (2002) conducted a study on QOL and 
symptom status with 93 CHF patients in a home-based disease management program. 
The average age was 70.5 ± 11.8 years (range was from 39 to 91 years of age). Eighty-
four percent were Caucasian; 13%, African American, and 3%, other ethnicities. The 
authors found that as the QOL scores became better, so did the symptom status scores. 
Bennett, Perkins, Lane, Deer, Brater, and Murray (2001) conducted a study with 
14 7 CHF patients related to HRQOL and social support. There were 52% (n = 117) 
women and 48% (n = 11 0) men. Fifty-three percent (n = 121) were African-American 
and 4 7% (n = 1 06) were Caucasian. The mean age was 64 years (SD = 12); range in age 
was 27-92. Seventy-two percent of the patients were not married. Hypertension was the 
most common comorbid condition at 59%, followed by diabetes mellitus at 50%, 
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coronary artery disease at 39%, previous coronary artery bypass graft at 9%, myocardial 
infarction at 8%, and angina at 8%. The authors found that less support was found in men 
less than 65 years of age as compared to men 65 years of age or older or the women in 
either age group. Changes in HRQOL were directly related to changes in social support. 
Age, lower income, readmission rates, NYHA functional status, comorbidities, 
gender, and ethnicity were found to play important roles in the health status and QOL of 
patients with CHF. Further studies of these and other possible predictors of health status 
and QOL are needed. 
Summary 
This chapter has reviewed the historical perspective of men and women in 
medical research. Until recent years, the majority of research has been on men; however, 
women have more recently been included and some gender differences identified. This is 
true concerning research specifically pertaining to CHF. Health status and quality of life 
are noted within the CHF population. Predictors of health status and HRQOL were 
reviewed. Key points from the literature are summarized below: 
1. Women are more likely to have lower socioeconomic status. 
2. There are gender differences (e.g., older women being more physically impaired 
than older men, women have worse QOL ratings than did men for intermediate 
activities of daily living and social activity) in research studies. 
3. The worse the HRQOL or health status, the higher the risk of mortality andre-
hospitalization. 
4. Patients with economic burden had a poorer health status. 
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5. Patients who had problems taking their medications had a poorer health status and 
had an increase in depressive symptoms. 
6. The higher the NYHA function class score, the poorer the HRQOL and health 
status in patients with CHF. 
7. Women with CHF when compared to normative groups had poorer QOL, vigor, 
activities of daily living, social activity, and ratings for general health; levels of 
anxiety and depression were greater. 
8. Positive health beliefs, higher income, social support, and better patient-physician 
communication were associated with greater HRQOL. 
9 . CHF patients expressed concerns about their cognitive, physical, and 
psychosocial functioning. 
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CHAPTER III 
PROCEDURE FOR COLLECTION AND TREATMENT OF DATA 
The purpose of this study was to examine the health status and HRQOL of men 
and women with a diagnosis of congestive heart failure (CHF). The procedure describes 
the research study's design, sample and setting, protection of human subjects, 
instruments, data collection, and treatment of the data. 
Research Design 
This study used a cross-sectional exploratory design which examined groups of 
participants at a certain moment in time (Bums & Grove, 2005; Polit & Beck, 2008). 
Incorporating correlational techniques allowed the researcher to explore relationships 
among variables (Polit & Beck). 
Sample and Setting 
The non-probability, convenience sample (N = 113) included 76 men and 37 
women with a diagnosis of CHF who were attending a CHF clinic for treatment. 
Inclusion criteria for this study included (a) a diagnosis of CHF, (b) 18 years of age or 
older, and (c) the physical and mental ability to complete the questionnaire packet. 
Exclusion criteria included (a) any history of a surgical procedure within the last 3 
months, (b) history of starting on a new beta blocker medication within the last 3 months, 
and (c) any history of hospitalization within the last 6 weeks. 
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Recruitment began with flyers placed in designated cardiology clinics to notify 
patients of the research study. Individuals 18 years and older diagnosed with CHF let the 
clinic receptionist know if they were interested in participating in the study. Once patients 
had expressed an interest in the study to the receptionist, either the principal investigator 
(P .I.) or the nurse liaison met with the patient on that day in a designated private room or 
in a sitting area, whichever was agreed upon by the patient and investigator or nurse 
liaison. The study was explained and the patient was invited to participate if the inclusion 
and exclusion criteria were met. 
Data Collection 
After the informed consent had been signed by participants, they were given the 
instrument packet. Instruments included (a) the General Information Form (GIF) to 
collect demographics and health-related information; (b) the Medical Outcomes Study 
Health Survey, Version 2.0 (SF-36v2TM) for assessing the perceived physical and mental 
health status; and (c) the Minnesota Living With Congestive Heart Failure® (MLHFQ) 
questionnaire for assessing health-related quality of life (HRQOL). The P.I. or nurse 
liaison remained available to answer any questions the participant may have had and to 
collect the completed forms. Participants were instructed not to put their names on the 
fo~s that were prenumbered. The participant received a copy of the consent form. The 
completed consent forms and tests were placed in a numbered folder and sealed. The P.l. 
or nurse liaison placed the folder in a locked filing cabinet in the clinic; at least bi-
monthly it was transported from the clinic area to the P.I. 's office where it was placed in 
a locked file drawer. The P.l. separated the consent forms and completed questionnaires 
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into different folders before storing them. Data were then entered for statistical analysis 
by the P.l. using SF-36 Health Outcome scoring software and SPSS Graduate Pack 
version 11.0 for Windows. The dataset used only the identification (I.D.) number; no 
identifiable information was used. 
At least 113 participants were recruited through nonprobability sampling. The 
sample size was based on the formula N2': I 04 + k where k was the number of independent 
variables (n=9) in the model that was tested using multiple regression (Newton & 
Rudestam, 1999).This rule assumes an alpha level of .05, a power of .80, and a medium 
effect size (Arslanian-Engoren, 2001).This number was also appropriate for examination 
of gender differences in health status and HRQOL (Garson, 2008; VanVoorhis & 
Morgan, 2001). 
Protection of Human Subjects 
Prior to data collection, approval was obtained from Texas Woman's University 
(TWU) Institutional Review Board (IRB). During the course of this research study, 
confidentiality of participants' information was maintained. All records were coded with 
a number used only for organizing the data. No names appeared on any papers. The 
purpose of the study was explained and the opportunity to ask questions was provided. 
Participants were assured that their participation was voluntary and that they could 
withdraw their participation at any time. The completed forms were stored in a locked 
file cabinet in the investigator's office. 
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Instruments 
Medical Outcomes Study Health Survey, Version 2. 0 (SF-36v2™) 
The SF-36v2 is a 36-item instrument used to measure physical and mental health 
status. The survey yields an 8-subscale profile of scores. Physical and mental health 
summary measures are provided. Individual scores are also provided for each of the 8 
subscales: (physical functioning {PF}, role-physical {RP}, bodily pain, {BP}, general 
health {GH}, vitality {VT}, social function {SF}, role-emotional {RE}, mental-health 
{MH} ). The SF-36 is a generic tool for measuring health status that can be used with any 
disease process (Ware, nd). 
Scoring for Analysis 
The SF-36v2 uses norm-based scoring algorithms for all scales. The scoring 
software for version 2 was used. The scores were scaled from 0 tol 00. For items missing 
on a subscale, simple mean imputation was performed. This consisted of only 3 cases. If 
a physical or mental health status score could not be computed due to data not being 
available, a simple mean imputation was used as it related to the person's gender and 
racial status. This consisted of only one case. The SF-36v2 items and scales were scored 
so that a higher score indicated better health status. 
Administration 
The instrument response format is designed for self-report. Approximately 10 to 
15 minutes was needed to complete the health status questionnaire. 
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Form Development 
The SF-36 was developed for individual measurement as well as for group 
comparisons. The eight concepts comprising the SF-36 were derived from the Medical 
Outcomes Study (MOS) which had 37 total concepts (Ware, nd). All but one of the 37 
items was used. From the 36 concepts, eight main concepts were formed. The eight 
concepts were derived from health surveys which were well known within the literature 
and were seen as having effects on diseases and the treatment of these diseases (Ware, 
1995; Ware, Snow, Kosinski, & Gandek, 1993). 
The SF-36 was designed from instruments dating back to the 1970s and 1980s 
(Stewart & Ware, 1992). Some of the items were from the General Psychological Well-
Being Inventory (GPWBI), physical and role functioning measures from various tools, 
the Health Perceptions Questionnaire (HPQ), and other measures from the Health 
Insurance Experiment (HIE; Ware, nd). In 1992, the Functioning and Well-Being Profile 
(FWBP) was developed using previous questionnaire items and new measures (Stewart & 
Ware, 1992). This tool was the primary influence for the SF-36 questionnaire. The SF-36 
was in the developmental stage during 1988 and the final form became available in 1990 
(Ware, 1988; Ware & Sherbourne, 1992). 
The second version of SF-36 was created in 1996. Changes made from the 
original version stemmed from studies in qualitative and quantitative research (Ware, 
Kosinski, & Dewey, 2000). Changes in the questionnaire included: (a) simplification and 
shortening of wording, (b) larger type-size, (c) better translation and cultural adaptations, 
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(d) five-level response choices in the two role functioning scales, and (e) five-level 
response categories in the Mental Health (MH) and Vitality (VT) scales (Ware, n.d). 
Validity and Reliability 
The SF-36 questionnaire has well known psychometric properties and those 
reported for several studies are mentioned below and summarized in Table 3. Internal 
consistency and test-retest methods were used to test reliability of the eight scales and 
two summary measures. The literature has shown reliability statistics exceeding the 
minimum standard of0.70 in more than 25 studies {Tsai, Baylis, & Ware, 1997). Many 
of these studies have exceeded 0.80 (McHorney, Ware, Lu, & Sherbourne, 1994; Ware, 
Snow, Kosinski, & Gandek, 1993). Content, concurrent, criterion, construct, and 
predictive evidence of validity have been documented in the literature using the SF-36 
questionnaire. 
Cleary, Epstein, Oster, Morrissey, Stason, and Debussey (1991) had an internal 
consistency with a coefficient alpha of .84 or greater for each scale at baseline in 
approximately 500 patients undergoing percutaneous transluminal coronary angioplasty 
(PTCA). Weinberger, Samso, Hanlon, Schmader, Doyle, and Cowper (1991) evaluated 
the health status of25 elderly male veterans using the SF-36. The reliability correlation 
coefficient was . 78 for physical function, .67 for social function, and . 73 for overall 
function. The researchers found that the shorter administration time of this instrument 
was a positive feature. Nerenz, Repasky, Whitehouse, and Kahdonen (1992) used the SF-
36 with 235 diabetic patients. The test-retest correlations between baseline and six 
months ranged from 0.60 to 0.90. A study was conducted by Kurtin, Davies, Meyer, 
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DeGiacomo, and Kantz ( 1992) of 39 outpatients who received hemodialysis. The 
internal-consistency reliability estimates during first-time administration ranged from 
0.62 to 0.90. Brazier et al. (1992) conducted a study with 1980 patients using the SF-36 
instrument. Reliability of the instrument was measured using internal consistency which 
resulted in Cronbach's alphas ranging from .73 to .96. Reliability coefficients ranged 
from .74 to .93 (p. 162). Stability of the instrument's subscales was measured using test-
retest reliability at two weeks. For all dimensions, 91-98% of cases lay within the 95% 
confidence interval constructed for a normal distribution (p. 162). 
Construct validity was demonstrated in a study by Brazier et al. (1992) by scores 
reflecting what might be expected. For example, the lower social class group participants 
demonstrated poorer health status in all dimensions (p < .05) except for general health 
perception. Poorer perceived health status was seen in patients who had consulted their 
general practitioner two weeks prior to testing than those patients who had not. 
Convergent and discriminant validity were satisfied by using correlation coefficients with 
the SF-36 and Nottingham health profile. Correlation coefficients for four comparable 
dimensions of the SF-36 questionnaire and Nottingham health profile were higher than 
correlations between non-comparable dimensions (p. 162). The SF-36 was able to detect 
low levels of illness along with the Nottingham scoring low which reflected good health 
(Brazier et al.). 
Katz, Larson, Phillips, Fossel, and Liang (1992) conducted a study of 106 patients 
who underwent hip surgery. Convergent validity was estimated to be high (r = .78) when 
the SF-36 was correlated with the Sickness Impact Profile (SIP). McHomey, Ware, Lu, 
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Table 3 
Reliability and Validity Estimates of the SF-36 
Study Sample Size Psychometric Properties 
Cleary, Epstein, Oster, 500 patients undergoing Cronbach's alpha = .84 or 
Morrissey, Stason, & PTCA at baseline greater for each of the 
Debussey ( 1991) scales 
Weinberger, Samsa, 25 elderly, male veterans Correlation coefficient = . 78 
Hanlon, Schmader, Doyle, (physical), .67 (social) and 
& Cowper (1991) . 73 (overall) 
Nerenz, Repasky, First cohort = 1 1 7 patients Test-retest correlations = 
Whitehouse, & Kahkonen Second cohort = 116 .60 to .90; except pain scale (1992) = .43 
Kurtin, Davies, Meyer, 39 hemodialysis out- Internal-consistency= .62 
DeGiacomo, & Kantz patients to .90 
(1992) 
Brazier et al. (1992) 1582 patients - first survey Cronbach's alpha= .73 to 
Repeat test 187 .96 
Reliability coefficients = 
.74 to .93 
Test retest= .60 to .81 
Construct validity = 
acceptable 
Convergent and 
discriminant validity = 
acceptable 
Katz, Larson, Phillips, 1 06 hip surgery patients Correlations= .78 
Fossel, & Liang (1992) 
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Table 3 (Continued) 
Reliability and Validity Estimates ofthe SF-36 
Study Sample Size 
McHomey, Ware, Lu, & 
Sherbourne (1994) 
3,445 patients and 24 
subgroups 
Psychometric Properties 
Item-internal consistency 
97% 
Item-discriminant validity = 
92% 
Reliability coefficients = 
.65 to .94 
and Sherbourne (1994) conducted a study using the SF-36 with 3,445 patients and 24 
subgroups including different sociodemographic characteristics and diseases. Item-
internal consistency was 97% and item-discriminant validity was 92%. Reliability 
coefficients ranged from .65 to .94 across all scales with variations across patient 
subgroups. A summary of reliability and validity of the SF-36 is in Table 3. 
Minnesota Living with Congestive Heart Failure® 
The Minnesota Living With Congestive Heart Failure® (MLHFQ) is a quality of 
life (QOL) instrument specifically for heart failure patients. This questionnaire consists of 
21 questions. Persons may respond to each question using a 6-point Likert-type scale 
where 0 equals no, 1 equals very little, and 5 equals very much. 
Scoring for Analysis 
The MLHFQ is scored by summating the responses to the 21 questions. A 
physical dimension score can be calculated by summating items 2, 3, 4, 5, 6, 7, 12, and 
13. An emotional dimension score can be calculated by summing items 17, 18, 19, 20, 
and 21. The remaining 8 questions asked the following questions: Did your heart failure 
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prevent you from living as you wanted during the past month (4 weeks) by (a) causing 
swelling in your ankles or legs; (b) making your working to earn a living difficult; (c) 
making your recreational pastimes, sports or hobbies difficult; (d) making your sexual 
activities difficult; (e) making you eat less of the foods you like; (f) making you stay in a 
hospital; (g) costing you money for medical care; and (h) giving you side effects from 
treatments? All items were included in the total score. The lower the score, the better the 
QOL. However, during data analysis, a decision was made by the researcher to reverse 
the scores so that the data would be interpreted in the same manner as the SF-36v2; thus, 
the higher the score, the better the quality of life. 
Administration 
The instrument response format is designed for self-report. Approximately 1 0 
minutes was needed to complete the questionnaire. 
Form Development 
The MLHFQ was developed in 1984 to specifically measure a person's quality of 
life when living with heart failure and the treatments that are involved. The questionnaire 
was designed to represent heart failure and treatments and their effects on a person's 
physical, emotional, social, and mental dimensions of quality of life. Physicians and 
nurses treating and caring for patients at the University of Minnesota were involved in 
developing questions that affected the QOL of patients with heart failure (Rector, 2005). 
Validity and Reliability 
The MLHFQ is a valid and reliable instrument. Rector, Francis, and Cohn (1987) 
constructed a questionnaire named the Sickness Impact Profile which was administered 
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to 45 individuals with CHF. This questionnaire demonstrated poor correlation with 
maximal exercise tests. In 1987, a new questionnaire was developed, the Minnesota 
Living with Heart Failure Questionnaire (Rector, Francis, & Cohn, 1987). A primary list 
of questions was generated by patients with CHF from the Sickness Impact Profile. From 
this list, questions specifically addressed by-patients with CHF were then selected to form 
a new, shorter set of questions which were chosen to be used in the MLHFQ. Internal 
consistency was acceptable with correlations of .35 to .86. Reliability of the instrument 
was measured by the differences between the two baseline scores and reproducibility was 
measured using weighted kappa. There was a weak relationship {Spearman's r = -.34, 
p < .01) seen in the differences between the two bas~line scores and the weighted kappa 
for reproducibility for both scores were .84. Validity ofthe instrument was noted in the 
high correlation (r = .80, p < .01) between the MLHFQ score and the patient's perception 
of global health as it relates to their heart failure as measured by the question "Overall, 
how much did your heart failure prevent you from living as you wanted during the last 
month?" (p. 205) The New York Heart Association (NYHA) classifications correlated 
with the MLHFQ score (r = .60, p < .01). Rector and Cohn (1992) assessed patient 
outcomes with the MLHFQ in a randomized, double-blind, placebo-controlled trial of 
pimobendan with 181 participants. The reliability of all three scores (i.e., total, physical 
and emotional), were, respectively, .93, .89, and .88 at baseline. The inter-item 
correlation means at baseline were .94, .94, and .90. Rector et al. (1993) conducted a 
randomized, controlled trial using different medication groups. Reliability of the MLHFQ 
was indicated by Spearman's correlation coefficient was .87. In a study by Gorkin, 
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Norvell, Rosen, Charles, Shumaker, and Mcintyre (1993) of 318 patients with left 
ventricular dysfunction quality of life was examined. Internal consistency reliability in 
that study was .95 when seen in participants with Class 1 (n = 135) using the NYHA 
classifications and .94 in Class II and III classifications (n = 123). Bennett, Pressler, 
Hays, Firestine, and Huster ( 1997) conducted a study with 65 patients in an outpatient 
CHF clinic. Cronbach's alpha reliability coefficients were .92 (total MLHFQ), .91 
(Physical subscale), and .79 (Emotional subscale). Bennett, Oldridge, Eckert, Embree, 
Browning, and Hou (2003) reported a total score or .95 Cronbach's alpha (with physical 
score being .94 and emotional .89) at baseline with 211 participants. At 26 weeks, with 
165 participants, the Cronbach's alpha was .95 (physical score was .91 and emotional 
score was .86). In another article by Bennett, Oldridge, Eckert, Embree, Browning, and 
Hou (2002), data from the previous study were used. Construct validity of the MLHFQ 
was supported by factor analysis with factors accounting for 70% of the observed 
variance. Convergent validity was supported for the MLHFQ as it was compared to the 
SF-12 and the Chronic Heart Failure questionnaire (CHQ). Divergent validity of the 
MLHFQ was supported by analyzing the differences in the questionnaire and scores of 
the New York Heart Association (NYHA) classifications. The lower the NYHA score, 
the better the MLHFQ scores: or the reverse was true with higher NYHA scores 
associated with poorer MLHFQ scores. A summary of reliability and validity of the 
MLHFQ is in Table 4. A summary linking terms and conceptual and operational 
definitions to instruments used within this study is provided in Table 5. 
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Table 4 
Reliability and Validity of the MLHFQ 
Study Sample Size 
Rector, Francis, & Cohn. 
(1987) 
83 patients 
Psychometric Properties 
Weighted kappa for 
reproducibility for both 
scores= .84 
Validity= highly correlated 
with global health (r = .80, 
p< 0.01); correlated with 
NYHA (r = .60, p < .01) 
Rector and Cohon (1992) Randomized, double-blind, Repeated baseline scores = r 
Rector et al. ( 1993) 
Gorkin, Norvell , Rosen, 
Charles, Shumaker, & 
Mcintyre (1993) 
placebo-controlled trial ; 181 = . 93, 0. 89 (physical), and 
participants 
152 participants 
318 patients with left 
ventricular dysfunction 
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.88 (emotional) 
Cronbach's alpha- .94, .94, 
and .90 (n = 197) 
Correlation coefficients 
between repeated baseline 
scores= .87 
Internal consistency= .95 
(Class I; n = 135) and .94 
(Class II and III; n = 123) 
Table 4 (Continued) 
Reliability and Validity of the MLHFQ 
Study Sample Size 
Bennett, Pressler, Hays, 65 patients with CHF 
Firestine, & Huster (1997) 
Bennett, Oldridge, Eckert, 211 participants 
Embree, Browning, & Hou 
(2003) 
Bennett, Oldridge, Eckert, 211 participants 
Embree, Browning, & Hou 
(2002) 
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Psychometric Properties 
Cronbach's alpha= .92 
(Total score), .91 
(Physical), and .79 
(Emotional) 
Cronbach's alpha= .95 
(Total); at 26 weeks .95 
(Total), .91 (Physical), and 
.86 (Emotional) 
Construct validity- factor 
analysis with 70% observed 
variance 
Convergent validity -
supported 
Divergent validity 
supported 
Table 5 
Terms, Conceptual and Operational Definitions, and Instruments 
Terms Conceptual Definition Operational Instrument 
Definition 
Age · The time, in years, The individual's self- General Information 
from birth to the reported age in years. Form (GIF) 
present year (Taber's 
Cyclopedic Medical 
Dictionary, 2005). 
Ethnicity/Race "of or relating to large Answered by the GIF 
groups of people client agreeing to 
classes according to complete the 
common racial, questionnaires. 
national, tribal, Categories, or items, 
religious, linguistic, or for response on the 
cultural origin or general information 
background" form (GIF) include: 
(Merriam-Webster American Indian or 
Online Dictionary, Alaska Native, 
2006, p. 1). Asian, Black or 
African American, 
Hispanic or Latino, 
Not Hispanic or 
Latino, Native 
Hawaiian or Other 
Pacific Islander, and 
White. 
Living Status Whether the individual The participant will GIF 
lives alone, lives with choose one of the 
someone. or lives in a following categories: 
residential setting. lives alone, lives 
with someone, or 
lives in a residential 
setting. 
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Table 5 (Continued) 
Terms, Conceptual and Operational Definitions, and Instruments 
Terms Conceptual Definition Operational Instrument 
Definition 
Perceived The individual's The participant will GIF 
General Health perception of his or her choose one of the 
Status health status. following categories: 
excellent, very good, 
good, fair, or poor. 
Perceived The individual's Symptom GIF 
Symptom perception of how the management will be 
Management symptoms of heart measured by a 
failure are being Likert-type scale 
managed or controlled. from I (symptoms 
not being managed 
well at all) to I 0 
(symptoms being 
managed extremely 
well). The higher the 
score, the better the 
symptom 
management. 
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Table 5 (Continued 2) 
Terms, Conceptual and Operational Definitions, and Instruments 
Terms 
Number of 
Comorbities 
Conceptual Definition 
The number of 
different health-related 
diagnoses the 
participant has. 
Operational 
Definition 
The participant will 
choose from the 
following categories: 
heart disease, high 
blood pressure, lung 
disease, diabetes, 
ulcer or stomach 
disease, kidney 
disease, liver disease, 
anemia or other 
blood disease, 
cancer, depression, 
osteoarthritis, 
degenerative 
arthritis, back pain, 
rheumatoid arthritis, 
thyroid disease, 
obesity, autoimmune 
disease, and other. 
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Instrument 
GIF 
Table 5 (Continued 3) 
Terms, Conceptual and Operational Definitions, and Instruments 
Terms 
Health-related 
quality of life 
Conceptual Definition 
"the relationship 
between two concepts, 
health or disease (in 
this case heart failure) 
and QOL" (A. Brown, 
personal 
communication, July 
12, 2006). 
Operational 
Definition 
The MLHFQ is a 
QO L instrument 
specifically for heart 
failure patients. This 
questionnaire 
consists of 21 
questions. Persons 
may respond to each 
question using a 6-
point Likert-type 
scale where 0 equals 
"no", 1 equals "very 
little", and 5 equals 
"very much". The 
lower the score, the 
better the QOL and 
the higher score 
represents a poorer 
QOL. Reliability for 
the MLHFQ is .95 -
.87 (Rector, 2005). 
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Instrument 
MLHFQ 
Table 5 (Continued 4) 
Terms, Conceptual and Operational Definitions, and Instruments 
Terms 
Health Status 
Conceptual Definition 
"an overall evaluation 
of an individual's 
degree of wellness or 
illness with a number 
of indicators, including 
quality of life and 
functionality" (Ware, 
Kosinski, & Dewey, 
2002). 
Operational 
Definition 
The SF-36v2 is a 36-
item instrument used 
to measure physical 
and mental health 
status. The survey 
yields an 8 scale 
profile of scores. 
Physical and mental 
health summary 
measures are also 
provided. Items and 
scales are scored so 
that a higher score 
indicates a better 
health status. 
Reliability of the SF-
36v2 scales range 
from .84 to .95 
(Ware, Kosinski, & 
Dewey, 2002). 
Data Collection 
Instrument 
SF-36v2 
This study used a cross-sectional exploratory design. The sample included men 
and women with a diagnosis of CHF who were attending a CHF clinic for treatment. 
Individuals 18 years and older diagnosed with CHF were asked to participate and 
complete three questionnaires while in the clinic setting. The questionnaires were 
numbered, with an assigned number given to each participant. Numbers were used only 
for organization of the data. They did not personally identify the participant. 
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Treatment of Data 
Descriptive statistics, as appropriate to the level of data, were used to describe the 
sample; these included such statistics as measures of central tendency, frequencies, and 
percentages. Frequencies and percentages were used to report gender, race, 
comorbidities, and living status; measures of central tendency (e.g., means and standard 
deviations) were appropriate for remaining data describing participants. Levels of 
measurement included nominal (e.g., gender, ethnicity/race, and living status, and 
specific comorbidities), ordinal (e.g., test score totals), and interval or ratio (e.g., number 
of comorbidities). A decision was made to treat the test scores (i.e., MANOVA, 
independent t tests, chi-square, hierarchical multiple regression analysis, and Kappa 
statistic) as interval data since they were arranged in almost equal intervals (Field, 2005). 
Initially, exploratory data analysis was used for reviewing these data to assure that 
assumptions were met for running the statistical analyses and to look for any underlying 
patterns. 
Research Question I 
Multiple analysis of variance (MANOV A) was the statistical test used to examine 
the research question: Are there differences in self-reported health status and HRQOL of 
men and women with a diagnosis ofCHF? MANOVA was used to test multiple 
dependent variables, examining the significance of differences in group means (Polit & 
Beck, 2008). The independent variable was gender and the dependent variables were 
health status and HRQOL. The null hypothesis was: There is no significant difference in 
the health status and HRQOL of women and men with a CHF diagnosis. 
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Research Question 2 
Independent t tests and chi-square test of independence tested the second research 
question: Are there gender differences in specified variables (i.e. , age, race/ethnicity, 
living status, number of comorbidities, perceived general health status, and perceived 
symptom management) of those with a diagnosis of CHF? Independent t tests were used 
to statistically test the difference in means of males and females with CHF on age, 
number of comorbidities, perceived general health status, and perceived symptom 
management (Portney and Watkins, 2009). Chi-square test of independence was used to 
test the independence between two variables (i.e., race/ethnicity and living status) 
measured on a nominal scale (Portney & Watkins, 2009). 
Research Questions 3 and 4 
Hierarchical multiple regression analysis was used to test Questions 3 and 4. 
Research Question 3 asked "Are gender, age, race/ethnicity, number of comorbidities, 
living status, perceived general health status, perceived physical health status, perceived 
mental health status, and perceived symptom management significant predictors of 
HRQOL?" Research Question 4 asked "Do symptom status (i .e., perceived symptom 
management), functional status (i .e., living status, perceived physical health status, and 
perceived mental health status), and general health perceptions (i.e. , perceived general 
health status) serve as mediating variables between the exogenous variables (i .e., gender, 
age, race/ethnicity, and comorbidities) and overall quality of life?" Hierarchical multiple 
regression analysis is primarily used to create an equation to help in understanding what 
variables are important in the prediction of some dependent variables (Mertler & 
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Vannatta, 2002). Prior to data analysis, the theoretical and statistical assumptions were 
tested. Residual plots were used to check assumptions of linearity and normality; any 
outlying values were examined and a decision was made about their inclusion in the 
analysis. Hierarchical multiple regression was conducted to determine any predictors of 
HRQOL. 
Research Question 5 
A kappa coefficient was used to analyze Research Question 5: Is there agreement 
of the New York Heart Association's (NYHA) Functional Class ratings made by the 
participant and his/her health care provider? Kappa statistic was used to measure chance-
corrected measure of agreement (Portney & Watkins, 2009). 
Significance of the Study 
There are long-term health-related effects in individuals diagnosed with CHF. 
This research study will increase the understanding of these and which are significant 
predictors of quality of life. Findings are expected to inform nursing practice so that 
interventions may be planned to improve the quality of life of individuals with CHF. 
Educating individuals with CHF while monitoring their health status, helping with goal 
setting, and establishing avenues of support for them and their families should enable 
them to make decisions that could add to a better HRQOL. 
Summary 
In summary, this chapter has presented the cross-sectional exploratory design for 
this study. Specific issues such as participant selection, setting, sample, protection of 
human subjects, instrument description including validity and reliability, data collection 
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techniques and treatment of data have been discussed. Five research questions guided the 
data analysis, and the statistical measures used in relation to each were discussed. 
Rationale for each step has been provided and selected techniques for statistical analysis 
substantiated. 
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CHAPTER IV 
ANALYSIS OF DATA 
The major study question addressed was "Are there differences in self-reported 
health status and health-related quality of life (HRQOL) of men and women with a 
diagnosis of congestive heart failure (CHF)?" This chapter presents the study findings 
that addressed the following five specific research questions using an exploratory cross-
sectional study design: 
1. Are there differences in self-reported health status and HRQOL of men and 
women with a diagnosis of CHF? 
2. Are there differences in age, race/ethnicity, living status, number of 
comorbidities, perceived general health status, and perceived symptom 
management of men and women with a diagnosis of CHF? 
3. Are gender, age, race/ethnicity, number of comorbidities, living status, 
perceived general health status, perceived physical health status, perceived 
mental health and perceived symptom management significant predictors of 
HRQOL? 
4. Do symptom status (i.e., perceived symptom management), functional status 
(i .e., perceived physical health status and perceived mental health status), and 
general health perceptions (i.e., perceived general health status) serve as 
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mediating variables between the exogenous variables (i.e., gender, age, 
race/ethnicity, and comorbidities) and HRQOL.? 
5. Is there agreement ofthe New York Heart Association's (NYHA) Functional 
Class ratings made by the participant and his/her health care provider? 
Description of the Sample 
The study sample met the following criteria for participation: (a) a diagnosis of 
CHF, (b) 18 years of age or greater, and (c) physically and mentally able to complete the 
study questionnaires. The majority of participants (n = 1 08) were recruited from a 
cardiology clinic in Houston, Texas, and the remaining participants (n = 5) were from a 
cardiology clinic in Dallas, Texas. A non-probability, convenience sample of 113 clients 
volunteers to participate in this study that extended over a 4-month period from May 
2007 to August 2007. 
Sample Demographics and General Health Information 
Sample demographics and general health information are displayed in Table 6. 
Participants ranged in age from 40 to 95 years with a mean age of 68 (SD = 11.9) years . 
Sixty-seven percent were male and 33% were female. Seventy-seven percent of 
participants were Caucasian, 11% were black or African-American, and 12% were listed 
as "other". Eighty-four percent lived with someone and 16% lived alone. The mean 
household income was estimated at $48,178.83 (SD = 15,177.62) and the mean house 
value was estimated at $84,623.64 (SD = 32,612.16). 
Sixty-one percent of participants perceived their general health status to be good 
or better when rated on a scale from poor to excellent. Using a Likert-type scale, 
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participants rated their CHF symptom management with scores ranging from 1 (not well 
at all) to 10 (extremely well). Their average CHF symptom management rating score was 
7.2 on a scale of 0 to 1 0. Participants were asked to identify all of their diagnosed 
diseases. Sixty percent had at least 3 comorbidities. Other than CHF, the most frequent 
major health issues of these participants were as follows: heart disease (79%), high blood 
pressure (66%), back pain (28%), diabetes(27%), and degenerative arthritis (22%). 
Sixteen percent indicated they were currently taking antidepressant medication. Cost of 
medications (22%) and cost of medical care (30%) were noted as contributing to financial 
stress affecting quality of life. 
Demographics of this sample varied among gender and ethnic groups. The sample 
included, in order of number of participants, Caucasian men (53%), Caucasian women 
(24 %), African-American men ·(7%), and African-American women (4%). Women 
(21.6%) were more likely to live alone than were males (13.2%). 
Women had a higher mean age (71 .19, SD = 12.09) than did men (67.05, SD = 
11.58). Women's ages ranged from 43 to 95 years of age, with men ranging in age from 
40 to 93 years. Women had a higher perceived general health status mean, 2.97 (SD 
= .928) than did men, 2.75 (SD = .940). However, men had a higher perceived CHF 
symptom management score mean (7.34, SD = 2.16) than did women (6.92, SD = 2.37). 
Men had a higher house hold income ($48, 746.49, SD = $16,032.18) and a higher 
house value ($87,067.57, SD = $35,958.92) than did women ($47,011 .97, SD = 
$13,387.80) ($79,600.00, SD = 24,014.60). Cost of medications and cost of medical care 
were noted as contributing to financial stress affecting quality of life. Twenty-seven 
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percent of women and 19.7% of men noted that their cost of medications impaired their 
QOL. Men had a slightly higher percentage (30.3%) than women (27%) in their 
perception that the cost of their medical care impaired their QOL. 
Women had a higher percentage in the following comorbidity categories: heart 
disease (83 .8%), blood pressure (67.6%), lung disease (13.5%), ulcer or stomach disease 
(16.2%), kidney disease (13 .5%), anemia and other blood disease (8.1 %), cancer (8 .1 %), 
osteoarthritis and/or degenerative arthritis (32.4%), back pain (35.1 %) , rheumatoid 
arthritis (16.2%), thyroid (16.2%), and sleep apnea (13.5 %). Men experienced a higher 
rate of diabetes mellitus (30.3%), liver disease (2 .6%), depression ( 14.5%), and obesity 
(19. 7%). While men had a higher incidence of depression, women (21.6%) noted taking 
more medication for depression than men ( 13 .2%). 
An overwhelming majority of participants (85, 75.2%) did not know their ejection 
fraction (EF) (see Table 1). From 50% to 100% of participants did not know their EF. By 
percentage, those who showed the greatest knowledge deficit were African American 
men (50%) and men of"other" descent (100%). 
Hospitalizations 
Hospitalizations and the reason for hospitalizations were of interest in learning 
more about the sample and their health status (see Tables 6 and 7). Participants were 
asked "When were you last admitted to the hospital?" Also, ''What symptoms prompted 
you to go to the hospital?" Thirty-four percent of the participants reported having been 
admitted to the hospital within the past year. Only 5% (n = 6) participants reported never 
having been hospitalized. Overall, the stated reasons for hospital admission were as 
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follows: shortness ofbreath, 33% (n == 37), chest pain, 26% (n = 29); fatigue (tiredness), 
19% (n == 21 ); swelling, 12% (n == 14); defibrillator responding, 1% (n == 1 ); and other 
reasons, 49% (n = 55). 
Women were admitted more often than men a year ago or more (70.3%) or less 
than 3 months ago (8.1 %). Men were more often admitted between 3 and 6 months 
( 11.8%) or 6 months to 1 year (21 .1 %) from the time of questioning. Approximately 5% 
of women and men had never been admitted to a hospital. 
Women had a higher percentage of swelling (21.6%), shortness of breath (35.1 %), 
and "other" symptoms (56.8%) prompting them to go to the hospital. Men had a higher 
percentage of chest pain (27.6%) and defibrillator responding (1.3%) as to the symptoms 
that prompted them. Fatigue was essentially the same, 18%, for both groups. 
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Table 6 
Demographics 
Age Co-Habituate Household Income Estimated Home Value 
All Participants M (SD): Yes: 84.1%(n=95) M (SD) = 48.178.83 M (SD): 84,623.64 
(N= 113) 68.41 ( 11.86) No: 15.9% (n = 18) (15,177.62) (32.612.16) 
All Women M (SD): 71.19 Yes: 78.4% (n = 29) M (SD): 47,011.97 M (SD) : 79,600 
33% (n = 37) (12.09) No: 21.6% (n =8) (13 ,387.80) (24,0 14.60) 
All Men M (SD): 67.05 Yes: 86.8% (n = 66) M (SD) : 48 ,746.49 M (SD) : 87,067.57 
67% (n = 76) (11.58) No: 13.2%(n = 10) (16,032.18) (35,958 .92) 
African American Women Only M (SD): 60 .50 Yes: 50 % (n = 2) M (SD): 31 ,371.50 M (SD): 
0\ 4%(n=4) (19 .50) No: 50 % (n = 2) (6,8 13.46) 58,950.00(17,845.73) ~ 
Caucasian Women Only M (SD): 72.33 Yes: 77.8% (n = 21) M (SD) : 50,565.38 M (SD): 85,288.46 
24% (n = 27) (10.83) No: 22.2 % (n = 6) (11 ,930.786) (22, 725.85) 
Women of"Other" Descent M (SD): 73.17 Yes: 100 %(n =6) M (SD) : 42,040.83 M (SD): 68,716.67 
5% (n =6) (10.55) No: 0 % (n = 0) (14,968.20) (24,737.94) 
Caucasian Men Only M (SD): 68.50 Yes: 83.3% (n =50) M (SD): 50,406.64 M (SD): 90,163.79 
53% (n = 60) (11.61) No: 16.7% (n = 10) (14,230.89) (34,977.10) 
African American Men Only M (SD): 58.13 (7 .10) Yes: 100%(n=8) M (SD): 46,824.63 M (SD): 86,575.00 
7% (n = 8) No: 0% (n = 0) (25,927.46) (50,124.47) 
Men of "Other" Descent M (SD): 65 .13 Yes: 100% (n = 8) M (SD): 38,632.25 M (SD): 65,112.50 
7% (n = 8) (11.77) No: 0% (n = 0) ( 14,669 .17) (19,483.07) 
Table 6 (Continued) 
Demographics 
General Health General Health General Health General Health General Health 
Status "Excellent" Status "Very Status "Good" Status "Fair" Status "Poor" 
" 
All Participants 2.7% (n = 3) 22.1% (n = 25) 36.3% (n = 41) 32.7% (n = 37) 6.2% (n = 7) 
(N= 113) 
All Women 2.7% (n = 1) 27% (n = 10) 40.5% (n = 15) 24.3% (n = 9) 5.4% (n = 2) 
33% (n = 37) 
All Men 2.6% (n = 2) 19.7% (n = 15) 34.2% (n = 26) 36.8% (n = 28) 6.6% (n = 5) 
67% (n = 76) 
African American Women Only 0% (n = 0) 25% (n = 1) 50% (n = 2) 25% (n = 1) 0% (n = 0) 
0'1 4%(n = 4) 
V1 
Caucasian Women Only 3.7%(n=1) 25 .9% (n = 7) 40.7% (n = 11) 25.9% (n = 7) 3.7% (n = 1) 
24% (n = 27) 
Women of"Other" Descent 0% (n = 0) 33.3% (n = 2) 33.3% (n = 2) 16.7% (n = 1) 16.7% (n = 1) 
5% (n =6) 
Caucasian Men Only 1.7% (n = 1) 20% (n = 12) 38.3% (n = 23) 31.7% (n = 19) 8.3% (n = 5) 
53% (n = 60) 
African American Men Only 0% (n = 0) 12.5% (n = 1) 12.5% (n = 1) 75% (n = 6) 0% (n = 0) 
7% (n = 8) 
Men of "Other" Descent 12.5% (n = 1) 25% (n = 2) 25% (n = 2) 37.5% (n = 3) 0% (n = 0) 
7% (n = 8) 
Table 6 (Continued 2) 
Demographics 
CHF Symptom Taking medication for Cost of medications Cost of medical care 
Management Score Depression impairs QOL impairs QOL 
All Participants M(SD) = 7.20 (2.23) 15.9% (n = 18) 22.1% (n = 25) 29.2% (n = 33) 
(N= 113) Range: 1-10 
All Women M (SD) = 6.92 (2.37) 21.6% (n = 8) 27% (n = 10) 27% (n = 10) 
33% (n = 37) Range: 1-10 
All Men M (SD) = 7.34 (2.16) 13.2% (n = 10) 19.7% (n = 15) 30.3% (n = 23) 
67% (n = 76) Range: 1-10 
African American Women Only M (SD) = 6.50 (2.38) 25% (n = 1) 25% (n = 1) 25% (n = 1) 
0\ 4% (n = 4) Range: 3-8 
0\ 
Caucasian Women Only M (SD) = 6.93 (2.27) 22.2% (n = 6) 18.5% (n = 5) 18.5% (n = 5) 
24% (n = 27) Range: 1-10 
Women of"Other" Descent M (SD) = 7.17 (3 .1 9) 16.7% (n = 1) 66.7% (n = 4) 66.7% (n = 4) 
5% (n =6) Range: 1-10 
Caucasian Men Only M (SD) = 7.27 (2.21) 16.7% (n = 10) 20% (n = 12) 30% (n = 18) 
53% (n = 60) Range: 1-10 
African American Men Only M (SD) = 7.25 (1 .58) 0% (n = 0) 25% (n = 2) 37.5% (n = 3) 
7% (n = 8) Range: 5-10 
Men of "Other" Descent M (SD) = 8.00 (2.39) 0% (n = 0) 12.5% (n = 1) 25% (n = 2) 
7% (n = 8) Range: 4-10 
Table 6 (Continued 3) 
Demographics 
Hospitalized Hospitalized Hospitalized Hospitalized Never 
< 3 months ago 3 to 6 months 6 months to >1 year ago Hospitalized 
ago < !year ago 
All Participants 6.2% (n = 7) 8.8% (n = 10) 18.6% (n = 21) 61.1%(n=69) 5.3% (n = 6) 
(N= 113) 
All Women 8.1% (n = 3) 2.7% (n = 1) 13.5% (n = 5) 70.3% (n = 26) 5.4% (n = 2) 
33% (n = 37) 
All Men 5.3% (n = 4) 11.8% (n = 9) 21.1 % (n = 16) 56.6% (n = 43) 5.3% (n = 4) 
67% (n = 76) 
0'\ 
African American Women Only 0% (n = 0) 0% (n = 0) 0% (n = 0) 100% (n = 4) 0% (n = 0) -.....} 
4%(n=4) 
Caucasian Women Only 7.4% (n = 2) 3.7% (n = 1) 14.8% (n = 4) 66.7% (n = 18) 7.4% (n = 2) 
24% (n = 27) 
Women of"Other" Descent 16.7% (n = 1) 0% (n = 0) 16.7% (n = 1) 66.7% (n = 4) 0% (n = 0) 
5% (n =6) 
Caucasian Men Only 6.7% (n = 4) 13.3% (n = 8) 21.7% (n = 13) 53.3% (n = 32) 5% (n = 3) 
53% (n = 60) 
African American Men Only 0% (n = 0) 12.5% (n = 1) 12.5% (n = 1) 75% (n = 6) 0% (n = 0) 
7% (n = 8) 
Men of "Other" Descent 0% (n = 0) 0% (n = 0) 25% (n = 2) 62.5% (n = 5) 12.5% (n = 1) 
7% (n = 8) 
Table 6 (Continued 4) 
Demographics 
Comorbidity Comorbidity Comorbidity Comorbidity Comorbidity 
Heart Disease High Blood Lung Disease Diabetes Ulcer or 
Pressure Stomach Disease 
All Participants 78.8% (n = 89) 66.4% (n = 75) 11.5% (n = 13) 27.4%(n=31) 8% (n = 9) 
(N= 113) 
All Women 83 .8% (n = 31) 67.6% (n = 25) 13 .5% (n = 5) 21.6% (n = 8) 16.2% (n = 6) 
33% (n = 37) 
All Men 76.3% (n = 58) 65 .8% (n =50) 10.5% (n = 8) 30.3% (n = 23) 3.9% (n = 3) 
67% (n = 76) 
0\ 
African American Women Only 75%(n=3) 00 75% (n = 3) 0% (n = 0) 50% (n = 2) 0% (n = 0) 
4%(n=4) 
Caucasian Women Only 92 .6% (n = 25) 63% (n = 17) 18.5% (n = 5) 14.8% (n = 4) 14.8% (n = 4) 
24% (n = 27) 
Women of"Other" Descent 50%(n=3) 83.3% (n = 5) 0% (n = 0) 33 .3% (n = 2) 33.3% (n = 2) 
5% (n =6) 
Caucasian Men Only 73.3% (n = 44) 66.7% (n = 40) 10%(n=6) 31.7% (n = 19) 5% (n = 3) 
53% (n = 60) 
African American Men Only 100% (n = 8) 75% (n = 6) 12.5% (n = 1) 12.5%(n= 1) 0% (n = 0) 
7% (n = 8) 
Men of "Other" Descent 75% (n = 6) 50% (n =4) 12.5% (n = 1) 37.5% (n = 3) 0% (n = 0) 
7% (n = 8) 
Table 6 (Continued 5) 
Demographics 
Comorbidity Comorbidity Comorbidity Comorbidity Comorbidity 
Kidney Disease Liver Disease Anemia or other Cancer Depression 
Blood Disease 
All Participants 9.7%(n=11) 1.8% (n = 2) 2.7% (n = 3) 7.1%(n=8) 14.2% (n = 16) 
(N= 113) 
All Women 13.5% (n = 5) 0% (n = 0) 8.1% (n = 3) 8.1%(n=3) 13.5% (n = 5) 
33% (n = 37) 
All Men 7.9% (n = 6) 2.6% (n = 2) 0% (n = 0) 6.6% (n = 5) 14.5% (n = 11) 
67% (n = 76) 
0\ 
African American Women Only 0% (n = 0) \0 0% (n = 0) 25% (n = 1) 0% (n = 0) 25%(n= 1) 
4%(n=4) 
Caucasian Women Only 11.1%(n=3) 0% (n = 0) 0% (n = 0) 11.1%(n=3) 11.1%(n=3) 
24% (n = 27) 
Women of"Other" Descent 33.3% (n = 2) 0% (n = 0) 33.3% (n = 2) 0% (n = 0) 16.7% (n = 1) 
5% (n = 6) 
Caucasian Men Only 8.3% (n = 5) 3.3% (n = 2) 0% (n = 0) 6.7% (n = 4) 16.7% (n = 10) 
53% (n = 60) 
African American Men Only 12.5% (n = 1) 0% (n = 0) 0% (n = 0) 12.5% (n = 1) 12.5% (n = 1) 
7% (n = 8) 
Men of "Other" Descent 0% (n = 0) 0% (n = 0) 0% (n = 0) 0% (n = 0) 0% (n = 0) 
7% (n = 8) 
Table 6 (Continued 6) 
Demographics 
Comorbidity Comorbidity Comorbidity Comorbidity Comorbidity 
Osteoarthritis Back Pain Rheumatoid Thyroid Disease Obesity 
Arthritis 
All Participants 22.1% (n = 25) 28.3% (n = 32) 12.4% (n = 14) 9.7% (n = 11) 18.6% (n = 21) 
(N= 113) 
All Women 32.4% (n = 12) 35.1%(n=l3) 16.2% (n = 6) 16.2% (n = 6) 16.2% (n = 6) 
33% (n = 37) 
All Men 17.1% (n = 13) 25% (n = 19) 10.5% (n = 8) 6.6% (n = 5) 19.7%(n= 15) 
67% (n = 76) 
-.....) 
African American Women Only 0% (n = 0) 0 25% (n = 1) 25% (n = 1) 0% (n = 0) 0% (n = 0) 
4%(n=4) 
Caucasian Women Only 33.3% (n = 9) 40.7% (n = 11) 11.1%(n=3) 18.5% (n = 5) 14.8% (n = 4) 
24% (n = 27) 
Women of "Other" Descent 50%(n=3) 16.7% (n = 1) 33.3% (n = 2) 16.7% (n = 1) 33.3% (n = 2) 
5% (n =6) 
Caucasian Men Only 20% (n = 12) 25% (n = 15) 6.7% (n = 4) 8.3% (n = 5) 23.3% (n = 14) 
53% (n = 60) 
African American Men Only 0% (n = 0) 25% (n = 2) 25% (n = 2) 0% (n = 0) 0% (n = 0) 
7% (n = 8) 
Men of "Other" Descent 12.5% (n = 1) 25% (n = 2) 25% (n = 2) 0% (n = 0) 12.5% (n = 1) 
7% (n = 8) 
Table 6 (Continued 7) 
Demographics 
Comorbidity Comorbidity Comorbidity Total Number Participants Participants 
Autoimmune Sleep Apnea "Other" of with One with Two 
Disease Comorbidities Comorbidity Comorbidities 
All Participants 0% (n = 0) 13.3% (n = 15) 3.5% (n = 4) M (SD) = 3.35 14.2% (n = 16) 25.7% (n = 29) 
(N= 113) ( 1.86) 
All Women 0% (n = 0) 13 .5% (n = 5) 0% (n = 0) M(SD) = 3.76 8.1% (n = 3) 27% (n = 10) 
33% (n = 37) (1.86) 
All Men 0% (n = 0) 13.2% (n = 10) 5.3% (n = 4) M(SD) = 3.16 17.1%(n=13) 25% (n = 19) 
67% (n = 76) (1.83) 
-....} 
African American Women Only 
-
0% (n = 0) 25% (n = 1) 0% (n = 0) M(SD) = 3.25 25% (n = 1) 25% (n = 1) 
4% (n =4) (2 .06) 
Caucasian Women Only 0% (n = 0) 7.4% (n = 2) 0% (n = 0) M(SD) = 3.63 7.4% (n = 2) 33.3% (n = 9) 
24% (n = 27) (1.86) 
Women of"Other" Descent 0% (n = 0) 33.3% (n =2) 0% (n = 0) M(SD) = 4.67 0% (n = 0) 0% (n = 0) 
5% (n = 6) (1.75) 
Caucasian Men Only 0% (n = 0) 13.3% (n = 8) 5% (n = 3) M(SD) = 3.23 18.3% (n = 11) 23.3% (n = 14) 
53% (n = 60) (1.96) 
African American Men Only 0% (n = 0) 0% (n = 0) 12.5% (n = I) M(SD) = 3 0% (n = 0) 37.5% (n = 3) 
7% (n = 8) (1.07) 
Men of "Other" Descent 0% (n = 0) 25% (n = 2) 0% (n = 0) M(SD) = 2.75 25% (n = 2) 25% (n = 2) 
7% (n = 8) ( 1.49) 
Table 6 (Continued 8) 
Demographics 
Participants with Participants with Participants with Participants with Participants with 
Three Four Five Six Seven 
Comorbidities Comorbidities Comorbidities Comorbidities Comorbidities 
All Participants 18.6% (n = 21) 17.7% (n = 20) 13.3% (n = 15) 2.7% (n = 3) 3.5% (n = 4) 
(N= 113) 
All Women 10.8% (n = 4) 16.2% (n = 6) 24.3% (n = 9) 2.7% (n = 1) 8.1%(n=3) 
33% (n ~ 37) 
All Men 22.4% (n = 17) 18.4% (n = 14) 7.9% (n = 6) 2.6% (n = 2) 1.3% (n = 1) 
67% (n = 76) 
-.....) 
African American Women Only 0% (n = 0) 0% (n = 0) 50% (n = 2) 0% (n = 0) 0% (n = 0) N 
4% (n =4) 
Caucasian Women Only 11.1% (n = 3) 11.1% (n = 3) 22.2% (n = 6) 3.7% (n = 1) 11.1% (n = 3) 
24% (n = 27) 
Women of "Other" Descent 16.7% (n = 1) 50% (n = 3) 16.7% (n = 1) 0% (n = 0) 0% (n = 0) 
5% (n = 6) 
Caucasian Men Only 21.7% (n = 13) 18.3% (n = 11) 6.7% (n = 4) 3.3% (n = 2) 1.7% (n = 1) 
53% (n = 60) 
African American Men Only 37.5% (n = 3) 12.5% (n = 1) 12.5% (n = 1) 0% (n = 0) 0% (n = 0) 
7% (n = 8) 
Men of "Other" Descent 12.5% (n = 1) 25% (n = 2) 12.5% (n = 1) 0% (n = 0) 0% (n = 0) 
7% (n = 8) 
Table 6 (Continued 9) 
Demographics 
Participants with Participants with Participants with Participants with Participants not 
Eight Nine Ejection Fraction Ejection Fraction knowing their 
Comorbidities Comorbidities >40% Equal or <40% Ejection Fraction 
All Participants 3.5% (n = 4) .9% (n = 1) 14.2% (n = 16) 10.6% (n = 12) 75.2% (n = 85) 
(N= 113) 
All Women 2.7% (n = 1) 0% (n = 0) 8.1%(n=3) 10.8% (n = 4) 81.1% (n = 30) 
33% (n = 37) 
All Men 3.9% (n = 3) 1.3% (n = 1) 17.1%(n=13) 10.5% (n = 8) 72.4% (n = 55) 
67% (n = 76) 
-....l 
African American Women Only 0% (n = 0) w 0% (n = 0) 0% (n = 0) 25% (n = 1) 75%(n=3) 
4%(n=4) 
Caucasian Women Only 0% (n = 0) 0% (n = 0) 7.4% (n = 2) 11.1% (n = 3) 81.5% (n = 22) 
24% (n = 27) 
Women of"Other" Descent 16.7% (n = 1) 0% (n = 0) 16.7% (n = 1) 0% (n = 0) 83.3% (n = 5) 
5% (n = 6) 
Caucasian Men Only 5% (n = 3) 1.7% (n = 1) 20% (n = 12) 8.3% (n = 5) 71.7% (n = 43) 
53% (n = 60) 
African American Men Only 0% (n = 0) 0% (n = 0) 12.5% (n = 1) 37.5% (n = 3) 50%(n=4) 
7% (n = 8) 
Men of "Other" Descent 0% (n = 0) 0% (n = 0) 0% (n = 0) 0% (n = 0) 100% (n = 8) 
7% (n = 8) 
Table 7 
Symptom That Prompted You 
to Go to Hospital 
Swelling Shortness of Fatigue Defibrillator Chest Pain Other 
Breath (Tiredness) Responded 
All Participants 12.4% (n = 14) 32.7% (n = 37) 18.6% (n = 21) .9% (n = 1) 25.7% (n = 29) 48.7% (n =55) 
(N= 113) 
All Women 21.6% (n = 8) 35.1% (n = 13) 18.9% (n = 7) 0% (n = 0) 21.6% (n = 8) 56.8% (n = 21) 
33% (n = 37) 
All Men 7.9% (n = 6) 31 .6% (n = 24) 18.4% (n = 14) 1.3% (n = 1) 27 .6% (n = 21) 44.7% (n = 34) 
67% (n = 76) 
-....J 
African American Women 25% (n = 1) 75% (n = 3) ~ 0% (n = 0) 0% (n = 0) 50% (n = 2) 25% (n = 1) 
Only 4% (n =4) 
Caucasian Women Only 18.5% (n = 5) 29.6% (n = 8) 18.5% (n = 5) 0% (n = 0) 22.2% (n = 6) 63% (n = 17) 
24% (n = 27) 
Women of"Other" Descent 33.3% (n = 2) 33.3% (n = 2) 33.3% (n = 2) 0% (n = 0) 0% (n = 0) 50% (n = 3) 
5% (n = 6) 
Caucasian Men Only 5% (n = 3) 28.3% (n = 17) 20% (n = 12) 1.7% (n = 1) 23.3% (n = 14) 50% (n = 30) 
53% (n = 60) 
African American Men Only 37.5% (n = 3) 50%(n=4) 25% (n = 2) 0% (n = 0) 25% (n = 2) 37.5% (n = 3) 
7% (n = 8) 
Men of "Other" Descent 0% (n = 0) 37.5% (n = 3) 0% (n = 0) 0% (n = 0) 62.5% (n = 5) 12.5%(n= 1) 
7% (n = 8) 
CHF Classifications 
Ejection fraction is the amount of blood that is ejected from each ventricle 
contraction and is the index of the left ventricular function. The normal percentage is 
65% (Mosby's Medical, Nursing, & Allied Health Dictionary, 1994). The New York 
Heart Association's (NYHA) Functional Classification is a classification which allows 
individuals to categorize their functional status while living with heart failure. Typically, 
as the heart begins to decline in function, the individual will start declining in functional 
status. Health care providers recorded each participant's EF percent (Table 8). The 
overall mean EF% was 45.82 (SD = 14.53). Of those scores, African American women 
had the highest mean EF% ( 54.25, SD = 21.45), while African American men had the 
lowest mean percentage (38, SD = 13.95). 
The NYHA was recorded by each participant and the participant's health care 
provider (Table 8). Participants' response ratings were as follows : classification of 1 was 
26.5%, classification of 2 was 53 .1 %, classification of3 was 16.8%, and a classification 
of 4 was 3.5%. African American women had the highest NYHA mean score of2.25 (SD 
= 1.26), with women of "other" descent having the lowest mean score (1.33, SD = .82). 
Health care providers also scored the participant's NYHA classification. The 
overall mean score was 2.43 (SD = .63). African American women, women of "other" 
descent and Caucasian men had the highest mean scores, 2.50. Men of"other" descent 
, 
had the lowest mean score, 2.13 (SD = .35) (Table 8). 
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Table 8 
NYHA Classifications and Ejection 
Fraction Summary 
Participant's Provider' s Participant's 
NYHAs Class NYHAs Class Ejection Fraction 
All Participants M (SD): 1.96 (.78) M (SD) : 2.43 M (SD): 45 .82 
(N= 113) (.63) (14.53) 
All Women M (SD): 1.89 (.77) M (SD): 2.43 M (SD): 48.16 
33% (n = 37) (.56) (14.48) 
All Men M (SD): 1.99 (.79) M (SD): 2.43 M (SD): 44.68 
67% (n = 76) (.66) (14.51) 
African American Women Only M (SD): 2.25 M (SD): 2.50 (1) M (SD): 54.25 
-.....) 4% (n =4) (1.26) (21.45) 
0\ 
Caucasian Women Only M (SD): 1.96 (.65) M (SD): 2.41 M (SD): 46.44 
24% (n = 27) (.50) (14.15) 
Women of"Other" Descent M (SD) : 1.33 (.82) M (SD): 2.50 M (SD) : 51.83 
5% (n = 6) (.55) (11.48) 
Caucasian Men Only M (SD): 1.97 (.76) M (SD): 2.50 M (SD): 44.54 
53% (n = 60) (.65) (14.78) 
African American Men Only M (SD): 2.13 (.84) M (SD): 2.25 M (SD): 38.00 
7% (n = 8) (.89) (13 .95) 
Men of "Other" Descent M (SD): 2.00 M (SD): 2.13 M (SD): 52.38 
7% (n = 8) (1.07) (.35) (10.07) 
Health status and HRQOL have been reported to be important indicators for 
health outcomes in patients with congestive heart failure (Mejhert, Kahan, Persson, & 
Edner, 2006; Rodriquez-Artalejo et al., 2005). Health status was measured by the SF-
36v2, a valid and reliable 36-item instrument used to measure physical and mental health 
status. (See Table 9 for sample summary.) Physical and mental health summary scores 
are viewed as separate components, thus the total scores for each are not combined. The 
SF-36v2 also yields an 8 subscale profile of scores. The SF-36v2 items and scales are 
scored so that a higher score indicates better health status. 
The physical and mental component scores (PCS and MCS) were obtained from 
the SF36-v2 questionnaire. The overall PCS mean score, of a possible score, for all 
participants was 37.83 (SD = 11.24); and the overall MCS mean score, of a possible score, 
for all participants was 50.46 (SD = 12.62). Examination of the gender and 
ethnicity/racial groups demonstrated that the highest mean PCS score occurred for men of 
"Other" descent (39.77, SD = 14.96). The lowest mean PCS score was for African 
American women (31.2, SD = 9.13). Men of"Other" descent also had the highest MCS 
mean score (56.80, SD = 9.95); African American men had the lowest mean score (47.05, 
SD = 13.09). 
The Minnesota Living with Congestive Heart Failure Questionnaire (MLHFQ) 
was used to measure health-related quality of life (HRQOL). The MLHFQ is a quality-of-
life instrument with reported validity and reliability specifically for heart failure patients. 
This questionnaire consists of21 questions with a 6-point Likert-type response scale 
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where 0 equals no, 1 equals very little, and 5 equals very much. Scores ranged from 0 to 
105, with the lower score reflecting a better QOL. However, for this study, the scale was 
reversed to be consistent with the SF-36v2, the higher the score the better the QOL. 
When the scores were reversed, the overall mean score of the MLHFQ was 38.73 (SD = 
15.15). African American men had the highest mean score (45.38, SD = 16.09). The 
lowest score was seen for men of"Other" descent (35.38, SD = 13.59) (Table 3). 
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Table 9 
Health Status and HRQOL Scores 
PCS MCS MLHFQ 
All Participants M (SD): 37.83 M (SD): 50.46 M (SD): 38 .73 
(N= 113) (11.24) (12.62) (15 .15) 
All Women M (SD): 34.50 M (SD): 50.89 M (SD): 37.91 
33% (n = 37) (9.89) ( 11.26) (14.08) 
-
All Men M (SD): 39.45 M (SD): 50.26 M (SD): 39.13 
67% (n = 76) (11.56) (13 .29) (15.72) 
African American Women Only M (SD): 31.2 M (SD): 48.83 M (SD): 39.25 
-....) 4% (n =4) (9.13) ( 16.65) (21.85) 
\0 
Caucasian Women Only M (SD): 34.30 M (SD): 51.96 M (SD): 38.25 
24% (n = 27) (10.36) (9.85) (10.09) 
Women of"Other" Descent M (SD): 37.61 M (SD): 47.44 M (SD): 35 .50 
5% (n = 6) (8.68) (14.78) (24.55) 
Caucasian Men Only M (SD): 39.72 M (SD): 49.81 M (SD): 38.80 
53% (n = 60) (11.12) (13 .61) (15 .95) 
African American Men Only M (SD): 37 .10 M (SD): 47.05 M (SD): 45 .38 
7% (n = 8) (12.59) (13.09) (16.09) 
Men of "Other" Descent M (SD): 39.77 M (SD): 56.80 M (SD): 35.38 
7% (n = 8) (14.96) (9 .95) (13.59) 
Data Analysis 
The data analysis related to each of the five research questions (see page 59) is 
discussed in this section. Prior to statistical analysis directly related to the research 
questions, the data were screened for missing data, outliers, and assumptions of the 
statistical tests used. These are discussed prior to the presentation of findings. The 
statistical analyses used to answer the questions were multivariate analysis of variance 
(MANOVA), analysis of variance (ANOVA), and hierarchical multiple regression. 
Additionally, a variety of parametric and nonparametric tests were used to examine 
sample demographics. 
Examination of Data 
Prior to the data analyses, the assumptions of the statistical tests were examined. 
Additionally, all variables were screened for accuracy of data entry and missing values. 
Errors found due to data entry were corrected. 
Missing data. Missing data issues and decisions concerning those issues were 
made a priori. In cases where the item was independent of others (i.e., not part of a scale), 
mean substitution was used if not more than 10 cases were missing. The researcher was 
on site and available when the instruments were completed, and a brief check of 
completed instruments was conducted; however, there were still some items not answered. 
On the General Information Form (GIF), one participant did not rate perceived 
symptom management. This question was independent from all others; therefore the 
simple group mean imputation was used (Mertler & Vannatta, 2002). 
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An additional question on the MLHFQ was part of the total scale score how , ever, 
it was not part of a subscale. This question that asked about money for medical care was 
left blank by 3 participants, more than occurred for any other question on any of the 
instruments. Simple mean imputatation was not performed for this item due to its 
individual nature (Fayers, Curran, & Machin, 1998). There was one participant who 
omitted a question concerning side effects from treatment. Again, a simple mean 
imputation was not appropriate for this item. The only other question missed with more 
frequency than one per group, was the missed question of loss of self-control (n = 2). 
Because this question belonged to a sub scale of the emotional dimension score, simple 
mean imputation was performed. For the 4 participants who did not have total MLHFQ 
scores, the simple group mean was used for their score (Mertler & Vannatta, 2002). 
Three participants did not answer 8 questions on the SF36v2; the occurrence of 
this missing data was apparently either random, based on individual decisions not to 
answer, or because they were simply overlooked. Mean imputation was used with 2 of 
the participants ' questions. For the third, who answered only I of the 5 subscale questions, 
the group mean for the subscale score was input (Mertler & Vannatta, 2002). Overall, 
less than 2% of all items were missing. 
Outliers. Evaluation of the data for outliers was comprehensive. Variables were 
screened for outliers using frequency distributions, box-plots, and histograms. The 
instruments were evaluated for univariate outliers by visual examination of q-q plots, and 
box plots. Participants' data were not normally distributed on some demographic 
variables (i.e., perceived symptom management, total number of comorbidities, 
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household income and house value). Age, total number of comorbidities, perceived 
general health status, perceived symptom management, household income and house 
value had outliers; however, the ratings and numbers were believed not to be in error. 
The PCS had no outliers; however, the MCS (n= 1) and MLHFQ (n = 3) had only a few. 
These values are considered important to the population being studied and are vital to the 
finding of new knowledge (Burns & Grove, 2005). None of the participant scores, 
therefore, were removed. 
Normality. The assumption of normality was evaluated using both univariate and 
multivariate methods. Both, graphical and statistical methods were used. As previously 
discussed, the data appeared to be skewed due to outliers that were identified as 
individual differences and not errors in data collection or analysis. 
Pearson's Skewness Coefficient was used to assess symmetry or to see if the data 
were normally distributed. If data for a variable are asymmetrical, they are skewed 
(Munro, 2001 ). Pearson's Skewness Coefficient was calculated using a nonalgebraic 
formula: Skewness = (mean - median)ISD (Munro). This formula was used for all 
continuous variables in this study. The values fell between -1 and + 1 SD units, indicating 
that these distributions were not substantially skewed (See Table 10 for Pearson's 
Skewness Coefficients). 
Further analysis was conducted using Kolmogorov-Smimov (K-S) test to 
determine whether the distributions of selected variables were significantly different from 
normal distributions. Departure from normality is indicated if the computed value is 
significant (Field, 2005). Physical component score (PCS) and age were not significant 
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(Table 10 forK-S). However, the mental component score (MCS), Minnesota Living 
with Heart Failure Questionnaire (MLHFQ), total number of comorbidities, perceived 
general health status, and perceived symptom management were significant. The data 
appear to be skewed due to individual differences and not errors in data collection or 
analysis. Outliers were removed to see if it would make a difference in the K-S statistic; 
it did not. 
Skewness was examined using descriptive statistics. The results are listed in 
Table 10. For skewness, a value that did not fall between -1 or+ 1 would indicate a 
substantially skewed distribution (Munro, 2001). 
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Table 10 
Normality Data 
Pearson 's SPSS Skewness Kolmogorov-
Skewness Smirnov (p) 
Coefficient 
Physical Component Score (PCS) .173 .032 .098 
Mental Component Score (MCS) -.299 -.784 .000 
Minnesota Living With Heart .180 .689 .002 
Failure Questionnaire 
00 Perceived Symptom Management .090 -.694 .000 
~ 
Age -.05 -.265 .151 
Total Number of Comorbidities .189 .883 .000 
Perceived General Health Status 
-.192 .098 .000 
Homogeneity of variance. The assumption that there are equal variances among 
groups (i .e., homogeneity of variance) is a requirement of most statistical tests comparing 
means. Levene's test was used to test variances in the groups (Field, 2005). The results 
suggested equality of variance for each variable between groups (see Table 11), with the 
exception of living status which was significant,p = .027. 
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Table 11 
Levene's Test of Equality of Error 
Variances 
F dfl df2 p 
Age .073 1 111 .787 
Perceived general health status .771 1 111 .382 
Perceived symptom management .000 1 111 .999 
PCS 3.274 1 111 .073 
00 
0\ 
MCS 1.041 1 111 .310 
Total number of comorbidities .585 1 111 .446 
Living Status 4.999 1 111 .027 
Ethnicity/Race 
.419 1 111 .519 
MLHFQ 2.221 1 111 .139 
Data Analysis of Research Questions 
In this section, each statistical test that was used to answer the five research 
questions will be discussed. Tests that were used were MANOV A (Question I), 
independent t tests and chi-square as appropriate to the level of data (Question 2), 
hierarchical multiple regression analysis (Questions 3 and 4), and kappa statistic 
(Question 5). 
Findings Related to Multivariate Analysis of Variance 
One-way MANOVA was conducted to address the first research question: Are 
there differences in self-reported health status and HRQOL of men and women with a 
diagnosis of CHF? The dependent variables were two instruments that were used in the 
research study, the MLHFQ and the SF36v2 and the independent variable was gender. 
Missing data were replaced using group means. Pre-analysis data screening was 
conducted to make certain the assumptions of MANOV A testing were met. Tests of 
normality using skewness and Kolmogorov-Smimov statistic indicated that data were 
normally distributed {Table 1 0). Homogeneity of variance was assessed using Levene's 
Test. The results demonstrated equality of variance for each variable between groups 
(see Table I 1 ). Homogeneity of covariance was evaluated within MAN OVA by 
calculating Box's Test of Equality of Covariance Matrices. The Box's Test results using 
these specific variables reveals that equal variances can be assumed (Box's M = 5.833, F 
(6, 33673.562) = .938, p = .466. Wilks' Lambda (A) was used as the multivariate test 
statistic (Table I 2). Based on the results of pre-analysis data screening, no transformation 
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was done to any of the dependent variables, nor was any case eliminated. A list of 
variables and the variable name of each as used in SPSS is provided in Table 13. 
Table 12 
Box's Test of Equality of Covariance Matrices 
Box'sM F 
5.833 .938 
Table 13 
SPSS Variables 
SPSS Variable Name 
PCS 
MCS 
MMLHFQTO 
AGE 
ETH MOD 
TOT COMO 
LIVEMOD 
Gender 
dfl 
6 
88 
df2 p 
33673.562 .466 
Variable Name 
Physical Component Score 
Mental Component Score 
Minnesota Living with Heart Failure 
Questionnaire Total Score 
Age 
Ethnicity/Race modified score 
Total number of Comorbidites 
Living status modified score 
Gender 
A one-way MANOV A was conducted to determine the effect of gender 
differences on health status (PCS and MCS) and health-related quality oflife 
(MMLHFQTO). Table 14 presents means and standard deviations for the three outcome 
measures. 
MANOVA results revealed no significant differences among gender categories on 
the dependent variables, Wilks' A= .082, F(3, 1 09.000) = 2.29, p = .082, multivariate IJ2 
= .059. Analysis of variance (ANOVA) was conducted on each dependent variable as a 
follow-up test to MANOV A. Gender category differences were significant for PCS, F (1, 
111) = 4.997,p = .027, partialiJ2= .043 . Differences in MCS and MMLHFQTO were not 
significant, F (1, 111) = .061,p = .805, partial 1)2 = .001 and F (1, 111) = .160,p = .690, 
partial IJ2 = .001 (Table 15 and 16). 
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Table 14 
Means and Standard Deviations for PCS, 
MCS, and MMLHFQTO 
95% CI 
Gender Mean SE Lower Bound Upper 
Bound 
PCS Female 34.498 1.815 30.901 38.096 
Male 39.447 1.267 36.937 41.957 
MCS Female 50.886 2.083 46.759 55.013 
\0 
0 
Male 50.257 1.453 47.377 53.136 
MMLHFQTO Female 37.913 2.500 32.958 42.867 
Male 39.133 1.745 35.676 42.590 
Table 15 
MANOVA Multivariate 
Table 
Effect Value F Hypothesis Effor (df) p Partial Eta 
(df) Squared 
Intercept Pillai's Trace .978 1646.567 3.000 109.000 .000 .978 
Wilk's Lambda .022 1646.567 3.000 109.000 .000 .978 
Hotelling's Trace 45 .318 1646.567 3.000 109.000 .000 .978 
Roy's Largest Root 45.318 1646.567 3.000 109.000 .000 .978 
\0 
-
·GENDER Pillai's Trace .059 2.294 3.000 109.000 .082 .059 
Wilk's Lambda .941 2.294 3.000 109.000 .082 .059 
Hotelling's Trace .063 2.294 3.000 109.000 .082 .059 
Roy's Largest Root .063 2.294 3.000 109.000 .082 .059 
Table 16 
MANOVA Univariate 
Test Results 
Source Dependent Type III Sum of Df Mean Square F p Partial 
Variable Squares 
Correcte Model PCS 609.333 1 609.333 4.997 .027 .043 
MCS 9.857 1 9.857 .06I .805 .OOI 
MMLHFQTO 37.074 I 37.074 .I60 .690 .OOI 
Intercept PCS 136067.857 1 136067.857 1115.868 .000 .910 
\0 
N 
MCS 254571.063 1 254571 .063 1586.294 .000 .935 
MMLHFQTO 147719.2IO 1 147719.2 10 638.583 .000 .852 
GENDER PCS 609.333 1 609.333 4.997 .027 .043 
MCS 9.857 1 9.857 .061 .805 .001 
MMLHFQTO 37.074 I 37.074 .I60 .690 .001 
Independent Samples t-tests 
Independent-samples t tests and chi square were used to evaluate the variables of 
Question 2: Are there differences in specified variables (i.e., age, race/ethnicity, living 
status, number of comorbidities, perceived general health status, and perceived symptom 
management) of men and women with a diagnosis of CHF? 
Independent-samples t tests were conducted to evaluate whether there were 
differences in age, number of comorbidities, perceived general health status, and 
perceived symptom management of men and women with heart failure. Levene's test was 
not significant for age (p = . 787), total number of comorbidities (p = .446), perceived 
general health status (p = .382), perceived symptom management (p = .999); therefore, 
the assumption of equality of variance was met. The independent-samples t tests were not 
significant for age, t (Ill)= 1.756,p = .082, for total number of comorbidities, t (111) = 
1.621, p = .1 08, for perceived general health status, t (111) = 1.188,p = .237, and for 
perceived symptom management, t (111) = -.947,p = .346. Though not a significant 
difference in age, females (M=71.19, SD = 12.092) had a higher mean age than males (M 
= 67.05, SD = 11.583) (Tables 17 and 18). 
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Table 17 
Gender Specific Mean, Standard Deviation and Standard Error for Certain Variables 
Gender N M SD Std. Error 
M 
Age Female 37 71.19 12.092 1.988 
Male 76 67.05 11.583 1.329 
Total Number Female 37 3.76 1.862 .306 
of 
Comorbidities 
Male 76 3.16 1.833 .210 
Perceived Female 37 2.97 .928 .152 
General 
Health Status 
Male 76 2.75 .940 .108 
Perceived Female 37 6.92 2.373 .390 
Symptom 
Management 
Male 76 7.34 2.157 .247 
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1.0 
VI 
Table 18 
Independent Samples t Test 
Results 
Age Equal variances assumed 
Equal variances not 
assumed 
Total Number of Comorbidities 
Equal variances assumed 
Equal variances not assumed 
Perceived general health status 
Equal variances assumed 
Equal variances not assumed 
Levene's Test for 
Equality of 
Variance 
F 
0.73 
.585 
.771 
!-test for 
p t 
.787 1.756 
1.730 
.446 1.621 
1.612 
.382 1.188 
1.194 
Equality of 
Means 
df 
lll 
68 .760 
111 
70.470 
111 
72.311 
p (2-tailed) 
.082 
.088 
.108 
.111 
.237 
.236 
Table 18 (Continued) 
Independent Samples Test Results 
t-test for Equality of 
Means 
95% Confidence Interval 
of the Difference 
Mean Difference Std. Error Lower Upper 
Difference 
Age Equal variances assumed 4.14 2.355 -.531 8.804 
1.0 
0\ 
Equal variances not 4.14 2.391 -.634 8.907 
assumed 
Total Number of Comorbidities 
Equal variances assumed .60 .369 -.133 1.331 
Equal variances not assumed .60 .371 -.142 1.339 
Perceived general health status .188 -.149 .595 
Equal variances assumed .22 
Equal variances not assumed .22 .187 -.149 .595 
1.0 
-....) 
Table 18 (Continued 2) 
Independent Samples t Test 
Results 
Perceived symptom management 
Equal variances assumed 
Equal variances not assumed 
Levene's Test for 
Equality of 
Variance 
F 
.000 
p 
.999 
t-test for 
-.947 
-.916 
Equality of 
Means 
df 
111 
65.693 
p (2-tai1ed) 
.346 
.363 
Table 18 (Continued 3) 
Independent Samples Test Results 
t-test for Equality of 
Means 
95% Confidence Interval 
of the Difference 
Mean Difference Std. Error Lower Upper 
Difference 
Perceived symptom management -1.309 .463 
\0 Equal variances assumed -.42 .447 
00 
Equal variances not assumed -.42 .462 -1 .346 .499 
Chi Square Test Results for Research Question 2 
A two-way contingency table analysis was conducted to evaluate whether there 
was a difference in gender and living status in men and women with a diagnosis of CHF. 
The two variables were (a) gender with two levels (female and male) and (b) living status 
(living alone or living with someone). Gender and living status were found to be 
independent, X 2 (1, N = 113) = 1.331, p = .249. 
A second contingency table analysis was conducted to evaluate whether there was 
a significant difference in gender and ethnicity/race groups. The two variables were (a) 
gender with two levels (female and male) and (b) ethnicity/race groups with three levels 
(white (Caucasian), black (African-American), and other). Gender and race/ethnicity 
were found to be independent of each other, x 2 (2, N = 113) = . 7 68, p = .681. 
Hierarchical Multiple Regression Test Results for Research Question 3 
Hierarchical multiple regression analysis was utilized to answer both Research 
Questions 3 and 4. The assumptions for multiple regression are applicable to both 
questions. Following discussion of the testing of these assumptions, the results of 
Question 3 will be presented. Research Question 4 will be discussed in the following 
section. 
Prior to performing this analysis, relationships of the independent variables with the 
dependent variable were tested using point biserial correlation and Pearson r to determine 
whether any demonstrated low or multicollinear relationships. Based on low correlations, 
gender, race/ethnicity, and living status were removed from the questions. Tabachnick 
and Fidell (1996) state that moderate violations oflinearity and homoscedasticity only 
99 
weaken the regression analysis. Research Question 3, revised, was: Are age, number of 
comorbidities, perceived general health status, perceived physical health status, perceived 
mental health and perceived symptom management significant predictors ofHRQOL? 
Hierarchical multiple regression was selected to allow the researcher to select the order in 
which each variable is entered into the analysis. The regression analysis was performed 
with HRQOL as the dependent variable (DV) and the six researcher-selected predictors 
as independent variables (IV). The six predictors included age, number of comorbidities, 
perceived general health status, perceived physical health status, perceived mental health 
status and perceived symptom management. 
The study's conceptual framework, Wilson and Cleary's (1995) health-related quality 
of life conceptual model provided the foundation for testing. Research Questions 3 and 4 
examine the relationships among overall quality oflife and other constructs as depicted in 
the Model (see Figure 1, p. 6). A review of the literature provided the basis for model 
testing. The research questions were tested using sequential multiple regression 
(Hierarchical multiple regression or Blockwise Entry). This approach, using the 
technique of multiple regression, examines theoretically predicted relationships among 
constructs. In hierarchical multiple regression, the researcher enters known predictors 
into the model first based on their importance in predicting the outcome (Field, 2005). 
Mertler and Vannatta (2002) state that multiple regression analysis allows the researcher 
to examine the contribution of the model's variables to the prediction of the dependent 
variable. 
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Data were tested as part of the regression analysis to assess the adequacy of fit 
between the data and the assumptions of regression process. Multicollinearity was 
assessed by examining bivariate correlations. Criteria used to measure against were the 
tolerance statistic (:S.1) and the variance inflation factor (VIF) (> 1 0) (Mertler & Vannatta, 
2002). As shown in Table 19, preliminary collinearity regression showed that 
multicollinearity was not assumed, indicating that a strong relationship did not exist 
between two or more of the predictors in this regression model (Field, 2005). 
Linearity between IVs and the specific DV using the scatterplot matrix of IVs and 
specific DV at each model stage was assessed by the researcher. Multivariate normality 
and homoscedasticity (i.e., the variances of the residuals for the predictors variables are 
similar) were examined using residuals plots. The assumptions for conducting the 
regression analysis were partially met. 
Homoscedasticity 
Homoscedasticity was examined in the regression analysis using scatterplots. The 
scatterplots show the residuals that are plotted against the predicted value, which in this 
study was health-related quality of life (HRQOL). The scatterplot showed a violation of 
the assumption of homoscedasticity. The predicted values width was narrow at small 
predicted values for the dependent value and increased in width as the dependent values 
increased. This pattern demonstrated a lack of constant variance, or heteroscedasticity. 
According to Tabachnick and Fidell (1996), this moderate violation may weaken the 
regression analysis, however it does not invalidate the analysis. 
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Table 19 
Tests for Multicollinearity 
Independent variable Dependent variable Tolerance VIF 
Total number of comorbidities Perceived .997 1.003 
symptom 
management 
Age Perceived .997 1.003 
symptom 
management 
Perceived Symptom Management PCS 1.00 1.00 
-
Perceived Symptom Management 
0 
MCS 1.00 1.00 
N 
PCS Perceived General .978 1.023 
Health Status 
MCS Perceived General .978 1.023 
Health Status 
Perceived General Health Status MMLHFQTO 1.00 1.00 
Total Number of Comorbidities MMLHFQTO 1.00 1.00 
Age MMLHFQTO 1.00 1.00 
Hierarchical regression analysis was used to test the paths in the model with 
successive multiple regression equations calculated to estimate path coefficients. The DV 
was regressed onto the IVs at each stage of the model testing, which allowed them to be 
connected to the DV. The DVs in the model included, in order of staging: (a) Perceived 
symptom management, (b) Physical component score (PCS) and Mental component score 
(MCS), (c) Perceived general health status, and (d) Minnesota Living with Heart Failure 
Questionnaire total score (MMLHFQTO). The independent variables in the total model 
included: (a) age and total number of comorbidities at Stage 1, (b) Perceived symptom 
management at Stage 2, (c) PCS and MCS at Stage 3, and (d) Perceived general health 
status at Stage 4. The dependent variable (HRQOL) represented Stage 5. 
In the initial regression analysis, SPSS casewise diagnostics listed two cases that 
were seen as outliers with standardized residuals greater than -3.0. After a closer 
examination of each participant's individual scores and their effects on the overall 
regression, the decision was made to leave these cases in the analysis. 
Using hierarchial multiple regression, path coefficients were estimated by 
entering the predictors for each dependent variable in the model. Coefficients were 
estimated by simultaneous entry of predictors for each hypothesized DV in the model, 
and the standardized betas for each path are given in Figure 2. The results of each of the 
five regression equations in the model are also summarized in Table 20. Standardized 
Betas (p) are given for each path (Table 21 ). The amount of DV variance that can be 
explained by the combination of the IV s is expressed as the R 2 . 
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Table 20 
Summary of Hierarchical Multiple 
Regression Analysis for Predicting 
Variables (N=ll3) 
Predictor Variable(s) Dependent R R2 R2adj Std. Error 
Variable Estimate 
Stage 1 
Age and Total Number of Perceived .409 .167 .152 2.05 
Comorbidities Symptom 
Management 
Stage 2 
Perceived Symptom Management PCS .392 .153 .146 10.39 
-0 
~ 
MCS .488 .238 .231 11.06 
Stage 3 
MCS,PCS Perceived General .548 .301 .288 .791 
Health Status 
Stage 4 
Perceived General Health Status MMLHDQTO .192 .037 .028 14.94 
Stage 5 
Total Number of Comorbidities MMLHDQTO .149 .022 .013 15.05 
Age MMLHDQTO .205 .042 .034 14.9 
Table 20 (Continued) 
Summary of Hierarchical Multiple 
Regression Analysis for Predicting 
Variables (N=113) 
Predictor Variables Dependent R2chg Fchg Sig. dfi dh 
Variables 
Stage 1 
Age and Total Number of Perceived .167 11.030 .000 2 110 
Comorbidities Symptom 
Management 
Stage 2 
Perceived Symptom Management PCS .153 20.11 .000 1 111 
0 
\Jl 
MCS .238 34.68 .000 I 111 
Stage 3 
MCS,PCS Perceived General .301 23.65 .000 2 110 
Health Status 
Stage 4 
Perceived General Health Status MMLHDQTO .037 4.26 .041 1 Ill 
Stage 5 
Total Number of Comorbidities MMLHDQTO .022 2.51 .116 1 111 
Age MMLHDQTO .042 4.89 .029 1 111 
Table 21 
Coefficients for Hierarchical 
Multiple Regression Analysis 
(N=JJ3) 
Predictor Variable Dependent B SEB fJ t Sig. 
Variable 
Stage 1 
Total Number of Comorbidities Perceived -.397 .105 -.331 -3 .79 .000 
Age Symptom 4 .170E-02 .016 .222 2.55 .012 
Management 
Stage 2 
....... Perceived Symptom Management PCS 1.98 .440 .392 4.48 .000 0 
0\ 
MCS 2.76 .469 .488 5.89 .000 
Stage 3 
PCS Perceived General 3.34£-02 .007 -.400 4.97 .000 
MCS Health Status 2.38E-02 .006 -.320 3.97 .000 
Stage 4 
Perceived General Health Status MMLHDQTO -3.11 1.51 .192 -2.06 .041 
Table 21 (Continued) 
Coefficients for Hierarchical 
Multiple Regression Analysis 
Variables =113 
Predictor Variable Dependent B SEB fJ t Sig. 
Variable 
Stage 5 
Total Number of Comorbidities MMLHDQTO 1.21 .766 .149 1.583 .116 
Age MMLHDQTO -.263 .119 -.205 -2.21 .029 
...... 
0 
-....l 
-0 
00 
Stage I 
Demographics 
Significance at the 
•• Significance at the 
Stage 2 
Symptom Management 
p = .05 level 
p = < .001 level 
R2 ~ .15 
Perceived Symptom 
Management 
-.205' 
.149 
Stage 3 
Functional Status 
R 2 ~ . 146 
R 2 ~ .231 
Mental Component 
Score 
Stage 4 
General Health Status 
-.400 '' 
-.320•• 
R2 = .288 
Perceived 
General 
Health Status 
.192' 
Figure 2. Conceptual model of predictors to health-related quality of life with empirical findings. 
Stage 5 
Health Related Quality 
of Life 
R2 =.028 
According to Mertler and Vannatta {2002), path analysis is a technique that is 
used under the broad heading of causal modeling. Path analysis is used to examine the 
relationships between a set of independent variables and a dependent variable (Munro, 
2001). Simple regression techniques are the bases of the path analysis. However, path 
analysis allows the researcher to examine these relationships a step further than the 
traditional use of multiple regression. Path models are considered a type of "causal 
model" (Munro, 2001). Figure 2 illustrates the path model for this research study. It 
demonstrates the theorized, directional relationships among this set of variables. Prior 
knowledge and theories are the underpinnings for the connection among the variables in 
the model, not statistical techniques (Polit, 1996). The independent variables {IV) may 
have a direct or indirect effect on the dependent variable (DV), depending on the 
hypothesized path. Regression analysis is used for the analysis of path models and each 
dependent variable is, in tum, regressed on the variables affecting it. 
The sum of the direct and indirect effects is the total effect (Pedhazur & 
Schmeklin, 1991 ). Path analysis provides information pertaining to the consistency 
between the data and the theorized path model. This is accomplished by analyzing all the 
paths. However, if the data do not fit the theorized relationships in the model, this may 
warrant a revision in the model (Munro, 2001). According to Mertler and Vannatta 
(2002), path analysis is an extension of multiple regression; therefore, the assumptions 
that were discussed previously in this chapter for multiple regression are also appropriate 
here. 
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Path analysis was conducted to examine the hypothesized paths in the model with 
successive multiple regression equations calculated to estimate path coefficients. During 
each stage of the model testing the DV was regressed onto the IVs that were linked to the 
DV. The DVs in the model included (a) Health related quality of life (MMLHDQTO); (b) 
Perceived general health status (PGHS); (c) Health status (i.e. physical component score 
(PCS) and mental component score (MCS); and (d) Perceived symptom management 
(PSM). Independent variables in the model included: (a) PGHS; (b) Health status (i .e. 
PCS and MCS); (c) PSM; (d) Age; and (e) Total number of co-morbidities. 
The results of each of the five regression equations, and seven paths in the model 
are summarized in Table 22. Listed in the table are the standardized Beta (/3) weights for 
each hypothesized path and the R2 revealing the amount of variance explained for each of 
the model's staged dependent variables. Figure 2 provides a visual depiction of the model, 
giving the standardized betas for all hypothesized paths. 
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Table 22 
Regression Analysis Calculated to Determine Path Coefficients in the Hypothesized 
Model 
Outcome Variable R- Predictor Variables fJ p 
Health Related .028 Perceived General .192* .041 
Quality of Life Health Status (PGHS) 
(MMLHDQTO) 
PGHS .288 Physical Component -.400* .000 
Score (PCS) 
Mental Component -.320** 
Score (MCS) 
PCS .146 Perceived Symptom .392** .000 
MCS Management (PSM) 
.231 .488** .000 
PSM .152 Age .222* .000 
Total Number of Co- -.331 ** 
Morbidities 
MMLHDQTO .034 Age -.205* .029 
.013 Total Number of Co- .149 .116 
Morbidities 
* Significant at the p = .05 level 
** Significant at the p = < .001 level 
Ill 
Regression results, based on the patli analysis, indicate an overall model of six variables 
(i.e., age, number of comorbidities, perceived symptom management, PCS, MCS and 
perceived general health status) that directly and indirectly influence HRQOL. Age and 
number of comorbidities are projected to have both direct and indirect paths to HRQOL, 
and their direct influence only accounted for approximately 2% of the variance in the 
dependent variable. The number of comorbidities was not in the predicted direction and 
was not a significant predictor ofHRQOL. Age (/J = -.205, p = .029) was a weak 
predictor. All other model variables were significant and, all but three were in the 
direction predicted (see Figure 2, p. 1 08). The Standardized Betas for the indirect paths 
from PGHS, PCS, MCS, PSM, age, and number of comorbidities were .192, 
-.400, -.320, .392, .488, .222, and -.331 respectively. PGHS, the persons perceived health 
status showed only a slight influence (/J = .192) on HRQOL. 
Research Question 3 was supported by the all of the tested paths in the model, 
except the direct path from comorbidities to HRQOL. Though the computed Beta was 
significant for PGHS, this relationship was weak. 
Research Question 4 
Research Question 4, revised, was: Do symptom status (i.e., perceived symptom 
management), functional status (i.e., perceived physical health status and perceived 
mental health status), and general health perceptions (i.e., perceived general health status) 
serve as mediating variables between the exogenous variables (i.e., age and comorbidities) 
and overall quality of life. To determine whether the variables at Stages 2, 3, and 4 of the 
model served as mediators between the exogenous variables of age and comorbidities and 
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the dependent variable of HRQOL, the indirect paths were computed to determine 
whether their placement in the model increased the total effect. Table 23 shows the direct 
and indirect paths, along with the total effect of age and comorbidities. The total effect 
for age and comorbidities increases, but the increase for comorbidity is slight. 
Explanation of computation for age was: (.222) (.392) ( -.400) (.192) + (.222) (.488) ( _ 
.320) (.192) = -.006683 + -.006656 = -.013. Computation for comorbidities was: (-.331) 
(.392) (-.400) (.192) + (-.331) (.488) (-.320) (.192) = .009964 + .009924 = .0199 = .020. 
Table 23 
Direct and Indirect Paths 
Exogenous Variable Direct + Indirect Total Effect 
Age -.205 + -.013 -.218 
Comorbidities .149 + .020 .169 
Research Question 5 
The kappa statistic was used to evaluate Research Question 5: Is there agreement of 
the New York Heart Association's (NYHA) Functional Class ratings made by the 
participant and his/her health care provider? The agreement between the health care 
provider's scoring of the New York Heart Association's classification and the 
participant's scores of the same classification were examined. The Kappa statistic was 
computed using the following formula: K = Po- Pc/1- Pc = .44 - .3 7/1-.3 7 = .11. 
Observer agreement (Po) was found by 1 + 35 + 12 + 2 I 113 = .44. Chance agreement 
(Pc) was found by (3)(30)/1132 + (63) (60)/ 1132 + (42)(19)/113 2 + (5)(4)/ 1132 = .37 
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(Fleiss, 1971; Pett, 1997). The percentage of interobserver agreement was 44% and the 
proportion of chance agreement was 3 7%. A kappa coefficient and obtained value of .11, 
p = .018, shows a poor agreement between patients and providers, using the criteria of 
Fleiss (1971). The significance of .018 rejects the null hypothesis that kappa~ 0. The 
agreements were beyond chance level. 
Summary 
This chapter has presented the study results using an exploratory cross-sectional 
design which examined groups of participants at a certain moment in time (Po lit & Be~k, 
2003). The results per MANCOV A indicate statistical significance in total number of 
comorbidities with respect to health status and HRQOL. Specifically, it was found that 
the total number of comorbidities was significant for PCS and not MCS. 
The results from the independent samples t tests, ANOV A, and chi-square 
indicated that there was not a statistically significant difference in gender on specified 
variables (i .e., age, race/ethnicity, living status, number of comorbidities, perceived 
general health status, and perceived symptom management) in a sample of patients with a 
diagnosis of CHF. Gender, therefore, was removed from further model testing when 
looking at HRQOL. 
Regression results, using a path analysis approach, indicated an overall model of six 
predictors (i.e., perceived symptom management, health status (PCS and MCS), 
perceived general health status, age, and total number of comorbidities) that directly and 
indirectly influence HRQOL. Age, but not comorbidities, was found to be a significant 
exogenous variable in the model with a direct causal link to HRQOL. Perceived general 
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health status, physical health status, mental health status, and perceived symptom 
management were found to mediate HRQOL. Symptom status (i.e., perceived symptom 
management), functional status (i.e., perceived physical health status and perceived 
mental health status), and general health perceptions (i.e., perceived general health status) 
served as mediating variables between the exogenous variable of age and health-related 
quality oflife in persons with CHF. Findings related to the placement of the number of 
comorbidities in the model were unclear. 
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CHAPTERV 
DISCUSSION OF FINDINGS 
In order to help adults improve their quality oflife (QOL) while living with 
congestive heart failure (CHF), it is important for health care providers to learn more 
about differences between the genders, as well as factors that may contribute to their 
QOL. Quality of life is used as a key indicator ofthe effectiveness of medical treatment 
in adults diagnosed with CHF. A primary goal of Healthy People 2010 is improving 
people's QOL and overall well-being (U. S. Department of Health and Human Services 
[DHHS], 2000). 
This chapter discusses the interpretation and significance of the results presented 
in the previous chapter. A summary of the study will be discussed. Discussion of the 
sample characteristics and findings from the research questions follow. Conclusions and 
implications is the next section. Recommendations for future study are then presented. 
Summary of the Study 
The purpose of this study was to examine the health status and health-related 
quality of life (HRQOL) of men and women with a diagnosis of CHF. The specific aims 
for the study, as initially identified, were to determine whether (a) there were differences 
in self-reported health status and HRQOL of men and women with CHF, (b) the variables 
of age, race/ethnicity, living status, number of comorbidities, perceived general health 
status, and perceived symptom management differ by gender, and (c) gender, age, race, 
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number of comorbidities, living status, perceived general health status, perceived 
symptom management, perceived physical health status, and perceived mental health 
status predict HRQOL. 
The research questions, modified slightly as the research and data analysis 
progressed, were as follows: 
Research Question 3: Are age, number of comorbidities, perceived general health 
status, perceived physical health status, perceived mental health and perceived symptom 
management significant predictors ofHRQOL? 
Research Question 4: Do symptom status (i.e., perceived symptom management), 
functional status (i.e., perceived physical health status and perceived mental health status), 
and general health perceptions (i.e., perceived general health status) serve as mediating 
variables between the exogenous variables (i.e., age and comorbidities) and overall 
quality of life. 
A cross-sectional exploratory research design was used to answer the specific 
research questions at a certain moment in time. A convenience sample included 113 men 
and women with a diagnosis ofCHF who were attending a cardiology clinic. Variables 
tested included gender, age, race/ethnicity, living status, number of comorbidities, 
perceived general health status, perceived symptom management, health related quality 
of life (HRQOL), and health status (physical and mental components). The study 
participants met the inclusion criteria for enrollment in the study. They attended a cardiac 
clinic, had documented CHF, and their ages ranged from 40 to 95 years of age. Data were 
collected with three paper-and-pencil measurements: the General Information Form (GIF) 
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developed for the study, the SF-36 Health Survey Version 2.0 (SF-36v2), and the 
Minnesota Living with Congestive Heart Failure (MLHFQ) As previously discusse<i in 
Chapter 3, these latter two questionnaires have demonstrated strong validity and 
reliability. 
Health status and HRQOL have been documented in the literature as important 
variables for individuals living with a chronic condition. Limited research related to these 
variables has been conducted with CHF patients, including whether there are gender 
differences. Also, little is known about the predictors of HRQOL for persons with CHF. 
Health status and HRQOL were evaluated using two different self-report 
instruments. The Minnesota Living with Heart Failure Questionnaire (MLHFQ) was used 
to measure HRQOL. The Medical Outcomes Study Health Survey, Version 2.0 (SF-36v2) 
measured health status. These measures were given to the participants at one point in 
time during a clinic visit. A general information form (GIF) was also given to the 
participants to gather demographics and evaluate perceived general health status, 
symptom management, ejection fraction, and New York Heart Association's 
classification. Also, the GIF included questions about comorbidities, certain medications, 
the time of the last hospitalization, and which symptoms prompted the patient to go to the 
hospital. 
The participants' responses obtained from all three questionnaires were placed in 
an SPSS data file . Participants' data on the outcome variables were evaluated against 
explicit research questions using multivariate analysis of variance (MANOVA), 
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independent t tests, chi square, hierarchical multiple regression analysis, and kappa 
statistic. 
Missing data were replaced using group means. Following recoding of the 
MLHFQ scores, data analyses were initiated. The average age of the participants was 
68.41 years. The majority of participants were male (n = 76), Caucasian (n = 87), lived 
with someone (n = 95), perceived their general health status to be "Good" or better (n = 
69) and had not been hospitalized within the last year (n = 69). The average total number 
of comorbidities was 3.35. The symptom most often prompting them to go to the hospital 
was shortness of breath (n = 37). 
The analyses for Research Question 1 revealed no significant differences among 
gender categories on the dependent variables measuring health status using the SF-36v2 
(physical component score {PCS} , mental component score {MCS}) and the health-
related quality of life (Minnesota Living with Congestive Heart Failure). 
For Research Question 2, independent-samples t tests were not significant for age, 
total number of comorbidities, perceived general health status, and perceived symptom 
management. Chi square test results revealed that gender and living status were 
independent, as were gender and race/ethnicity. Based on the findings for Questions 1 
and 2, the independent variables of gender, living status, and race/ethnicity were removed 
from the regression analysis which followed for Questions 3 and 4. 
For Research Question 3, hierarchical regression analysis showed all predictors 
for each hypothesized dependent variable in the model contributed to the outcome. 
Perceived symptom management (PSM) was a direct predictor of functional status, and 
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its prediction of the mental health component of functional status (/J = .488) represented 
the model's highest relationship. The only nonsignificant path in the model was the direct 
prediction ofHRQOL by the number of comorbidities. Two of the model's paths (see 
Figure 2, page I 08) were not in the expected direction. Comorbidities to HRQOL was 
positive, rather than negative, and perceived general health status to HRQOL was 
negative, rather than positive. 
The analyses for Research Question 4 showed that the variables between age and 
HRQOL serve as mediating variables, though they do not contribute to the outcome when 
comorbidities is the exogenous variable. In other words, the variables of perceived 
general health status, physical health status, mental health status, and perceived symptom 
management contributed to the outcome of HRQOL when age, but not comorbities, was 
the exogenous variable. 
Research Question 5 examined the agreement between patients and their health 
care providers regarding their Functional Class rating using the rating scale of the New 
York Heart Association. Using kappa statistic, only 44% agreement between patients and 
provider was found, adjusted to 37% for ·chance agreement. 
The findings from this study will be discussed thoroughly in the next section of 
this Chapter. There are limited generalizations when a small nonprobability sample is 
drawn from a specific population. This may lead to a Type II error. However, the results 
of this study suggested variables that contribute to quality of life in people with CHF. 
Also, the study showed a poor level of agreement between the participants' perceptions 
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of their New York Heart Association's (NYHA) function classification as compared to 
that of their health care providers. 
Discussion of the Findings 
Sample Characteristics 
The sample characteristics in this study are similar to other studies. As is the case 
in studies reported in the literature, the majority of participants in this study were male 
(Cowie et al., 2002; Gott et al. , 2006; Gottlieb et al., 2004; Juenger et al., 2002) and 
Caucasian (Lafata, Pladevall, Divine, Heinen, & Philbin, 2004). 
Age. The mean age of participants was approximately 68 years. Women had a 
higher mean age 71 .19 than did men, 67.05. These findings are similar to Chin, Zhang, 
and Rathouz (2003) and Chin and Goldman (1998). This reflects the lower incidence of 
coronary heart disease in women (Ho, Pinsky, Kannel, & Levy, 1993). However, this 
statistic changes as age increases beyond the age of 75 (Friedman, 1993). Kimmelstiel 
and Konstam (1995) found that women were significantly older than men when 
diagnosed with CHF (72 versus 68 years). Vaccarino, Chen, Wang, Radford, & 
Krumholz (1999) found that women tend to live longer after a diagnosis of CHF than 
men. This could be due to estrogen use in ageing women (Reis et al., 2000). 
Living arrangement. The majority of participants lived with someone. These 
findings are similar to those of other studies (Gott et al., 2006). Men were more likely to 
live with someone than were women. These findings were similar to the findings of Kim 
et al (2000) where fewer women than men were married. In a study by Hamner and 
Ellison (2005), patients who lived with family, other than in a facility, were associated 
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with readmissions. In a study by Luttik, Jaarsma, Veeger, and van Veldhuisen (2006), 
patients living alone were consistently lower on their QOL scores than those living with a 
partner. 
Comorbidities. Sixty percent of participants had at least 3 comorbidities. These 
findings are similar to a study conducted by Gott et al. (2006). In that study, 69% of 
participants experienced two or more comorbidities in addition to their heart failure. 
However, only 79% of the participants identified that they had heart disease. This finding 
was confusing to the investigator considering the study was being conducted in a cardiac 
clinic. However, when asked, the participants did not feel they had any serious heart 
issues. Sixty-six of the participants stated they had high blood pressure and 27% had 
diabetes. The leading comorbidity with CHF was hypertension with 66.4%. Women 
experienced hypertension (67.6%) slightly more often than men (65.8%). These findings 
were similar to those of studies conducted by Chin and Goldman (1998) and Levy, 
Larson, and Vas an ( 1996). However, future studies might consider combining heart 
disease and hypertension into one category representing cardiovascular disease. 
Depression. Antidepressant medication was being taken by 16% of study 
participants; however, 14.2% stated they had depression as a comorbidity. While men 
had a higher incidence of depression, women noted taking more medication for 
depression than men. In a qualitative study involving 23 CHF patients conducted by 
Bennett, Cordes, Westmoreland, Castro, and Donnelly (2000), women more often 
reported emotional symptoms of fear, depression, and sadness. In another study which 
conducted routine screening for depression and QOL in outpatients with CHF, almost 
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every third patient screened positive for depression. There was also a high prevalence rate 
of reduced QOL (Holzapfel, Muller-Tasch, Wild, Nelles, Hugo, & Junger, 2007). 
Gottlieb et al. (2004) conducted a study on the influence of age, gender, and race on the 
prevalence of depression in CHF patients. They found that 48% of the patients scored as 
depressed, and women were more likely (64% were depressed and 36% were not) to be 
depressed than men (44% were depressed and 66% were not). 
Costs and finances. Cost of medications (22%) and cost of medical care (30%) 
were noted as contributing to financial stress affecting quality of life. Women believed 
the cost of medications impaired their QOL (27%) as compared to men (19.7%). Men 
believed the cost of medical care impaired their QOL (30.3%) as compared to women 
(27%). However, women of"other" descent believed their cost of medications and 
medical care impaired their QOL an overwhelmingly 66. 7%. In this study, this 
population was primarily Hispanic culture. These findings could be a reflection of 
Hispanic women having jobs that did not provide adequate salaries and/or health 
insurance. Therefore, these financial constraints could have an impact on their QOL. 
Men had a higher household income and higher house value than did women. 
These findings are similar to a study conducted by Kim et al. (2000) who studied 
differences between men and women in anxiety early after acute myocardial infarction 
and found that women had a lower income than did men. In another study conducted by 
King (2002), women were predominantly in the lowest socio-economic group following a 
myocardial infarction. Chin and Goldman (1998) found that women were "poorer" than 
male respondents (p. 1036). 
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Perceived symptom management and QOL. The majority of participants (61.1 %) 
rated their perceived general health status to be good or better. Their CHF symptom 
management rating was 7.2 on a scale ofO to 10. Women perceived their general health 
status higher (70.2% as good or better) than men (56.2%). Women rated their perceived 
symptom management to be less (6.92) as compared to men (7.32). Men were 
hospitalized more (n = 29) than women were (n = 9) within a year time frame. These 
findings were consistent with those findings of Bennett, Baker, and Huster (1998) where 
women with CHF had high physical symptom impact and poor perceived physical health 
status. Also, in a study by Shahar, Lee, Kim, Duval, Barber, and Luepker (2004) men had 
a higher rate of hospitalizations than among women. In another study, Chin and Goldman 
(1998) found women with CHF had significantly lower scores for physical function and 
vitality than did men. Women had a higher perceived general health status mean than did 
men; however, men had a higher perceived CHF symptom management score mean than 
did women. The implications of this finding are not entirely clear. It may indicate that 
women may not require the same level of CHF symptom management as men or it could 
mean that women rate their QOL higher even when not managing their symptoms as well. 
This leads to the following question: "Do expectations of symptom management vary by 
gender?" Another question deserving further exploration might be "Do health conditions 
other than heart failure contribute to person's responses?" 
Ejection fraction. Thirty eight percent (n = 43) of participants had an ejection 
fraction (EF) of< 40% and 62% (n = 70) had an EF of~ 40%. The overall mean EF% 
was 45.82, with African American women having the highest mean (M= 54.25%) and 
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African American men having the lowest mean (M= 38%) percentage. Women's mean 
EF% was 48.16; the mean EF% for men was 44.68. These findings are consistent with 
the findings of Friedman (2003) were the mean EF for men was 32.3 (SD = 12.5) as 
compared to the mean EF for women was 35 (SD = IS). 
Hospitalizations. Overall, 61.1% of participants documented that they had not 
been hospitalized in over I year. Women were the highest (8 .1 %) in recent 
hospitalizations (those less than 3 months ago) as compared to men (5.3%). Similar 
results were found in a study by Ho, Pinsky, Kannel, and Levy (1993) where women 
were more often admitted to the hospital for CHF than men. In a study by Shahar, Lee, 
Kim, Duval, Barber, and Luepker (2004), the hospitalization rate, in contrast to this study, 
was about 50% higher among men than among women. Within one year of being 
hospitalized, 3 7% of male patients and 30% of female patients had died. By the end of a 
follow-up 5 to 6 years after the hospitalization, cumulative mortality reached 72% in men 
and 66% in women. In this same group, the hospitalization rate increased dramatically in 
ascending age groups: from a few dozen hospitalized patients per 100,000 patients ages 
35 to 44 years to more 2000 per 100,000 patients ages 75 to 84. Shahar's study 
documented a high mortality of heart failure patients relative to the general population. A 
heart failure-related hospitalization conferred at least 10,000 excess deaths per 100,000 
patients; more than 30,000 excess deaths per 100,000 elderly residents; and on average, 
I 0 times mortality risk. 
Shortness of breath was the primary symptom that prompted participants to go to 
the hospital. However, when looking at gender differences, women had shortness of 
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breath, swelling, and chest pain in that order. Men had shortness of breath, chest pain and 
then fatigue. In a study by Rector, Anand, and Cohn (2006), women reported more 
dyspnea and fatigue. 
CHF ~lassifications. The NYHA was recorded by both participants and their 
health care providers. Lower scores indicated less interference with function. The overall 
mean score of participants was 1.96; however, the health care providers' overall mean 
score was 2.43 . Participants did not view their function with heart failure as severely 
affected as did their health care provider. Health care provider's responses on the NYHA 
classification were as follows: classification of I was 2. 7%, classification of II was 55.8%, 
classification ofiii was 37.2%, and a classification of IV was 4.4%. These finding were 
similar to those of a study conducted by Krethong, Jirapaet, Jitpany, and Sloan (2008) in 
which most of the participants were placed in NYHA functional class II or III . 
Perceived physical and mental health status. The physical health status (PCS) 
mean score for all participants was 37.83, with women's mean score (34.50) slightly less 
than men's mean scores (39.45). African American women had the lowest PCS mean 
scores of 31.2. These finding were similar to those found by Chin and Golman ( 1998) 
where women's PCS scores were lower than men's scores at study baseline. 
The overall mental health status (MCS) mean score for all participants was 50.46. 
Mental health was perceived to be about the same by both genders, with women's mean 
score at 50.89 and men's 50.26. African American men had the lowest MCS mean score 
47.05. 
126 
Health-related quality of life. The overall mean score for HRQOL, as measured 
by the MLHFQ, was 38.73 out of a possible score of 105. (Note: The HRQOL scores 
were reversed for this study so that a higher score meant higher HRQOL.) While the 
scores were not significantly different by gender, men had a mean score of 39.13 and 
women had a slightly lower mean score of 37.91. Men of"other" descent had the lowest 
mean score of 35.38. Compared with the health-related quality of life of other groups, De 
long, Moser, and Chung (2005) studied predictors of health status for heart failure 
patients and found a mean socre of 51 .62 (SD = 22.58), which they reported as poor 
HRQL. In a more recent study, Krethong, Jirapaet, Jitpanya, and Sloan (2008) found the 
mean score ofHRQOL for participants was 55.13 (SD = 20.63). They reported these 
findings to indicate that participants perceived their HRQOL as moderate. According to 
the interpretation of these studies, the HRQOL mean score for the current study could be 
considered "moderate". 
Research Questions 
Research question 1. Findings were presented for the frrst Research Question, 
"Are there differences in self-reported health status and HRQOL of men and women with 
a diagnosis of CHF? These findings indicated that there were no significant differences 
among gender categories on the dependent variable (HRQOL). Health status was found 
to be significant only for the physical component based on analysis of variance 
performed on each dependent variable as a follow-up procedure to the MANOV A . This 
finding of gender significance in relation to physical health is consistent with that of Chin 
and Goldman (1998). 
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Findings from this study can be compared to the study completed by Chin and 
Goldman (1998) because the instrument is the same. The difference between Chin and 
Goldman's study and this research study is that their study was longitudinal for one year 
survival and HRQOL following hospital admission of patients admitted with CHF. Their 
study looked at 179 patients at baseline (upon admission), women had lower scores than 
men for vitality, physical function, and PCS. These findings would be consistent with 
decompensated CHF. However, women still had lower scores than men at the 2-month 
time point for health perception, vitality, physical function, social function, and PCS. At 
1 year, women continued to have lower scores than men for all domains except role 
mental function and MCS, which was consistent with the findings in this study. 
Research question 2. Research Question 2, "Are there differences in age, 
race/ethnicity, living status, number of comorbidities, perceived general health status, and 
perceived symptom management of men and women with a diagnosis of CHF?" was 
addressed. Results for Research Question 2 demonstrated no statistical significant 
difference in gender and age, race/ethnicity, living status, number of comorbidities, 
perceived general health status, and perceived symptom management of men and women 
with a diagnosis of CHF. However, females had a higher mean age than males. The time 
of CHF diagnosis is not known, but as indicated within the literature (Chin & Goldman, 
1998; Hussey & Hardin, 2003; and Rhodes & Bowles, 2002) diagnosis generally occurs 
later for women than men. 
Analysis results for this question led to a revision of the original analysis planned 
for this study. Gender differences were not significant for perceived health status and 
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HRQOL, as had originally been conjectured by the researcher. Gender, therefore, was 
removed as an independent variable in the model to be tested. The results of these 
findings may be specific to this population. 
Research question 3. The third research question was revised for analysis, with 
the independent variables of gender, race/ethnicity, and living status removed: "Are age, 
number of comorbidities, perceived general health status, perceived physical health status, 
perceived mental health, and perceived symptom management significant predictors of 
HRQOL?" This research question was addressed with hierarchical multiple regression 
analyses which allowed staged path analysis to examine the predicted relationships 
between the independent variables (IV s) and the dependent variable (DV) based on the 
theorized path model. The model was based on Wilson and Cleary's (1995) health-related 
quality of life conceptual model.(Figure 1, p. 6). This model incorporates five main 
concepts (biological and physiological variables, symptom status, functional status, 
general health perceptions, and overall quality of life) which are staged in order. Path 
analysis is seen as a type of"causal modeling," where the IVs may have a direct or 
indirect effect on the DV. The total effect is a result of the sum of the direct and indirect 
paths. By analyzing the data of all the paths, this analysis allows researchers to gain 
knowledge about the consistency between the data and theorized path model (Munro, 
2001). 
Path analysis was performed to determine the causal effects among the variables 
of the "Conceptual Model of Predictors to Health-Related Quality of Life" (see Figure 2, 
p. 1 08). The model includes five stages: (a) age and total number of comorbidities at 
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Stage 1 (Demographics); (b) Perceived Symptom Management at Stage 2 (Symptom 
Management); (c) Physical Component Score and Mental Component Score at Stage 3 
(Functional Status); (d) Perceived General Health Status at Stage 4 (General Health 
Status); and (e) MMLHGQTO score at Stage 5 (Health Related Quality of Life). The 
dependent variable(s) at each stage was regressed on the independent variable(s) with a 
variance (R2) given for each of the dependent variables. The variance discussed at each 
stage and associated path coefficients with each dependent variable (see Table 22) will be 
discussed. 
Stage 2 (Symptom Management) of model testing involved the dependent 
variable ofPSM and the two independent variables predicted to influence PMS: (a) age 
and (b) total number of comorbidities. They explained 15% of the variance in the 
outcome variable. The strongest predictor of Symptom Management was total number of 
comorbidities which had a negative influence W = -.331, p = .000). In a study conducted 
by Gott et al. (2006), the number of comorbidities showed a significant association with 
PCS and MCS. For example, people reporting more than I comorbidity had a lower PCS 
score and a lower MCS score than those with none or 1. The current study, with the 
added variable of PSM preceding health status (PCS and MCS) similarly found that a 
greater number of comorbidities resulted in a decrease in PSM, meaning the higher the 
number of comorbidities, the poorer the perception of symptom management. The Stage 
1 variables also had a direct path to the model's dependent variable, HRQOL. Path 
analysis revealed that age had a direct path to HRQOL, which was found to be negative 
(p = -.205) and significant (p = .029) which would mean the higher the participants age, 
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the lower the HRQOL. Comorbities also had a direct path to HRQOL (~ = .149, p = .116). 
Tills relationship was not significant and, though the computed Beta was low, it was a 
positive relationship. The direction of this relationship was not as anticipated, since it 
might be expected that one with more comorbidities would have a lower QOL. 
Age was a modest Predictor of PSM. This relationship was predicted to be 
positive, that is, the older the individual, the better the PSM. Path analysis revealed that 
age had a positive CP = .222) and significant (p = .000) influence on PSM. Age also had a 
direct path to HRQOL, and this was found to be significant (p = -.205, p = .05). The ages 
of participants in this study ranged from 40 to 95 years with a mean age of 68 (SD = 11.9. 
Findings related to age and QOL have been mixed. Age has also been associated with a 
decrease in QOL (Gott et al., 2006), as was found in this study. Riedinger, Dracup, and 
Brecht (2000), though, found age to have a positive relationship with OOL. In evaluating 
the results of studies, it is important to consider the measures used. The measurement of 
HRQOL may be broad or narrow. The MHLFQ might be classified as a broad measure, 
including items that address physical function, mental health, symptoms, and social 
function (Albert, 1997). 
At Stage 3 (Functional Status), the dependent variables of Physical Component 
Scale (PCS) and Mental Component Scale (MCS) represented the functional status 
response of the individual within the context ofCHF. The independent variable predicted 
to influence the PCS and MCS was Perceived Symptom Management (PSM). It 
accounted for 15% and 23% ofthe variance in PCS and MCS, respectively. PSM was a 
moderate(~= .392) and significant predictor (p = .000) ofPCS and a moderate CP = .488) 
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and significant predictor (p = .000) of MCS. These findings would support the 
importance of better symptom management in increasing perceived functional status. 
The fourth dependent variable in Stage 4 (General Health Status) represents 
Perceived General Health Status. The two function status variables (PCS and MCS) were 
proposed to directly influence General Health Status. These accounted for 29% of the 
variance in the outcome variable of the two variables. The PCS was found to be a 
significant predictor ofPGHS (p = -.400, p = .000). The MCS was found to be a 
significant predictor of PGHS (p = -.320, p = .000). These findings reflected how the 
patients perceived their overall health status through physical and mental well being. 
Although these predictions were not in the direction expected, this outcome may be 
explained by the person's general health outlook and rating of that general statement as 
compared to specific questions about one's health status (both physical and mental). 
Model testing at Stage 5 (Health Related Quality of Life) examined the direct 
influence of Perceived General Health Status (PGHS), as well as the direct effects of the 
two Stage I variables (comorbidities and age) discussed earlier. Perceived health status 
was a l-item general rating ofhow the person perceived health status, thus it was a 
narrow measure with limited variance. PGHS was a significant predictor (p = .192, p 
= .05) ofHRQOL, though it explained only about 3% of the variance in HRQOL. As 
noted earlier, the MLHFQ is a broad measure of QOL, whereas the PGHS captures only 
the person's self-rating ofhealth. Globally, individuals may tend to rate their health status 
higher than when they rate more specific aspects of their health as requested by the array 
of questions on the MLHFQ. 
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In summary, the strongest predictor in the HRQOL model was the influence of 
PSM on MCS. This finding suggests that participants' perception of their symptom 
management influences their mental health well being. This may indicate the importance 
of one's mental health in coping with the chronic condition of CHF. This finding 
deserves further exploration. Total number of comorbidities was found not to be a 
significant predictor of HRQOL. 
Research question 4. Research Question 4, revised, was, "Do symptom status (i.e. , 
perceived symptom management), functional status (i.e., perceived physical health status 
and perceived mental health status), and general health perceptions (i.e., perceived 
general health status) serve as mediating variables between the exogenous variables (i.e., 
age and comorbidities) and HRQOL?" The variables PSM, PCS, MCS and PGHS serve 
as mediating variables (see Figure 2, p. I 08). Findings suggested that age, but not the 
number of comorbidities, be retained in the HRQOL model as an exogenous variable. 
The number of comorbidities did not have a significant direct influence on HRQOL, and 
its influence was not increased by other variables in the model. 
Research question 5. The fifth Research Question was "Is there agreement of the 
New York Heart Association's (NYHA) Functional Class ratings made by the participant 
and his/her health care provider?" Findings indicated that patient's perceptions and 
provider's assessments of their functional status were poor, though they were beyond the 
level of chance. There was only "slight" agreement between the patient and provider 
regarding the NYHA functional class ratings (Viera & Garrett, 2005). This finding was 
consistent with that of Subramanian, Weiner, Gradus-Pizlo, Wu, Tu, and Murray (2005) 
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that patient perception (n = 156) and provider assessment showed slight agreement either 
over the phone or in person. In that study, however, the patient's NYHA class was 
derived, using an algorithm, from the patient's response to the Kansas City 
Cardiomyopathy Questionnaire (KCCQ). In the current research, the actual NYHA 
classifications were obtained from the patients and health care providers in person in the 
clinic setting. 
Participant's perception of their NYHA's classification was lower than the 
provider's classification. This indicated that participants classified themselves as having 
none to slight limitation in physical activity, whereas their providers classified them as 
having slight to marked limitations. The study by Subramanian, Weiner, Grad us-Pizlo, 
Wu, Tu, and Murray (2005) found the alternative, that patients placed themselves in a 
worse category than did their health care providers. However, the NYHA classification 
does not take age into consideration, which may need to be investigated further. Also, as 
mentioned previously, 38% (n = 43) of participants had an ejection fraction (EF) of< 
40% and 62% (n = 70) had an EF of~ 40%. This could have been a contributing factor 
because less than 40% indicates systolic heart failure and greater than 40% indicates 
diastolic failure. 
Study Methodology 
Data collection was conducted at two different cardiology clinics to enhance 
generalizability by including participants of different ages and race/ethnicities. The 
participants represented middle to older adults who were diagnosed with CHF. 
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Cardiology clinics were used as sites for recruiting participants since individuals were 
there because they were receiving treatment for their heart failure. 
The physicians and nurse practitioner in the two clinics were extremely helpful 
with suggesting dates for the study based on activities within the office and related 
screening for participants who might be interested in participating in the study. Flyers 
were placed in the clinics prior to the start of the study; these were found to be helpful to 
recruitment. 
A major weakness of this study was that participants primarily had a pay source 
that assisted with paying for their healthcare. This excluded many adults who did not 
have a primary pay source. The majority of adults in this study were older adults (M = 
68.41, SD = 11.86), living independently, and able to drive to the clinics. There were a 
few participants whose family members helped with transportation. This study included 
participants in urban as well as rural settings. Since the study focused on adults who were 
living independently and managing their heart failure, results cannot be generalized to 
adults who are living in either assisted living centers or nursing homes. 
Conclusions and Implications 
The findings from this study support the conclusions from previous research that 
HRQOL among those with congestive heart failure (CHF) is impacted by numerous 
variables. The caution is that each conclusion has to be considered within the context of 
how HRQOL was defined and measured for that particular study. Information from this 
exploratory study increases the support for the idea that changes made in symptom 
management can bring about positive changes in physical and emotional wellbeing, 
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perceived general health status, and, ultimately, HRQOL. The finding that the success of 
symptom management was related to mental health function suggests that teaching CHF 
patients how to use psychological coping strategies to deal with their symptoms may be 
important. 
The results of model testing provide health care providers with information that 
can be used in guiding treatment approaches to help improve QOL. Wilson and Cleary's 
( 1995) framework was supported by the findings that age, symptom management, 
functional status, and general health status influence HRQOL in patients diagnosed with 
CHF. Future model testing might be done with the subtraction of comorbidities and the 
addition of other variables yet to be identified. 
The implications for the nursing profession are the need to disseminate the 
findings from this study to nurses, patient's and their family members, and the general 
public. Among the findings that have clear clinical implications are the following: 
1. More discussion of function between patients and health care providers needs to 
occur. 
2. Symptom management is important to QOL outcomes, thus emphasis on ensuring 
that individual patients learn to use management strategies appropriately is important. 
3. Socio-economic status may play a role in one's QOL, for example, whether or not 
individuals have the finances to purchase medications or follow-up their care for CHF. 
In some cases, individuals with CHF may not be able to work, which could cause 
further difficulties in QOL. 
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This information needs to move beyond the clinical setting, all~wing it to be 
disseminated through presentations and publications. Providing this information to health 
care providers will allow them to gain a realistic picture of the patient's perception of 
QOL, realizing that the patient's perception may not always be the same as the health 
care providers. 
Recommendations for Further Study 
Based on the findings of this study, recommendations for future study are 
1. There is a need to gain an understanding of the meaning ofthe difference in 
health status and HRQOL between men and women. A qualitative exploration 
of these phenomena could provide better understanding. 
2. Conduct longitudinal studies of health status and HRQOL in heart failure, 
preferably using the same instruments as previous research. 
3. Develop and test interventions designed to improve health status and HRQOL 
in heart failure patients. 
4. Determine whether the cost of medication and medical care impairs the QOL 
for women of non-white ethnicity. 
5. Determine whether expectations of symptom management vary by gender. 
6. Conduct studies in populations with more variation and different types of 
insurance, or financial health care coverage, and socioeconomic status. 
7. Explore the removal ofPGHS as a variable in the model. 
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Patients Diagnosed with 
Congestive Heart Failure 
Needed for a Research Study 
The purpose of this study is to learn more 
about the Health Status and Health-
Related Quality of Life of persons with 
congestive heart failure (CHF). 
Participation in this study is voluntary. 
For more information, please contact the 
front desl< or Karen Landry (at the 
number below). 
Karen Ainsworth Landry, RN, MSN 
Doctoral Candidate 
Texas Woman's University 
318/677-3100 or 3109 
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Receptionist script 
Receptionist: 
Would you be interested in participating in a research study that is looking at health 
status and health-related quality of life of persons diagnosed with congestive heart failure 
(or CHF)? Participation in this study is voluntary. This study is being conducted by a 
nurse, Karen Ainsworth Landry, for her doctoral dissertation at Texas Woman's 
University. She is interested in learning more about these characteristics in order to 
better plan nursing care. 
Patient: 
If "Yes". 
Receptionist: 
Thank you, the primary investigator or the nurse liaison will be with you in a few 
minutes. 
Patient: 
If "No". 
Receptionist: 
Thank you .. 
Note: Patient may ask something like: 
"How long will this take?" Answer: At most, about 35 minutes. 
"What do I have to do?" Answer: Participation involves filling out 3 
questionnaires. 
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TEXAS WOMAN' S UNIVERSITY 
CONSENT TO PARTICIPATE fN RESEARCH 
Title: Health Status and Health-Related Quality of Life in Congestive Heart Failure 
Investigator: 
Advisor: 
Karen Ainsworth Landry . . .......... .. . . . . . ... .... . ... .. ... . .... . _ 318/795 -9488 
Gail Davis, EdD ... .... ...... .. .. ...... .. ... . ... . ... .... .. .. .... ..... _ .940/898-2401 
Explanation and Purpose of the B.qsear..fb 
r:ou are being asked to participate in a research study for Ms. Karen Ainsworth Landry 's 
cllssertatJOn's study at Texas Woman's U niversity. The purpose of this research is to 
determine the relationship between certain characteristics of your health status and 
health-related quality of life with congestive heart failure. 
Research Procedures 
Pa11icipants in this study, patients with congestive heart failure, will complete a general 
information form (Part A) and two questionnaires. You will be given these by the 
researcher or a nurse in the clinic, and the time for completing them should not exceed 35 
minutes. The researcher or nurse will be available to answer questions you may have 
while filling them out. This will take place in a private area within the clinic . Your health 
care provider will complete Part B of y our general information form. He or she will 
document ho"v your heart is functi o ning (functional classification) and how it is pumping 
(ej ection frac tion) . 
Potential Risks 
Potential risks related to your participation in the study include fatigue and emotional 
discomfort while completing the questionnaires. To avoid fatigue, you may take a break 
(or breaks) while completing the questionnaires as needed. If you experience fatigue or 
emotional discomfort while completing the questionnaires, you may stop or postpone 
participation at any time please let the P .I. or nurse liaison know. Jf completion of the 
forms arc too tiring, the P.L or nurse li a ison will volunteer to make the marks on the form 
as directed by you . If you feel as though you need to discuss this emotional discomfort 
with a professional, the investigator or nurse liaison will provide you with a referral list 
of counselors ' names ami phone nun1bers . 
Another possible risk to you as a result of your participation in this study is release of 
confidential information . Confidentiality will be protected to the extent that is allowed 
by law. The interv1ew will take place in a private area within the clinic. A code number. 
such as 00 I and 002, will be used on the questionnaires and the general information form 
(Parts A and B) instead of your name to organize the information . Only the investigator 
Approveo by th e 
'e-..as Vv'orn~n·s Uni·.JCfS !ty 
;nsl lfLtt.DP-c11 R cvV!o.•; Boarc~ 
Approved . 
Revised · 
r, p nl 5 . 2007 
A ortl 20. 2007 
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Participant initials 
Page I of 2 
and her advisor will have access to the questionnaires and general information form . 
These completed forms will be stored in a locked filing cabinet in the investigator's 
office. They will be shredded within 5 years. It is anticipated that the results of this 
study will be published in the investigator's dissertation as well as in other research 
publications . However, no names or other ident ifyi ng information will be included in 
any publication. 
Another potential risk to you is coercion. Your participation in this research study is 
voluntary and you may withdraw at any time. Your health care will not be affected in 
anyway based on your decision regarding participation . Your health care provider will not 
be informed of your decision regarding participation . 
The researcher will try to prevent any problem that could happen because of this 
research . You should let the researchers know at once if there is a problem and they wi ll 
help you. However, TWU docs not provide medical services or financial assistance for 
injuries that might happen because you arc taki ng part in this research. 
Participation and Benefits 
Your involvement in this research study is completely voluntary, and you may 
discontinue your participation in the study at any time without penalty. The only direct 
benefit of this study to you is that at the completion of the study a summary of the results 
will be mailed to you upon req uest.* 
Questions Regarding the Study 
If you have any questions about th e research study you may ask the researchers; their 
phone numbers arc at the top of this fonn . If you have questions about your rights as a 
participant in this research or the way this study has been conducted, you may contact the 
Texas Woman's University Office of Research and Sponsored Programs at 940-898-3378 
or via e-mail at IRB@twu .ed u. You will be given a copy of this signed and dated consent 
form to keep. 
Signature of Participant Date 
* If you would like receive a summary of the results of this study, please provide an 
address to which this summary should be sent: 
Appro·;ed by th e 
Texas \f./om an's U n .-Jers •ly 
tnstnullcn<. l Rev .e~...v B oard 
Approved : 
Rev1sed · 
Apnl 5 . 2007 
Aoril 2 0 . 2007 
Page 2 of 2 
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March 2. 2007 
Karen Landr} 
7343 University Drive 
Shrevepon, LA 7 I I 05 
Dear Ms. Landry: 
CAR:JIAC 
ASSOCIAiES 
,- - L A 1, • 
I am pleased to know that you're planning a study that is aimed at health status and health 
related quality of life patients with congestive heart failure. Tllis is a topic that is of 
interest to us in improving the quality of care in our institution. We would be pleased for 
you to access our patients to determine if they would like to participate in your study . /\ 
person who "viii serve as a liaison from our staff to work out the procedures with you will 
be assigned to you at a later date. Prior to beginning your recruitment of participants, 
please provide us with a copy of the human subjects approval letter. 
We look forvva.rd to working with you. 
Dissertation/Theses signature page is here. 
To protect individuals we have covered their signatures. 
June 24. 2006 
PREMIER HEART SPECIALISTS, PA 
Practice II/ Cardiac & Periph~rallllfen•enrlonul Cf/rdiolox.r 
nr. Ajil V. Adyanlhaya, MD. f ACC 
Diplomate American Hoard nf Cardio' ascular Diseases 
Dr. P.V. llalakrishnan, Mn. J)M, FACC, FSCAI 
J)iplomale American Hoard of Cardiovascular Diseases 
Premier Heart Specialist ·. P.r\. 
0r. P. v. Balakri shnan. \10. DM 
Dr. A. V. Ad)antha)a. MD 
11914 Astoria Blvd. Suite 410 
lloustnn. f\ 770X9 
Dear Ms. landry : 
1'111 pil:J~ed lu Kno\\ that ~·ou'n: planning a ~tudy that i> aim~J at examining specific 1·ariables as pn.:di~o:tors ,I) 
health stmus and of quali1y of life in worn en wi1h c·ongestiH~ heart f~tilun.: . This is a topic that is of interest toll> 
in improving the quality of care: in our institution. We would he pleased f(lr you til access our patients to 
detcm1inc if' they ~ould like to participate in your stud} . The person who \\ill sern.: as a liai son from our stall to 
work out the pmccdures with you is 11randi Pipes. R:-,:. HS :-.4. st udell! adult Af' N. Pri<1r to beginning yPur 
recruitment of participants. please pwvidc u.s with a cop~ (lf'the human subj ects approl'allettcr. 
We look f()rward to working with you. 
Sincerely. 
Dissertation/Theses signature page is here. 
To protect individuals we have covered their signatures. 
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Karen Ainsworth Landry 
7343 University Dr. Shreveport, LA 71105 
18 April 2007 
Dr. David Nichols. Chair 
Institutional Review Board 
Box 425619 
Denton. TX 76204-5619 
Dear Dr. Nichols, 
( 318) 795-9488 
Based on suggestions from committee members during my Prospectus Defense, 1 am 
sending a revised IRB application . General Information Form (GIF) and consent form . 1 
have highlighted areas that were added . Basically, these changes are requested in 
order to detemnine whether the patient's functional classification rating matches that of 
the health care provider. The procedure used will maintain anonymity; the health care 
provider will not know which patients are or are not participating. 
On the GIF fomn, an addition section was added. There will be one section for 
participants to complete (Part A) and another section (Part B) that the health care 
provider will complete. Part B will be placed on a cabinet within each patient's 
examination room . Each form will be pre-numbered in order to provide anonymity for all 
patients (those who do participate and those who do not) . Only the forms for those 
participating in the study will be collected ; those for non-participants will be shredded 
and discarded when retrieved by the data collector. 
Revisions (which are highlighted) were made to the IRB application. These revisions 
include: 
• #1 - Research Questions # 4 & # 5 (Q #4 was already implied from Q #3 , and Q 
#5 was suggested by the physician in the Dallas agency who is serving on my 
dissertation committee. I will send a letter to the Houston agency for approval to 
collect this added data by the health care provider) 
• #4- Included the procedure for Part B of the GIF 
• #9- GIF (Part B) 
• #1 0 - GIF (Parts A and B) ; information was added to loss of confidentiality and 
coercion sections 
• #11 b & c - GIF (Part B) 
Also, I am sending the consent form with revisions (which are highlighted). 
Please contact me if you have any questions at the address or phone number above, or 
at laQQ.i:y~ ·§;D.?~.JI.<.'I.~!Q.\J 
Sincerely, 
Karen Ainsworth Landry 
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EXAS WOMAN'S UNJVERSITI 
DENTON 0.\ll AS HOUSTON 
0671143 
Ms. Karen Ainsworth Landry 
7343 l..l nivcrs ily Drive 
Shrc vcrort L.-\ 7 I I 05 
Dear rv1s . l .andry: 
The Graduate School 
P.O. Box. 425649, Denton, TX 76204·5649 
940·898 34 1.5 Fa> QAO·S9S· 34 l 2 
April 23. 2007 
1 h:-~vc rt:cc ivc d and aprronxl tht: pro~ pcctus cntiikd "Health Status and llclath-Rclatcd 
Quality of Li"·e in Congestive Heart Failure" for your Dt sso::: rtati on research proJeCt. 
Besr wishes to you in the research and wTiting of your project. 
Dissertation/Theses signature page is here. 
To protect individuals we have covered their signatures. 
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General Information Form 
Health Status and Health-Related Quality of Life in 
Congestive Heart Failure 
Patient's Response- Part A 
Please circle which category you currently find yourself 
belonging to. 
GENDER 
1. Female 
2. Male 
AGE 
ETHNICITY !RACE 
1. American Indian or Alaska Native 
2. Asian 
3. Black or African-American 
4. Hispanic or Latino 
5. Not Hispanic or Latino 
6. Native Hawaiian or Other Pacific Islander 
7. White 
LIVING STATUS 
1. Lives alone 
2. Lives with someone 
3. Lives in a residential setting 
What is your Zip code? -------
167 
PERCEIVED GENERAL HEALTH STATUS 
Would you say your health in general is? 
1. Excellent 
2. Very good 
3. Good 
4. Fair 
5. Poor 
PERCEIVED SYMPTOM MANAGEMENT 
Please circle the number which best describes your symptom management 
with congestive heart failure. 
1 
Not Well 
at All 
2 3 4 5 6 7 
COMORBIDITES (Please circle all that apply) 
I. Heart Disease 
2. High blood pressure 
3. Lung disease 
4. Diabetes 
5. Ulcer or stomach disease 
6. Kidney disease 
7. Liver disease 
8. Anemia or other blood disease 
9. Cancer 
10. Depression 
11. Osteoarthritis, degenerative arthritis 
12. Back pain 
13. Rheumatoid arthritis 
14. Thyroid disease 
15. Obesity 
16. Autoimmune disease 
17. Sleep Apnea 
18. Other 
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8 9 10 
Extremely 
Well 
What is your ejection fraction (your hearts ability to pump blood)? 
1. Greater than 40% 
2. Equal to 40% or less than 40% 
3. Unknown 
Are you currently taking an anti-depressant medication(s)? 
I. Yes 
2. No 
Are the costs of your medications causing restraints on your quality-of-
life? 
I. Yes 
2. No 
Is the cost of your medical care causing financial stress on your quality-
of-life? 
I. Yes 
2. No 
PERCEIVED NEW YORK HEART ASSOCIATION'S (NYHA) 
FUNCTIONAL CLASS 
Please circle the number which best describes your congestive heart failure 
class. 
1. You have no limitation of activities; you suffer no symptoms from 
ordinary activities. 
2. You have slight, mild limitation of activity; you are comfortable with 
rest or with mild exertion. 
3. You have marked limitation of activity; you are comfortable only at 
rest. 
4. You should be at complete rest, confined to bed or chair; any physical 
activity brings on discomfort and symptoms occur at rest. 
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When were you last admitted to the hospital? 
I. Less than 3 months 
2. 3 months to less than 6 months 
3. 6 months to less than 1 year 
4. I year or greater 
5. Never 
What symptoms prompted you to go to the hospital? (Check all that 
apply.) 
I. 
2. 
3. 
4. 
5. 
6. 
Swelling 
Shortness of Breath 
Fatigue (Tiredness) 
Defibrillator responded 
Chest pain 
Other 
-------
THANK YOU FOR COMPLETING THIS QUESTIONAIRE! 
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General Information Form 
Health Status and Health-Related Quality of Life in 
Congestive Heart Failure 
Health Care Provider's Response- Part B 
Patient's EF0/o -
------
NYHA classification - 1 2 3 4 
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Your Health and Well-Being 
This surve)' asks for your views about your health. This information will help 
keep track of how you feel and how well you arc able to do your usual 
activities . Thank you for completing this .Htrvey! 
For each of the following questions, please mark an [ZJ in the one box that best 
describes your answer. 
1. In general, would you say your health is : 
Exce ll e nt 
"Y 
o. 
Very good Good 
"Y 
D· 
Fa ir 
... 
D· 
2. Compared to one vear ago, how would you rate your health in gene r a l 
rum? 
Much bcn e r Somewhat About the Somewh at Much worse 
rww tha n on e better now sa me as on<: worse now now than one 
year ago than one yea r yea r ago than one year yea r ago 
ago ago 
"Y ... "Y "Y ... 
0 : 0 : D; o, D· 
SF-Jbv.!n• Ht!..'llth Sun-~ y ~ 1996. 2000 hf C)uailtyMctnc l ncorporar~d and Mt:dlCfl! Ouli.." Ornf:~ I ru~l :\II Rtghts Rc:!:tr.cd 
~F- .H'I(l< !5 u rt: g t!' rt r cJ ~r:td~rnark o l ~ .. techcal Ow comes 'J ru.:-;1 
tSf-- H1\ ~ St;.tndnnl. l .! S \'·;:r~HJn 2. <n 
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3. The following questions are about activities you might do during a typical 
day. Does your health now limit you in these activities? If so, how much? 
~-y~~~ Yes. No. not 
: limited limited limited 
I a lot a little at all I 
... .. .. 
, Vigorous activities, such as running. liliing 
heavy objects, participating in strenuous 
sports .. .. ...... . ............... .... .. ....... . ................ . o, ............... ol ............. ..... o , 
• Moderate acti vi tie~ . such as moving a table. 
pushing a vacuum cleaner, bowling, or 
playing golf .. ..... .. ........ ..... .... ..... , ... .... .. ..... .. .... ...... . O, ..... .... .. ....... o, ... ... .. .......... D · 
, Lifting or carrying groceries ... .... . .. . .. ......... .. .. ...... . 0, ......... .... ...... O, ........... ... .... 0 , 
" Climhing ?-~-~~m! flights of stairs .. 
, C limbing one fli gh t of sta ir-, 
0 1 ... 
r-···, · · · ·~1 
......... o . 
... .. ..... .... 0 :. 
1 Bending. kneeling, or stooping .. [], . .. .. .. .. .. ... . . 0: ..... .. .... .. 
" Walking more than a mile .. .. ....... .. .. o ... ... .... .. ... o, ........ .... ..... D· 
h \Valking several hundred yards. .. .. .. . 0: .. .. . ... Oo ... 
, Walking one hundred yards .... .... . . . 
, Bathing o r dressi ng yo urself .. .. .. .. .. .. .. ... .. ...... .. ...... 01 .. Do .. ... . . 
s F - ) o .... - ~ T ... 1 ie~1 !t h Su r' c ~ ,~~ l'i9b. 2P0{) h} ()u:lllly M t.'!: K I ncdrpv r,lk·d 1il'ld ,\ ·ft .:il c:.11 f hH L"~m1e:; ·r n1::,:1. .-\I! R1giHS Rc'>crvcd 
S F . J, (r}t' 15 J rcgJ.stcrcd tradcm~'rk 1.1 i ~fr:d Ku l nulc~m;l;!·· Trn .":: 
tSt-' -30 ~: 2 Srand:mi. US \·crsJon 2.0) 
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.. o . 
4. During the past 4 weeks, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of vour physical health? --
r-·--···--
i All of Most of Some of A little I the time the time the time of the 
! 
time 
T .. ... ... 
• Cut do \vn on the ;:mwunt_gf_!i!~ _vou s pent 
None of 
the tune 
... 
on work or other activities ........ .. ...... ................ .... O, .... ... O, .. .. .. . Q, .... . . O, . . . 0 
' Accomplished less than you would like .... .......... .. D · ......... O , ........ 0 > ...... ... 0 ... ....... Q, 
\Vere limited in the kiilQ of work or other 
act ivities .... .. .. ... .. ...... .. ... ...... . ..... .. .... .. . . 
J Had difficulty perfonning the work or other 
activi ties (for example, it took extra effort) .. .. 
.0 : .. .. . 01 
0 o: ...... o. 
5. During the past 4 weeks, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of anv emotional problems (such as feeling depressed or anxious)? 
, All of Most of Some of A little None of 
the time the time the time of the the time 
tllne 
, Cu t down on the amount of time you spent 
on work or o rher activities. .. .. ... .. .......... .. 0 , .. .. .. . 0 : ...... 0 -' D -· .. . 0 ; 
.o. ' .. 0 • • Acco mplished less than yo u would like .. 
D1d work o r other activitie~ less carcfullv 
th an usual. . .... ...... .............. .... . . . o, ... .. . 0 : .... .... Q, . ... . . o .. ..... D· 
;F . 1 1 , ,. ~ ' ' ' Health ~rlf\' C')' €~/ I'JlJb, 200U by Qualuy\ktric I ncnrporJted o:md M::Jr-.. 31 Ou!l..:uml!!- Tru~t t\ II R~ght s Rcs-:r•:~,.·d 
;f . JQ.). 1.s 3 rcga:;lcteJ tr.u .. krnark uf Mcd1Cil l Outcorn~!\ Tms t 
Sf- -3<n:2: ShLmJurd. US Vcr~11111 2.0) 
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9. These questions are about how you feel and how things have been n 'ith vou 
during the past 4 weeks. For each question, please give the one answer that 
comes closest to the way you have been feeling. How much of the time 
during the past 4 weeks ... 
All of Most of Some of A little None of I the time the time th.: time of the the rime 
time 
T ... T ~ T 
• Did you feel full of life? .. ..... .. ..... ... ...... ..... ... ..... .. 0 . .... ..... 0 ] .. .... .. 0 ; ..... .. 0 . .... ...... 0 ; 
• Have you been very nervous? .... ...... .. .. .. ....... ..... 0 ...... ... 0 2 .... O, .... .. D · ...... . D· 
, Have you felt so down in the dumps 
that noth.ing could cheer you up? .. ... .. ................. 0 1 ...... ... . O, .. ....... 0 .. ...... Q , .... .. . O, 
< Have you felt calm and peaceful ? ... 
, Did you have a lot of encrgy '1 . .... .. .. ......... . 
r Have you felt downhearted and 
depressed '.>.. . .. ........ .. .. 
, Did you feel worn out'l 
" Have you been happy'! .... .... ........ ........ .. 
. o .. 
. o, 
.o , .... . o .... ... o ...... o . 
.. .. o, ........ . o, .... .. . !J .... ... o . 
D. .0: . D· .o. 
o . .. ...... . o: o, ....... o . 
, Did you feel tired? ............................ ... . ... . 0 1 ... .... . O, .. 0 • ... .... D· ....... 0 , 
t 0. During the past 4 weeks, how much of the time has your physical health 
or emotional problems interfered with your social activities (like visiting 
friends, relatives, etc.)? 
~-------··-------· ---··-·-··-·-·--·------, 
All of the Most of the Some of the A little of the None of the 
time time time time time 
T T ... ... T 
0 · o, o, o. D· 
S F. lO ·: ~ r~oJ Health Sun.ey t£) \996. 2000 by Quahr~Mctric ll l~')rpmah:J and \lc(1 1cJI OutrNncli Trw'i! ,\ ll K•ghll;: Rc5i.:rvcd 
SF.Jf1~· 1S a rcgJstr rcd trademark of Medical Outcome!t Trust 
rSF · H•\ ~ :">landJn.l, US Vl..'fSiPn:! 0 • 
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I 
11. How TRUE or FALSE is each of the following statements for you'? 
r-r.~itely Mostly Don't Mostly Defin ite! 
true tme know false false 
T T T T T 
• I seem to get sick a little easier 
than other people .. .. ........ ............ ........... O, ........... 0? ........... O, .. .. ....... D· ........... 0 ; 
• I am as healthy as anybody I know ...... O, ........ 0: ....... .. O , .......... D·.. .. .... . O, 
, I expect rny health to get worse .. ...... .... O, .. . .. o, .......... o ... ........ o .. .. ........ o, 
" My health is excellent .. .. .. ... .... .. .. o ........... o, .. ........ o l .......... o .. .. ........ o~ 
TH4NK YOU FOR COil-fPLETING THESE QUESTIONS.' 
F·Jtlv.:!n.l Health Survey © 1996.2000 hyQuall t;·Metnc lncorpor3ted .1nd r<,.t<.>d1c:·d OlJtcornes Tru">l .-\I! R'!~hts Rcscr-.·..:d 
f-- -36-A- r~ u n:g15otcre<J tr..s.dcmnrk of Mt:\h c~l! Outc(Hnc~ Tru~r 
! f . ;h .. ) ~t;Jndnrd \ !S Ve-r'J (ln 2 Ol 
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MINNESOTA LIVING WITH HEART FAILURE~ QUESTIONNAIRE 
~he fol_lowing questions ask how much your heart failure (heart condition) affected your 
hfe dunng the past month (4 weeks). After each question, circle the 0, 1, 2, 3, 4 or 5 to 
show how much your life was affected . If a question does not apply to you, circle the o 
after that question. 
Did your heart failure prevent 
you from living as you wanted during Very Very 
the Qast month (4 weeks} b)£- No Little Much 
1. causing swelling in your ankles or legs? 0 2 3 4 5 
2. making you sit or lie down to rest during 
the day? 0 2 3 4 5 
3. making your walking about or climbing 
stairs difficult? 0 2 3 4 5 
4. making your working around the house 
or yard difficult? 0 2 3 4 5 
5. making your going places away from 
home difficult? 0 2 3 4 5 
6. making your sleeping well at night 
difficult? 0 2 3 4 5 
7. making your relating to or doing things 
with your friends or family difficult? 0 2 3 4 5 
8. making your working to earn a living 
difficult? 0 2 3 4 5 
9. making your recreational pastimes, sports 
or hobbies difficult? 0 2 3 4 5 
10. making your sexual activities difficult? 0 2 3 4 5 
11. making you eat less of the foods you 
like? 0 2 3 4 5 
12. making you short of breath? 0 2 3 4 5 
13. making you tired, fatigued, or low on 
energy? 0 2 3 4 5 
14. making you stay in a hospital? 0 2 3 4 5 
15. costing you money for medical care? 0 2 3 4 5 
16. giving you side effects from treatments? 0 2 3 4 5 
17. making you feel you are a burden to your 
family or friends? 0 2 3 4 5 
18. making you feel a loss of self-control 
in your life? 0 2 3 4 5 
19. making you worry? 0 2 3 4 5 
20. making it difficult for you to concentrate 
or remember things? 0 2 3 4 5 
21. making you feel depressed? 0 2 3 4 5 
© 1986 Regents of the University of Minnesota, All rights reserved. Do not copy or reproduce without permission. 
LIVTNG WITH HEART F AlLURE® is a registered trademark of the Regents of the Umvers1ty of Minnesota. 
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0UALITYMETAIC 
........... , .. 
MEDICAL 
OUTCOMES 
TRUST 
UCENSE AGREEMENT 
License Number: Fl-030906-25727 
This License Agreement is entered into, by, and between QualityMetric Incorporated (the "Licensor"), 640 George 
Washmgton H1ghway, Lincoln, RI 02865 and Texas Woman's University (the "Licensee"), Karen Landry, 7343 
University Drive, Shreveport, LA, 71105. 
Licensor owns or has the exclusive commercial rights to the survey(s) named below. The Ucensor is engaged in 
the business of hcens1ng the rights to use the survey(s), including survey items and responses, scoring algorithms, 
and normative data (the "Intellectual Property") to organizations wishing to use the Intellectual Property either in 
conJUnction with projects or studies or as part of a product or service offering. 
Upon payment of the fees described in the sections below captioned "License Fee" and "Payment Term", this 
agreement will authorize Licensee to reproduce the survey(s) in the languages indicated below, perform data 
collection, perform data entry, use the scoring algorithm and normative data published in the manuals, in 
connection with the study indicated below. Licensor understands Licensee may publish the results for the study 
indicated below. 
Licensee is the only licensed user under this License Agreement, of the survey(s) indicated below (the "Licensed 
Survey(s)") in the language(s) indicated below. Licensee may administer an unlimited amount of survey 
administrations from April 3, 2006 through April 3, 2007 using any language combination of the survey(s) listed 
below. 
SF-36v2"" Health Surveys 
United States (English)- Standard Recall 
This license cannot be assigned or transferred, nor can it be used by the Licensee to obtain data to be used in 
studies other than "I am a PhD student in the College of Nursing at Texas Woman's University at Denton, TX. I 
would like to use the SF-36 to collect data for my dissertation. Thank you, Karen Ainsworth Landry". 
This agreement, including the attachment(s), contains the entire understanding of the parties with respect to the 
subject matter contained herein, and supersedes all prior written or oral communications. This agreement may not 
be modified or amended except by an instrument in writing signed by both parties. 
~~-~~~~WS~' ·m~--.--..-a.-..a.a.aa&B&Ba 
Licensee agrees to reproduce the appropriate copyright and trademark symbols on all written or displayed versions 
of the Licensed Survey(s) and/or the results attributed to the Licensed Survey(s), as indicated in the footer of the 
licensed surveys distributed by QualityMetric Incorporated. 
·-.f~¥~1-.. 1-I· .IGIIB.IIItiJ~!-~•1~~ 
Licensee shall maintain accurate records containing Information suffident to verify the completeness and accuracy 
of the number of survey administrations completed each year. Licensor shall have the right, on reasonable advance 
notice to the Licensee, during usual business hours, to examine such records for the sole purpose of verifying the 
completeness and accuracy of the number of survey administrations completed each year, such examination is to 
be conducted by employees of the Licensor or other representatives selected by the Licensor and reasonably 
acceptable to the Ucensee. In the event that such examination shall disclose the survey administration exceeds the 
maximum number of survey administrations allowed to the Licensee, the Licensee shall Immediately pay the 
Licensor an amount equal to such understated amount and Licensee shall reimburse Licensor for its costs and 
expenses incurred in conducting, or having conducted, such examination . 
March 27. 2006 Customer Initials: _...J.I..c=Jft!.-.-'-'-'- - Date Signed: 
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License Number: Fl-030906-25727 
idi~~JIIIIIir~Jtlllll··~lllllllllllllllllllllllllmll~ 
The Intellectual Property and any and all copyrights or rights under the trade secret laws of any jurisdiction shall be 
and remain at all times the property of the Licensor. The Ucensee shall have no rights, title, or interest in the 
Intellectual Property except as expressly provided in this Agreement. 
The Licensee acknowledges that the Intellectual Property is a valued asset of the Ucensor, that the Intellectual 
Property is of great commerdal value to the Licensor, and that the value of the Intellectual Property would be 
significantly impaired by the unauthorized distribution or use of the Intellectual Property. The Licensee shall protect 
the Intellectual Property from unauthorized use by its employees, agents and customers and shall limit the use to 
the permission granted to Licensee by this Agreement. 
wa&r~Aa-..vw~JIIIIiWillliB . .-aw 
The Licensee understands and acknowledges that a complex and sophisticated product such as the Intellectual 
Property is inherently subject to undiscovered defects. The Ucensor cannot and does not represent or warrant to 
the Licensee that the Intellectual Property is free from such defects, that operation of the Intellectual Property will 
be uninterrupted or error-free, or that its results will be effective or suitable with respect to any particular 
application. Furthermore, the Licensor does not represent or warrant that the Intellectual Property is capable of 
industrial realization or commerdal exploitation, the risks of which are being assumed solely by the Licensee. THE 
INTELLECTUAL PROPERTY IS LICENSED AS-IS, AND THE LICENSOR DISClAIMS ANY REPRESENTATIONS OR 
WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY REPRESENTATIONS OR 
WARRANTIES AS TO MERCHANTABILITY OR FITNESS FOR A PARTICUlAR PURPOSE, RESPECTING ANY OF THE 
INTELLECTUAL PROPERTY OR ANY OTHER MATTER RELATED TO THIS AGREEMENT. 
~~-J' a"" ""'~t$.%U. . . t'Al!!WW.&r.?$~~~~M:W.U1ll.'fll 11:.!111 lb"t'lutUIJi:IUaJ ~W".f~B'.iir'.tr.i;1£j.~$ll%Kii1miM~I~.4llil'll!~'iif!i!iiU'4\lilliMiil'!!il'lillillii!'liiM.I'lll&il\li:i 
This License Agreement shall be effective from April 3, 2006, the date the Licensee will start reprodudng the 
Licensed Survey. This License Agreement shall terminate on April 3, 2007, the date the Licensee will score the last 
Licensed Survey. 
Licensor may terminate this Agreement in the event of a material breach of its terms by Licensee or any of its 
agents by written notice delivered at least fifteen ( 15) days prior to the effective date of the termination. 
m~mi.fe ~·.·~ :\'i , ·· ·~ · - .,. .• •~·"~ .. --IillO"'"' 
This License ("the License") 1s royalty free. This License is limited to the number of survey administrations in the 
languages indicated on the first page of thiS License. 
XcfmiruwAtiblii. l~ .. BRIBIIIB~~:t~\~fkllllllllr,fti!IIIIIIIIIIBIRIMIJIE~l~!3. 
The administration fee for the licensed surveys ("the License") is $100.00. 
This License is limited to the languages indicated on the first page of this License. 
liifiiw. fme""'"'$ 
Licensee shall pay $100.00 upon execution of this License Agreement, per the enclosed invoice. 
March 27. 2006 Customer Initials: .. _Kft~::.____ Date Signed: 3/ ' 1 } 0 I; Page 2 of 3 
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LICENSE AGREEMENT 
License Number: Fl-030906-25727 
Licensee is required to have purchased or purchase the manuals indicated below for the Licensed Survey(s) 
indicated on the first page of this License. 
How to Score Version 2 of SF-36® Health Survey 
.................................. 
In addition to the rights described above, Licensee may access Ucensor's Online Scoring Service for an additional 
fee. 
EXECUTED, as of the date set forth in the paragraph captioned Terms and Termination, by the duly authorized 
representatives as set forth below. By Executing this License Agreement, the undersigned Licensee represents tha 
1t 1s an organization that will only use the Licensed Survey(s) in the languages indicated on the first page and 
according to the terms of this License to obtain data for un-funded scholarly research. 
Texas Woman's University 
Karen Landry 
7343 University Drive 
Shreveport, LA 71105 _ " 
/ . / ' c/:;, _/ 
Signature: __ ,t·./2-a../ / ( .At(/;a . *;-"' 
Name: ...}::.u.~.-.) /Z.E:::uPf!.L'#- /l%'~'7d 'l 
Title: _!~.l:!_~c~.d.£nl: _ 
Date: ~~__,0,_,/.r.___ _ 
March 27. 2006 Customer Initials: __ k---'-~{,~' 'i._/ __ Date Signed : --"'..fL-i'-
1
i_.i ._/f._-1/_r _ Page 3 of 3 
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l ··~- ~ '~ ;l' .. 
UCENSE AGREEMENT AMENDMENT 
Ucense Number. f1-o30SI06-25727 
Subject to the full execution of this li!tter amendment, Kareh. Landry \Ucensee'") hereby amends License 
Agreement# Fl-Q30906-25727 with ucensor as follows: '\,tr'•'c 1 .. • 
·' "'·,~1 ' l'i/1' . , 
The Parties shall amend me ContraCt Start and End Dati!S ofJ~y "I am a Pb6 student'" the COllege of Nursrng at 
Texas Woman':; University at Denton, TIC I would like to U!le the SF-36 tq~l-~ data for my dissertation . Thank 
you, Karen Ainsworth Landry" under License #Fl-030906-25727 as folloWs: 
The ContCICt Start Date shall be Apri l 15,,.?Q07. -.., 
· ~ 
• The eont~ct End Date shall be April 15,2006/' ' tL> 
All other terms and rondltions of the: Agreement shall ~~ In full force·~· ~ffect durtng the extended term of 
this Agreement. 
If foregoing term:; and conditions are acceptable, please have an authorized repn!Sentative of Licensee stgn and 
date below. 
ucensee 
Karen Landry 
7343 University Drive 
Shreveport. LA 71105 
~!WI lUre: 
Na,.,.: 
Title: 
' ~ . 
' f I. 
,. 
) . 
... . 
'I ) 
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U040-0~51 
LICENSE fl 3/9/2006 11:04 AM 
M.inmsola LJVING W1Tif HEART FAILURE8 Quationnalre 
COPYRIGIIT USER'S LICENSE 
The Regents of the Univm:ity of Minnesota ~r refemd to as "UNTVERSIIT"), a corutirurion:ll corporation of 
the State of Minnesota having an office and principal place of business at 450 McNaman Alumni CentcT, 200 Oak St 
SE, Minneapolis, MN 55455 has created a copyrighled WORK entitled the Minnesota UV!NG WITH HEART 
FAILURE~ Questi001111ire iDimded fat" use by authorized hulth care professionals llld researchers. aud desires to 
make the WORK available for use WOI"Idwide. 
Completion of this COPYRJGIIT USER'S LICENSE ("LICENSE"). whereby the LICENSEE agrees to the terms 
spe<:itied herem. is required to use the WORK. Users tml.!t legibly complete iterrn 1.3, 6.1. 6.2 and 7.2, if applicible. A 
Signature and date on also require<l on the last page pnor to submitting tlu.~ docurntDt as dl!ected in item 7.1. 
1.1 WORK means the Minnesotl LIVING WlTH HEART f AlLURE® Questionnaire and lnstructioll5 for Data 
CoUection 8lld Sconng. This WORK is in tbe English language, and is ideotilied as UIM Docketlf94019. An 
electronic copy of tbe WORK and supplem:nral infomution including infonnation about nnslatiom is 
availllble at www mlhfQ.onz. 
1.2 APPROVED COPIES means duplicates of the WORK that sbaU include the following statements: 
01986 Regents of the University of M!Mcsota, AU rights reserved. Do not copy or 
reproduce without permission. LIVING WITH HEART FAILURE~ is a registered 
uademarlc of the Regent5 of the Univenit:y of Minnesota. 
1.3 LICENSEE means (complete all of the foUowin') 
Name of person or organization: K=:u Ainsworth LAndry 
Address: 7343 University Dr., Shrcvepon, LA 71105 
Telephone nwnber: 318·795 ·9488 
Facsirmle number: 318-677·3127 
Electronic mail address: lancJryk@nsula.edu 
ARTICLE II -LICENSE 
2.1 l.JN'IVP.RSITY if811ts to LICENSEE the right to reproduce the WORK and use APPROVF.D COPfES of 
the WORK for purposes described below in Anicle 6.1 upon, (i) submission of a completed LICENSE to 
the U!1;1VERSITY, (il) payment to the Ur..1VERSITY of the applicable nonrefundable LICNESE FEE 
specified below in Article 6.2, and (ii1) notification of acceptance ofli) and (ii) by the UNIVERSITY. The 
EFFECTIVE DATE of this LICENSE is the date of(iii). 
2.2 LICENSEE is granted oo other bcense to or rights in the WORK other than as expressly stated in Article 2.1 . 
2.3 UNIVF.RSITY retairu all rights in the WORK not granted to the LICENSEE under 2. I. UNIVERSITY retains 
ownership of rhe copyright 10 lhe WORK. 
2.4 UNIVERSITI' does not grant to UC8-ISEE any right 10 use the name or maik.s of the UNJVERSJTY in any 
manner except as may be expressly provided in this LJCI!NSE. 
-I of 4-
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! 5 LJCENSEE may nor wign its license lights under thi! LICENSE to any entity oilier lhan a wholly-owned 
sub5idiaty of lhe LICENSEE. 
ARTICLE ill· ITR\1 AND ITR\fiNATION 
J.l The tmn of Ibis L!CF.-ISE shall be from the EFFECITVE DATE of thi> LICENSE specified tn Artie~ 2 I 
until lhe UCENSEE completes or ceases use of lhe WORK described below 1n Artu:le 6.1, or the 
l .i'NJVERSITY lellllinates the UCEJiiSE as de&cribed below in Article 3.2. Ho\\'eVn, in no event shall the tenn 
of this bcense exceed ten (10) years. 
3.2 UNIVERSITY may terminate this LJCENSE upon breach of lhe UCENSE by UCENSEE. UNIVERSITY 
shall give LICENSEE 1m1teo notice of the btuch and notice oftbe intelliiO terminate. If LICENSEE does oot 
cure the breach w!lllbl thirty (30) days ortli!"'lll>tici!","ll>: LICENSE shall ~enninate . Upon suc:h termination, 
LICENSEE's right to use lhe WORK shall terminate. 
3.3 Termination of this LICENSE shall not extin~ish any of LICENSEE's obli~ioru under this LICENSE 
which, by their teTl'M, continue after the date of such termination or expiration. 
ARTICLE IV· PROTECilON OF PROPRIETARY RIGHTS 
4.1 LICENSEE shall take all steps reasonable to protect UNIVERSITY's ownership rights in !he WORK. 
LICENSEE shaU not distn'bute copies of tbe WORK to thin! parties or employee. without appropriate notice, 
agreetm~t, and/or instruction with respecl to use, copying. modification, and cop)Tight pro~tion of the 
WORK. 
4.2 LICENSEE will not remove the UNIVERSITY copyright ooticc and/or other proprietary notices. 
ARTICLE V- WARRANTIES AND LIMITATIONS; INDEMNIFICATION 
5 .I UNIVERSITY and LICENSEE warrant that they lave the right to enter into this LICENSE and the ability to 
CO!l1llY with i~ 1mnS. 
5.2 UNIVERSITY MAKES NO REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED. BY 
WAY OF EXAMPLE, BUT NOT LIMITATION, UNIVERSITY MAKES NO REPRESENTATIONS OR 
WARRANTIES OF MERCHANTABlUTY OR FITNESS FOR A."'N PARTICULAR PVRPOSF. OF Tiffi 
WORK. UNTVERSrTY SHALL NOT BE HELD LIABLE FOR ANY LIABILfrY OR FOR ANY 
INDIRECT OR CONSEQUENTIAL DAMAGES RESULTING FROM TilE USE OF rnE WORK. 
5.3 LICENSEE agrees to indemnify and hold UNIVERSITY harmless against any claims or damages resultmg 
from LICENSEE's use of lhe WORK including all liability to third panies arising from the negligence of 
LICENSEE. LICENSEE assumes no responsibility for any lhird party claims that the WORK, UlllOOdified by 
LICENSEE, infringes a copyright of the third party, or for damages arising from the willful or negligent 
behavior or conduct ofL'NIVERSITY. 
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ARTICLE VI- LICENSED USE OF WORK AND FEE 
6.1 . I The LICENSEE's use of the WORK under this LICENSE is restricted to uses indicated bv an "X" in a bo~ 
preceding each intended use. LICENESE FEES ue In U.S. dollars. ' 
C8J The LICENSEE iJ a student or teacher who will use tbe WORK only for & !itlldcnt proJect(s) or didactic 
p~cs. LICENSE FEE iJ waived. 
0 The LICENSEE is a health Cllre professional or health care organi7.ation who will use the WORK only in the 
care of panents or to evaluate m-house services. LICENSE FEE is $500. 
--0 The UCENSEE is. aprinctpal- iovestigat~r who will use lhc WORK in oat-for-profit research projects. 
LICENSE FEE i~ $500 per project. Type the title(s) of each project to be covered by this LICENSE m the 
following space: 
0 The LICENSEE is a pharmaceutical medical device, biotc:chnology. diseue management or other for-profit 
entity who will use the WORK to evaluate a product or service that is in development or on the market. 
LICENSE FEE is S2,500 per protocol. Type the title and number of each protocol to be: c{wered by this 
LICENSE in the following space. 
6.2 Enter the total of aU applicable LICENSE FEES from Article 6.1. SO.OO 
ARTICLE VII- SUBMISSION OF LICENSE & PAYMENT; NOTIFCATIO:"i OF ACCEPTANCE 
7 I The fully completed LICENSE including signature and LICENSE FEE listed above in Article 6.2 should be 
sent to the following addreas. An incomplete or illeg~ble LICENSE will not be accepted The UNVERSITY 
will not send a sc:parate invoice. Please keep a copy of your submission for your records. Paymetll should be 
sent as a checlc for U.S. dollan made payable to the: Univen;ity of Minnesota. If you do oot send the completed 
UCENSE and payment together, make sure your payment identifies the UCENSEE and the Millnesolll 
LIVING WITH HEART FAILURE® Questionnaire as the reason sendina the payment to the UNIVERSITY. 
Send completed Ucrf';SE and LICENSE FEE to; 
Minnesota LIVING WITH HEART f AlLURE® Questionnaire 
Patents & Technology Marketing 
U ru versity of Minnesota 
450 :1-fcNunara Alwnni Center 
200 Oak St. SE 
Minneapohs. ~ 55455-2070 
7. 2 An electronic ootification of acceptance will be sent by the UNIVERIS'TY when both a completed UCENSE and 
LICENSE FEE are received If this notification is to be sent to an electronic address other than tbe one listed above 
in article I.J, type the person's name and electronic address here: 
Name: Email address : 
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ARTICLE VID- !\IISCELLAl'IEOUS 
8.1 A.IJ qUClibOIIS about the UCENSE or WORK should be sent to iniQ(<i!mlhfu.om. The UNIVERSITY IS Wlder 
oo obligation ID provide suppon for the WORK. 
8.2 This UCENSE contains the cnllle agrenocnt of the pmies concerning this subject motttT and 111persedes 
all other prl'vious undo:ntandings and stlltemelll$, wrillen or oral, concerning tlili molter. 
8.3 This UCENSE is binding upon and shall inurt 1D the benefit of the LICENSEE's successtn and/or assigns. 
8.4 This UCENSE shall be intetpreted and applied in accord4nce with the laws of the State of Minnesota. 
8.5 Headings are f~r c~wenc; only and are not~o be used in interpreting tbi; LICENSE. _ 
8.6 The terms of this LICENSE cannot be orully modified. A modification is not effective unless it is in writing 
and signed by the LICENSEE and the UNIVERSITY. 
IN WITNESS WHEREOF, the LICENSEE agrees ID the above terms by the signature below of their duly 
autboriud n:preseotatives. 
(l.ICENSEE) 
By: 
(authorized signature) 
ltt?I'(//V /J;tV$,;.11/"1-
(print name and title) 
Date: ____J_L/~1/,utJ~~'----
LIVING WITH HF..ART F AlLURE® is a registered tradernul: of the Regenu of the Univrnity of Minnesota. 
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Permission to Use Wilson and Cleary's (1995) Health-Related Quality of Life 
Conceptual Model 
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Karen Landry 
From: 
Sent: 
To: 
Rachel Stanaszek [Rachel Stanaszek@ama-assn.org) 
Wednesday . March 05, 2008 3:20PM 
Karen Landry 
Subject : Perm1ssion Granted - Print.rtf 
March 5. 2008 
Karen Landry 
Texas \Vorncn's University 
Journal Name Year Citation llcm(s) used 
JAMA 1995 273 :59-65 Figure 
Intended Usc: Material "ill he used in a doctoral dissertation. 
Permission Granted: 
Page I of I 
Thank yo u for your imerest in J:\M/\. Archives and AM News. Rights granted herein are non-exclusive 
and limited to o ne time onl y reproduc tion as spcc ili cd in thi s request. in printed format in the English 
Langunge . Your credit line must include the name of the publiciltion. issue date , volume and page 
number. as we ll as ''Copyright '!;: t.Y~~LQfl:'.!-il?li.catiQ.ojJ_American l'vledica l Association. A ll Rights 
reserved . .. 
Best wishes. 
Rhonda Bailey Bro>vn 
Permission /\ssistant 
Publishi ng Operations 
1\M/\ 
].!5/2008 
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